<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>TMA Knowledge Center Alert -- Obesity</title>
    <link>https://search.ebscohost.com/login.aspx?direct=true&amp;an=&amp;site=ehost-live&amp;alertid=1152678</link>
    <description>EBSCO Syndicated Feed for "TMA Knowledge Center Alert -- Obesity" Alert</description>
    <copyright>2016 EBSCO Information Services</copyright>
    <image>
      <url>http://content.ebscohost.com/static/ebscoimages/12.3.23.0/ehost/logoEhost.gif</url>
      <title>TMA Knowledge Center Alert -- Obesity</title>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;an=&amp;site=ehost-live&amp;alertid=1152678</link>
    </image>
    <pubDate>Thu, 04 Jun 2026 13:26:54 GMT</pubDate>
    <ttl>7893</ttl>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42120324&amp;site=ehost-live&amp;scope=site</link>
      <author>Gong Z; Yu S; Lyu Z; Huang W; Zhang T</author>
      <category>Heart Rate drug effects</category>
      <category>Blood Pressure drug effects</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Young Adult</category>
      <category>Oxidation-Reduction</category>
      <category>Adult</category>
      <category>Students</category>
      <category>Double-Blind Method</category>
      <category>Dose-Response Relationship, Drug</category>
      <category>Universities</category>
      <category>Caffeine administration &amp; dosage</category>
      <category>Caffeine pharmacology</category>
      <category>Overweight metabolism</category>
      <category>Overweight physiopathology</category>
      <category>Exercise physiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Lipid Metabolism drug effects</category>
      <title>Effects of different caffeine doses on fat oxidation and cardiovascular response during exercise at FATmax in overweight/obese female college students.</title>
      <description>Journal of the International Society of Sports Nutrition; 12/31/2026&lt;br/&gt;(AN 42120324); ISSN: 1550-2783&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42120324</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42218768&amp;site=ehost-live&amp;scope=site</link>
      <author>Alipour M; Saeidi A; Hejazi K; Laher I; Zouhal H</author>
      <category>Biomarkers blood</category>
      <category>Blood Glucose metabolism</category>
      <category>Blood Glucose analysis</category>
      <category>Tumor Necrosis Factor-alpha blood</category>
      <category>Inflammation blood</category>
      <category>Interleukin-6 blood</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Flavonols</category>
      <category>Insulin Resistance</category>
      <category>Adult</category>
      <category>Specialized Pro-Resolving Mediators</category>
      <category>Middle Aged</category>
      <category>Obesity therapy</category>
      <category>Obesity blood</category>
      <category>Docosahexaenoic Acids blood</category>
      <category>Flavonoids administration &amp; dosage</category>
      <category>Dietary Supplements</category>
      <category>Resistance Training</category>
      <title>12‑weeks fisetin supplementation and interval resistance with aerobic training: changes in Maresin‑1 and inflammatory markers in men with obesity: a randomized controlled trial.</title>
      <description>Journal of the International Society of Sports Nutrition; 12/31/2026&lt;br/&gt;(AN 42218768); ISSN: 1550-2783&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42218768</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42216483&amp;site=ehost-live&amp;scope=site</link>
      <author>Jared MC; Koehler B; Cohen SS</author>
      <category>Adult Survivors of Child Abuse psychology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Qualitative Research</category>
      <category>Young Adult</category>
      <category>Adolescent</category>
      <category>Body Image</category>
      <category>Obesity psychology</category>
      <category>Self Concept</category>
      <category>Adverse Childhood Experiences</category>
      <title>Impaired boundaries, sense of self, and personal control: the lifelong trajectory of co-occurring obesity and adverse childhood experiences for adult women.</title>
      <description>International journal of qualitative studies on health and well-being; 12/31/2026&lt;br/&gt;(AN 42216483); ISSN: 1748-2631&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42216483</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41459804&amp;site=ehost-live&amp;scope=site</link>
      <author>van Kalkeren CAJ; van Deuren T; Coenjaerds MMJ; Galazzo G; Barnett DJM; Penders J; Hartmann B; Holst JJ; Canfora EE; Blaak EE</author>
      <category>Fatty Acids, Volatile metabolism</category>
      <category>Obesity metabolism</category>
      <category>Solanum tuberosum chemistry</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Fermentation</category>
      <category>Middle Aged</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Dietary Supplements</category>
      <category>Dietary Fiber metabolism</category>
      <category>Dietary Fiber administration &amp; dosage</category>
      <category>Overweight metabolism</category>
      <category>Overweight diet therapy</category>
      <category>Overweight microbiology</category>
      <category>Insulin Resistance</category>
      <category>Diet, High-Protein</category>
      <title>Effects of a slowly fermentable fiber mixture against the background of a high-protein diet on insulin sensitivity and metabolic health in individuals with overweight: a randomized, placebo-controlled trial.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41459804); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41459804</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41536238&amp;site=ehost-live&amp;scope=site</link>
      <author>Corona-Cervantes K; Urrutia-Baca VH; Gámez-Valdez JS; Jiménez-López B; Rodríguez-Gutierrez NA; Chávez-Caraza K; Espiricueta-Candelaria F; Villalobos UAS; Ramos-Parra PA; Uribe JAG; Brunck M; Chuck-Hernández C; Licona-Cassani C</author>
      <category>Feces microbiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Infant, Newborn</category>
      <category>Adult</category>
      <category>Pregnancy</category>
      <category>Longitudinal Studies</category>
      <category>Infant</category>
      <category>Mexico</category>
      <category>Body Mass Index</category>
      <category>Metagenomics</category>
      <category>Young Adult</category>
      <category>Mothers</category>
      <category>Milk, Human chemistry</category>
      <category>Milk, Human metabolism</category>
      <category>Oligosaccharides metabolism</category>
      <category>Oligosaccharides analysis</category>
      <category>Bacteria classification</category>
      <category>Bacteria isolation &amp; purification</category>
      <category>Bacteria genetics</category>
      <category>Bacteria metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity microbiology</category>
      <category>Pregnancy in Obesity metabolism</category>
      <category>Pregnancy in Obesity microbiology</category>
      <category>Gastrointestinal Microbiome</category>
      <title>Maternal obesity alters human milk oligosaccharides content and correlates with early acquisition of late colonizers in the neonatal gut microbiome.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41536238); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41536238</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41511159&amp;site=ehost-live&amp;scope=site</link>
      <author>Paone P; Petitfils C; Puel A; Latousakis D; de Vos WM; Delzenne NM; Juge N; Van Hul M; Cani PD</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Mucins metabolism</category>
      <category>Mucins genetics</category>
      <category>Animals</category>
      <category>Mice, Inbred C57BL</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Intestinal Barrier Function</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Akkermansia</category>
      <category>Obesity metabolism</category>
      <category>Obesity etiology</category>
      <category>Obesity microbiology</category>
      <category>Intestinal Mucosa metabolism</category>
      <category>Intestinal Mucosa microbiology</category>
      <category>Mucus metabolism</category>
      <category>Mucus chemistry</category>
      <category>Verrucomicrobia</category>
      <title>Akkermansia muciniphila modulates intestinal mucus composition to counteract high-fat diet-induced obesity in mice.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41511159); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41511159</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41566927&amp;site=ehost-live&amp;scope=site</link>
      <author>Bullich-Vilarrubias C; Romaní-Pérez M; López-Almela I; Pomares-Díaz C; Franzin SB; Esposito G; Benítez-Páez A; Tolosa-Enguís V; Sanz Y</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Mice, Obese</category>
      <category>Male</category>
      <category>Humans</category>
      <category>Mice, Inbred C57BL</category>
      <category>Signal Transduction</category>
      <category>Disease Models, Animal</category>
      <category>Peptide YY metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity microbiology</category>
      <category>Probiotics administration &amp; dosage</category>
      <category>Weight Gain</category>
      <category>Eating</category>
      <title>Phascolarctobacterium faecium reduces food intake via PYY signaling, contributing to the mitigation of body weight gain in diet-induced obese mice.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41566927); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41566927</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42015346&amp;site=ehost-live&amp;scope=site</link>
      <author>Li Z; Samui S; Liu J; Yang Y; Liu X; Chen Q; Li J; Gopinath D; Luo P; Shan D</author>
      <category>Prebiotics administration &amp; dosage</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <category>Diabetes Mellitus, Type 2 microbiology</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Metabolic Syndrome microbiology</category>
      <category>Metabolic Syndrome metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Fecal Microbiota Transplantation</category>
      <category>Probiotics</category>
      <category>Precision Medicine</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Metabolic Diseases microbiology</category>
      <category>Metabolic Diseases metabolism</category>
      <category>Metabolic Diseases therapy</category>
      <title>Gut microbiome and metabolic health: mechanisms and precision interventions.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 42015346); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42015346</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41845563&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu S; Schlicht K; Beckmann A; Hartmann K; Wang W; Kruse L; Wietzke-Braun P; Hollstein T; Becker U; Ziegenbruch U; Baumgartner F; Diederich W; Laudes A; Muchaier J; Stobbe M; Homeister L; Remy S; Dornstauder N; Vogel M; Schindler C; Türk K; Geisler C; Rohmann N; Laudes M</author>
      <category>C-Reactive Protein metabolism</category>
      <category>Diabetes Mellitus, Type 2 microbiology</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Weight Loss</category>
      <category>Insulin Resistance</category>
      <category>Obesity microbiology</category>
      <category>Obesity therapy</category>
      <category>Obesity metabolism</category>
      <category>Gastrointestinal Microbiome</category>
      <title>Parasutterella excrementihominis is associated with attenuated metabolic improvements during obesity therapy in humans.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41845563); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41845563</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41928384&amp;site=ehost-live&amp;scope=site</link>
      <author>Valdez-Palomares F; Noriega LG; Reyes-Romo D; Canizales-Quinteros S; Nambo-Venegas R; Salinas-Lara C; Tovar-Palacio A; Menjivar M; Peña-Espinoza B; Ortiz G; Palacios-González B</author>
      <category>Bacteria classification</category>
      <category>Bacteria isolation &amp; purification</category>
      <category>Bacteria genetics</category>
      <category>Feces microbiology</category>
      <category>Obesity etiology</category>
      <category>Obesity metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Humans</category>
      <category>Mice, Inbred C57BL</category>
      <category>Child</category>
      <category>Fecal Microbiota Transplantation adverse effects</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Growth Disorders microbiology</category>
      <category>Growth Disorders therapy</category>
      <category>Growth Disorders metabolism</category>
      <category>High Fructose Corn Syrup adverse effects</category>
      <category>High Fructose Corn Syrup administration &amp; dosage</category>
      <category>Metabolic Diseases etiology</category>
      <title>Human fecal transplantation from stunted children promotes metabolic dysfunction in mice fed with a high-fat and high-fructose corn syrup diet.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41928384); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41928384</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41999240&amp;site=ehost-live&amp;scope=site</link>
      <author>Wyss J; Baehler S; Ferracini J; Kroell D; Rossier AM; Krupka N; Misselwitz B; Yilmaz B; Wiest R</author>
      <category>RNA, Ribosomal, 16S genetics</category>
      <category>Obesity microbiology</category>
      <category>Intestinal Mucosa microbiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Phylogeny</category>
      <category>Bariatric Surgery</category>
      <category>Duodenum microbiology</category>
      <category>Bacteria classification</category>
      <category>Bacteria genetics</category>
      <category>Bacteria isolation &amp; purification</category>
      <category>Nutrients metabolism</category>
      <category>Gastrointestinal Microbiome</category>
      <title>The duodenal microbiota is compartmentalized and clinically stable yet rapidly responsive to nutrient exposure.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 41999240); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41999240</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42010766&amp;site=ehost-live&amp;scope=site</link>
      <author>Combs D; Landeros K; Garza K; Azari H; Abdelrahman M; Albracht-Schulte K</author>
      <category>Bacteria classification</category>
      <category>Bacteria genetics</category>
      <category>Bacteria metabolism</category>
      <category>Bacteria isolation &amp; purification</category>
      <category>Fatty Acids, Volatile metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Physical Conditioning, Animal</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <category>Exercise physiology</category>
      <title>Exercise intensity as a modulator of gut microbiota and host metabolic health in obesity.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 42010766); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42010766</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42083504&amp;site=ehost-live&amp;scope=site</link>
      <author>Torres-Mayo A; Liébana-García R; Olivares M; Pellón A; Anguita J; Sanz Y</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Gastrointestinal Microbiome immunology</category>
      <category>Obesity immunology</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <title>Gut microbiota and immunometabolism in obesity.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 42083504); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42083504</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42092775&amp;site=ehost-live&amp;scope=site</link>
      <author>Lv J; Zhou L; Dai X; Landberg R; Meng H; Tian H; Zhang S; Liu T; Yin X; Zhang J; Song X; Bonny C; Blum S; Cao Y; Guo J; Peng W; Tan Y; Shi L</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Feces microbiology</category>
      <category>Probiotics administration &amp; dosage</category>
      <category>Animals</category>
      <category>Humans</category>
      <category>Mice</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Glucagon-Like Peptide 1 metabolism</category>
      <category>Obesity prevention &amp; control</category>
      <category>Obesity metabolism</category>
      <category>Obesity etiology</category>
      <category>Bile Acids and Salts metabolism</category>
      <category>Amidohydrolases metabolism</category>
      <category>Amidohydrolases genetics</category>
      <title>A novel bile salt hydrolase-producing Ligilactobacillus salivarius prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 42092775); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42092775</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42105281&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhao Z; Shi R; Ye J; Wang D; Zhao B; Ren B; Wang L; Liu X; Liu X</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Colon microbiology</category>
      <category>Colon metabolism</category>
      <category>Colon pathology</category>
      <category>Animals</category>
      <category>Circadian Rhythm</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Fecal Microbiota Transplantation</category>
      <category>Inflammation</category>
      <category>Oligosaccharides</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Glutathione metabolism</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity complications</category>
      <category>Colitis microbiology</category>
      <category>Colitis metabolism</category>
      <title>Gut microbiota-regulated glutathione metabolic rhythms restore obesity-induced colonic inflammatory oscillations.</title>
      <description>Gut microbes; 12/31/2026&lt;br/&gt;(AN 42105281); ISSN: 1949-0984&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 31 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42105281</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41838446&amp;site=ehost-live&amp;scope=site</link>
      <author>Guldhammer A; Drivsholm T; Tomova-Olsen SA; Tranberg Jensen K</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Denmark</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Qualitative Research</category>
      <category>Rural Population</category>
      <category>Interviews as Topic</category>
      <category>Weight Loss drug effects</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Glucagon-Like Peptides adverse effects</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <title>A qualitative study exploring experiences about using semaglutide for weight loss in a rural setting in Denmark - 'she is probably on the meds'.</title>
      <description>Scandinavian journal of primary health care; 12/01/2026&lt;br/&gt;(AN 41838446); ISSN: 1502-7724&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41838446</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41778393&amp;site=ehost-live&amp;scope=site</link>
      <author>Singh A; McElroy JP; Weng DY; Reisinger SA; Freudenheim JL; Shields PG; Song MA</author>
      <category>Adiponectin blood</category>
      <category>Adiponectin genetics</category>
      <category>Insulin-Like Growth Factor I metabolism</category>
      <category>Insulin-Like Growth Factor I genetics</category>
      <category>Insulin-Like Growth Factor Binding Protein 3 blood</category>
      <category>Insulin-Like Growth Factor Binding Protein 3 genetics</category>
      <category>Leptin blood</category>
      <category>Biomarkers, Tumor genetics</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Epigenesis, Genetic</category>
      <category>Risk Factors</category>
      <category>Body Mass Index</category>
      <category>Breast Neoplasms genetics</category>
      <category>Breast Neoplasms metabolism</category>
      <category>Breast Neoplasms etiology</category>
      <category>Obesity genetics</category>
      <category>Obesity complications</category>
      <category>Aging genetics</category>
      <category>Breast metabolism</category>
      <category>DNA Methylation</category>
      <title>Associations of breast DNA methylation-based measures of biological ageing with obesity-related breast cancer risk markers.</title>
      <description>Epigenetics; 12/01/2026&lt;br/&gt;(AN 41778393); ISSN: 1559-2308&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41778393</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41490034&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen Y; Li B; Liu J; Liu J; Liu C; Zhu Y; Shen M; Lin Z; Zhang J; Li Y</author>
      <category>Myocytes, Cardiac metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Action Potentials</category>
      <category>Diet, High-Fat</category>
      <category>Mice, Obese</category>
      <category>Atrial Fibrillation metabolism</category>
      <category>Atrial Fibrillation physiopathology</category>
      <category>Chemokines metabolism</category>
      <category>Heart Atria metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity complications</category>
      <category>Potassium metabolism</category>
      <category>Receptors, Chemokine metabolism</category>
      <category>Intercellular Signaling Peptides and Proteins metabolism</category>
      <category>Potassium Channels metabolism</category>
      <title>Association of the chemerin-CMKLR1 with atrial potassium current dysregulation and atrial fibrillation in obese mice.</title>
      <description>Channels (Austin, Tex.); 12/01/2026&lt;br/&gt;(AN 41490034); ISSN: 1933-6969&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41490034</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42228778&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu Y; Wang Y; Teng H; Nie W; Qiao X; Shen Y; Wang Z; Yao X</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Dysbiosis</category>
      <category>Obesity complications</category>
      <category>Obesity microbiology</category>
      <category>Obesity physiopathology</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Microcirculation</category>
      <title>From gut microbiota metabolism to microvascular injury: Exploring the role and mechanisms of gut microbiota in obesity-induced coronary microcirculation dysfunction.</title>
      <description>Virulence; 12/01/2026&lt;br/&gt;(AN 42228778); ISSN: 2150-5608&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_42228778</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41503874&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen C; Gao H; Tian Q; Cao J</author>
      <category>Obesity metabolism</category>
      <category>Cardiovascular Diseases metabolism</category>
      <category>Fatty Liver metabolism</category>
      <category>Signal Transduction</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Cyclic AMP metabolism</category>
      <category>Cyclic AMP-Dependent Protein Kinases metabolism</category>
      <category>Homeostasis</category>
      <category>Lipid Metabolism</category>
      <category>Guanine Nucleotide Exchange Factors</category>
      <title>cAMP-PKA/EPAC signaling pathways: crucial regulators of lipid homeostasis.</title>
      <description>Adipocyte; 12/01/2026&lt;br/&gt;(AN 41503874); ISSN: 2162-397X&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41503874</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41510997&amp;site=ehost-live&amp;scope=site</link>
      <author>Du Z; Wu J; Zhang T; Ma X; Li Z; Xu J; You J; Chen N; Wu J</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Reactive Oxygen Species metabolism</category>
      <category>Glycation End Products, Advanced metabolism</category>
      <category>Sirtuin 1 metabolism</category>
      <category>Adipocytes metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Knockout</category>
      <category>Mice, Inbred C57BL</category>
      <category>Oxidative Stress</category>
      <category>Receptor for Advanced Glycation End Products metabolism</category>
      <category>Receptor for Advanced Glycation End Products genetics</category>
      <category>Receptor for Advanced Glycation End Products deficiency</category>
      <category>Adipose Tissue metabolism</category>
      <category>Adipose Tissue pathology</category>
      <category>Obesity metabolism</category>
      <category>Cellular Senescence</category>
      <title>Lack of receptor for advanced glycation end products attenuates obesity-induced adipose tissue senescence in mice.</title>
      <description>Adipocyte; 12/01/2026&lt;br/&gt;(AN 41510997); ISSN: 2162-397X&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41510997</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41973649&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu H; Chen J; Qiu DQ; Jiang MW; Chen HQ; Li L; Chen SQ</author>
      <category>Obesity metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Adipocytes metabolism</category>
      <category>Unfolded Protein Response physiology</category>
      <category>Mitochondria metabolism</category>
      <title>The role and mechanism of UPRmt in adipocytes.</title>
      <description>Adipocyte; 12/01/2026&lt;br/&gt;(AN 41973649); ISSN: 2162-397X&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Dec 2026 00:00:00 -0500</pubDate>
      <guid isPermaLink="false">cmedm_AN_41973649</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41974261&amp;site=ehost-live&amp;scope=site</link>
      <author>Huang SY; Liao CY; Chang CW; Wu CY; Chiang PY; Chang CC; Kao WY</author>
      <category>Perilipin-2 metabolism</category>
      <category>Fatty Liver metabolism</category>
      <category>Fatty Liver etiology</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Rats, Wistar</category>
      <category>Rats</category>
      <category>Adaptation, Physiological</category>
      <category>Gastrectomy</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Liver metabolism</category>
      <category>Liver pathology</category>
      <category>Obesity surgery</category>
      <category>Obesity metabolism</category>
      <category>Autophagy</category>
      <category>Lipid Metabolism</category>
      <category>Bariatric Surgery</category>
      <title>Sustained high-fat diet intake differentially regulates hepatic lipophagy and metabolic adaptation after bariatric surgery in obese rats.</title>
      <description>The Journal of nutritional biochemistry; 09/01/2026&lt;br/&gt;(AN 41974261); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Sep 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41974261</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41997457&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhang S; Yang S; Kong B; Zhang Q; Zhou Z; Zhao W; Wang J; Tang Y; Yao P</author>
      <category>Animals</category>
      <category>Mice</category>
      <category>Mice, Knockout</category>
      <category>RAW 264.7 Cells</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Flavanones pharmacology</category>
      <category>NF-E2-Related Factor 2 metabolism</category>
      <category>NF-E2-Related Factor 2 genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Obesity etiology</category>
      <category>Macrophages metabolism</category>
      <category>Macrophages drug effects</category>
      <category>Adipose Tissue metabolism</category>
      <category>Adipose Tissue drug effects</category>
      <category>Diet, Western adverse effects</category>
      <title>Baicalein alleviates Western diet-induced obesity via metabolically activated adipose tissue macrophages by inducing Nrf2.</title>
      <description>The Journal of nutritional biochemistry; 09/01/2026&lt;br/&gt;(AN 41997457); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 01 Sep 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41997457</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42172902&amp;site=ehost-live&amp;scope=site</link>
      <author>Kulshrestha S; Narad P</author>
      <category>Humans</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Molecular Sequence Annotation</category>
      <category>Mutation</category>
      <category>Genetic Predisposition to Disease</category>
      <category>Protein Processing, Post-Translational genetics</category>
      <category>Systems Biology methods</category>
      <category>Obesity genetics</category>
      <title>Systems biology-driven analysis of obesity-associated genes with transcript mapping and post-translational modification annotations.</title>
      <description>Biochemical and biophysical research communications; 08/06/2026&lt;br/&gt;(AN 42172902); ISSN: 1090-2104&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 06 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42172902</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41985575&amp;site=ehost-live&amp;scope=site</link>
      <author>Pektaş F; Kalkan KT; Çelık E; Oklaz A; Ağca M; Tan B</author>
      <category>Prefrontal Cortex drug effects</category>
      <category>Prefrontal Cortex metabolism</category>
      <category>Prefrontal Cortex pathology</category>
      <category>Oxidative Stress drug effects</category>
      <category>Behavior, Animal drug effects</category>
      <category>Depression drug therapy</category>
      <category>Animals</category>
      <category>Rats</category>
      <category>Male</category>
      <category>Animals, Newborn</category>
      <category>Disease Models, Animal</category>
      <category>Rats, Sprague-Dawley</category>
      <category>Anxiety drug therapy</category>
      <category>Anxiety chemically induced</category>
      <category>Anxiety prevention &amp; control</category>
      <category>Carnitine pharmacology</category>
      <category>Carnitine administration &amp; dosage</category>
      <category>Carnitine therapeutic use</category>
      <category>Obesity chemically induced</category>
      <category>Obesity complications</category>
      <category>Neuroprotective Agents pharmacology</category>
      <category>Sodium Glutamate</category>
      <title>Effect of monosodium glutamate-induced obesity on anxiety-like behavior and the possible protective role of L-carnitine.</title>
      <description>Physiology &amp; behavior; 08/01/2026&lt;br/&gt;(AN 41985575); ISSN: 1873-507X&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41985575</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41956327&amp;site=ehost-live&amp;scope=site</link>
      <author>Li Z; Liu B; Zhou L; Chen N; Wang Y; Yang S; Fan X; Wang Y; Chen X</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Signal Transduction drug effects</category>
      <category>Ferroptosis drug effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Molecular Docking Simulation</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Humans</category>
      <category>NF-E2-Related Factor 2 metabolism</category>
      <category>NF-E2-Related Factor 2 genetics</category>
      <category>PPAR gamma metabolism</category>
      <category>PPAR gamma genetics</category>
      <category>Selenomethionine pharmacology</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Obesity pathology</category>
      <category>Obesity genetics</category>
      <category>Phospholipid Hydroperoxide Glutathione Peroxidase metabolism</category>
      <category>Phospholipid Hydroperoxide Glutathione Peroxidase genetics</category>
      <category>Phospholipid Hydroperoxide Glutathione Peroxidase antagonists &amp; inhibitors</category>
      <category>Sarcopenia drug therapy</category>
      <category>Sarcopenia metabolism</category>
      <category>Sarcopenia pathology</category>
      <category>Sarcopenia genetics</category>
      <category>Sarcopenia etiology</category>
      <category>Biphenyl Compounds pharmacology</category>
      <title>Computational-experimental integration reveals PPARγ/Nrf2-GPX4 dual-targeting by combined selenomethionine-magnolol as a novel therapy for sarcopenic obesity.</title>
      <description>Free radical biology &amp; medicine; 08/01/2026&lt;br/&gt;(AN 41956327); ISSN: 1873-4596&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41956327</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41864440&amp;site=ehost-live&amp;scope=site</link>
      <author>Korsmo HW; Bhavsar H; Trasino S; Caviglia JM; Jiang X</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Liver metabolism</category>
      <category>Liver pathology</category>
      <category>Leptin blood</category>
      <category>Animals</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Maternal Nutritional Physiological Phenomena</category>
      <category>Phenotype</category>
      <category>Obesity</category>
      <category>Choline administration &amp; dosage</category>
      <category>Choline pharmacology</category>
      <category>Fatty Liver etiology</category>
      <category>Fatty Liver prevention &amp; control</category>
      <category>Diet, Western adverse effects</category>
      <category>Prenatal Exposure Delayed Effects</category>
      <category>Dietary Supplements</category>
      <category>Pregnancy in Obesity</category>
      <title>Prenatal and postnatal choline supplementation alters metabolic dysfunction-associated steatohepatitis (MASH) phenotypes in offspring exposed to maternal obesity and following a western diet into adulthood: A preliminary study.</title>
      <description>The Journal of nutritional biochemistry; 08/01/2026&lt;br/&gt;(AN 41864440); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41864440</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41921669&amp;site=ehost-live&amp;scope=site</link>
      <author>Marasinghe CK; Dayarathne LA; Suryaningtyas IT; Jasmadi; Je JY</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Signal Transduction drug effects</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <category>Adipogenesis drug effects</category>
      <category>Membrane Proteins metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>NF-E2-Related Factor 2 metabolism</category>
      <category>NF-E2-Related Factor 2 genetics</category>
      <category>Heme Oxygenase-1 metabolism</category>
      <category>Heme Oxygenase-1 genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Obesity etiology</category>
      <category>Peptides pharmacology</category>
      <category>Peptides chemistry</category>
      <title>Oligomeric peptides LLRLTDL and GYALPCDCL alleviate obesity through HO-1/Nrf2-dependent pathways in high-fat diet-induced mice.</title>
      <description>The Journal of nutritional biochemistry; 08/01/2026&lt;br/&gt;(AN 41921669); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41921669</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42026430&amp;site=ehost-live&amp;scope=site</link>
      <author>Agraib LM; Hourani HA; Alkhatib B</author>
      <category>Jordan epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adolescent</category>
      <category>Adult</category>
      <category>Child</category>
      <category>Body Mass Index</category>
      <category>Middle Aged</category>
      <category>Young Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Energy Intake</category>
      <category>Nutrients</category>
      <category>Diet Surveys</category>
      <category>Obesity epidemiology</category>
      <category>Obesity etiology</category>
      <category>Diet statistics &amp; numerical data</category>
      <category>Feeding Behavior</category>
      <title>Investigating the relationship between nutrient intake patterns and obesity indices among Jordanians.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 08/01/2026&lt;br/&gt;(AN 42026430); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42026430</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42048756&amp;site=ehost-live&amp;scope=site</link>
      <author>Mazzola G; Rondanelli M; Cabrini C; Perna S</author>
      <category>Obesity diet therapy</category>
      <category>Humans</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Diet, Ketogenic methods</category>
      <category>Diet, Carbohydrate-Restricted methods</category>
      <category>Diet, Vegetarian methods</category>
      <category>Patient Compliance statistics &amp; numerical data</category>
      <category>Metabolic Diseases diet therapy</category>
      <title>Metabolic, adherence, and sustainability outcomes of plant-based low-carbohydrate and ketogenic diets: A systematic review of clinical evidence.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 08/01/2026&lt;br/&gt;(AN 42048756); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 01 Aug 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42048756</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42105573&amp;site=ehost-live&amp;scope=site</link>
      <author>Erik Z; Erik İ; Şener SÖ; Yalçın CÖ; Kutlu A; Yenilmez E; Aliyazıcıoğlu R</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Body Weight drug effects</category>
      <category>Liver drug effects</category>
      <category>Liver pathology</category>
      <category>Animals</category>
      <category>Rats</category>
      <category>Male</category>
      <category>Rats, Sprague-Dawley</category>
      <category>Obesity drug therapy</category>
      <category>Obesity blood</category>
      <category>Obesity pathology</category>
      <category>Chalcones therapeutic use</category>
      <category>Chalcones pharmacology</category>
      <category>Chalcones chemistry</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <category>Anti-Obesity Agents chemistry</category>
      <title>Methoxychalcones: a promising therapeutic agent for obesity management.</title>
      <description>Biochemical and biophysical research communications; 07/09/2026&lt;br/&gt;(AN 42105573); ISSN: 1090-2104&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 09 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42105573</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41747920&amp;site=ehost-live&amp;scope=site</link>
      <author>Atluri N; Herty L; Runge C; Wells J; Scisney-Matlock M; Hummel SL</author>
      <category>Motivational Interviewing methods</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Middle Aged</category>
      <category>Meals</category>
      <category>Obesity diet therapy</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Hypertension diet therapy</category>
      <category>Hypertension physiopathology</category>
      <category>Hypertension complications</category>
      <category>Dietary Approaches To Stop Hypertension methods</category>
      <category>Blood Pressure physiology</category>
      <category>Counseling methods</category>
      <category>Diet, Sodium-Restricted methods</category>
      <category>Veterans</category>
      <category>Patient Compliance</category>
      <title>Remote dietitian counseling with short-term meal delivery improves DASH diet adherence and lowers blood pressure in veterans with hypertension and obesity.</title>
      <description>American heart journal; 07/01/2026&lt;br/&gt;(AN 41747920); ISSN: 1097-6744&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41747920</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41528053&amp;site=ehost-live&amp;scope=site</link>
      <author>Wootton RE; Crowley JJ; Pol-Fuster J; Holmberg A; Rück C; Mataix-Cols D; Fernández de la Cruz L</author>
      <category>Mendelian Randomization Analysis methods</category>
      <category>Genetic Predisposition to Disease genetics</category>
      <category>Genome-Wide Association Study methods</category>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Obesity genetics</category>
      <category>Polymorphism, Single Nucleotide genetics</category>
      <category>Humans</category>
      <category>Phenotype</category>
      <category>Body Mass Index</category>
      <category>Obsessive-Compulsive Disorder genetics</category>
      <category>Cardiovascular Diseases genetics</category>
      <title>Are There Causal Associations Between Obsessive-Compulsive Disorder and Cardiometabolic Phenotypes? A Genetic Correlation and Bi-Directional Mendelian Randomization Study.</title>
      <description>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics; 07/01/2026&lt;br/&gt;(AN 41528053); ISSN: 1552-485X&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41528053</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41688031&amp;site=ehost-live&amp;scope=site</link>
      <author>Ramadan FHJ; Zahradka P; Taylor CG</author>
      <category>Liver metabolism</category>
      <category>Liver pathology</category>
      <category>Triglycerides metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Rats, Zucker</category>
      <category>Rats</category>
      <category>Caseins</category>
      <category>Insulin Resistance</category>
      <category>Soybean Proteins</category>
      <category>Obesity complications</category>
      <category>Obesity diet therapy</category>
      <category>Obesity metabolism</category>
      <category>Fatty Liver diet therapy</category>
      <category>Fatty Liver metabolism</category>
      <category>Dietary Proteins administration &amp; dosage</category>
      <category>Diet, High-Protein</category>
      <title>Amelioration of hepatic steatosis in male obese rats by high-protein diet is dependent upon protein source.</title>
      <description>The Journal of nutritional biochemistry; 07/01/2026&lt;br/&gt;(AN 41688031); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41688031</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41794382&amp;site=ehost-live&amp;scope=site</link>
      <author>Lowry DE; Cho NA; Sampsell K; Sales KM; Noye Tuplin EW; Biddle M; Wang W; Chleilat F; Chow MR; Buzatto AZ; Reimer RA</author>
      <category>Oligosaccharides pharmacology</category>
      <category>Animals</category>
      <category>Rats, Sprague-Dawley</category>
      <category>Female</category>
      <category>Male</category>
      <category>Pregnancy</category>
      <category>Rats</category>
      <category>Mice</category>
      <category>Lactation</category>
      <category>Prebiotics administration &amp; dosage</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Anti-Bacterial Agents adverse effects</category>
      <category>Obesity prevention &amp; control</category>
      <category>Obesity chemically induced</category>
      <category>Obesity microbiology</category>
      <category>Milk microbiology</category>
      <category>Prenatal Exposure Delayed Effects prevention &amp; control</category>
      <title>Prebiotics partially protect offspring from maternal antibiotic-induced obesity risk by altering maternal milk microbiota and gut colonization in Sprague-Dawley rats.</title>
      <description>The Journal of nutritional biochemistry; 07/01/2026&lt;br/&gt;(AN 41794382); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41794382</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41830869&amp;site=ehost-live&amp;scope=site</link>
      <author>de Souza LLL; Rodrigues ALC; Costa-Pereira JP; Serpa MG; Severine AN; Murahara EYH</author>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Nutritional Status</category>
      <category>Philadelphia Chromosome</category>
      <category>Enteral Nutrition</category>
      <category>Hematopoietic Stem Cell Transplantation adverse effects</category>
      <category>Precursor Cell Lymphoblastic Leukemia-Lymphoma therapy</category>
      <category>Precursor Cell Lymphoblastic Leukemia-Lymphoma complications</category>
      <category>Malnutrition etiology</category>
      <category>Malnutrition therapy</category>
      <category>Preoperative Care methods</category>
      <category>Gastric Bypass</category>
      <title>Nutritional care before hematopoietic stem cell transplantation in a patient with Philadelphia-positive acute lymphoblastic leukemia and gastric bypass: A case report.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 07/01/2026&lt;br/&gt;(AN 41830869); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41830869</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41832849&amp;site=ehost-live&amp;scope=site</link>
      <author>Gonzalez MC; Matijasevich A; Marques GA; Rosses APO; Machado AF; Colvara CC; Ferro DV; Heller GT; Brina KR; da Conceição VB; Heymsfield SB; Tovo-Rodrigues L; Santos IS</author>
      <category>Plethysmography methods</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Cross-Sectional Studies</category>
      <category>Adolescent</category>
      <category>Brazil</category>
      <category>Young Adult</category>
      <category>Sensitivity and Specificity</category>
      <category>Reference Values</category>
      <category>ROC Curve</category>
      <category>Body Composition</category>
      <category>Cohort Studies</category>
      <category>Obesity diagnosis</category>
      <category>Overweight diagnosis</category>
      <category>Body Mass Index</category>
      <category>Adipose Tissue</category>
      <category>Adiposity</category>
      <title>Defining BMI cutoff points for detecting excess body fat in young adults.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 07/01/2026&lt;br/&gt;(AN 41832849); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41832849</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41832848&amp;site=ehost-live&amp;scope=site</link>
      <author>DiNatale JC; Ellis AC; Ard JD; Locher JL; Crowe-White KM</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Aged</category>
      <category>Predictive Value of Tests</category>
      <category>Risk Factors</category>
      <category>Body Mass Index</category>
      <category>Caloric Restriction</category>
      <category>Anthropometry</category>
      <category>Aged, 80 and over</category>
      <category>Middle Aged</category>
      <category>Metabolic Syndrome diagnosis</category>
      <category>Metabolic Syndrome etiology</category>
      <category>Intra-Abdominal Fat physiopathology</category>
      <category>Obesity complications</category>
      <category>Obesity, Abdominal complications</category>
      <category>Adiposity</category>
      <title>The Visceral Adiposity Index (VAI) as a predictor for metabolic syndrome in a sample of older adults with obesity.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 07/01/2026&lt;br/&gt;(AN 41832848); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41832848</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41865857&amp;site=ehost-live&amp;scope=site</link>
      <author>Aronne LJ; Horn DB; Kokkinos AD; Falcon BL; Wang H; Hoffmann HT; Lee CJ; Dunn JP</author>
      <category>Adult</category>
      <category>Female</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Semaglutide</category>
      <category>Tirzepatide</category>
      <category>Treatment Outcome</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Anti-Obesity Agents adverse effects</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Glucagon-Like Peptides adverse effects</category>
      <category>Obesity drug therapy</category>
      <category>Weight Loss drug effects</category>
      <title>Relationship of early rapid weight loss to efficacy and safety of tirzepatide and semaglutide for obesity: SURMOUNT-5 post hoc analysis.</title>
      <description>The American journal of medicine; 07/01/2026&lt;br/&gt;(AN 41865857); ISSN: 1555-7162&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41865857</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41932263&amp;site=ehost-live&amp;scope=site</link>
      <author>Chang JE; Seol T; Won D; Lee JM; Kim TK; Goo Y; Hwang JY</author>
      <category>Thyroid Cartilage anatomy &amp; histology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Neck</category>
      <category>Patient Positioning methods</category>
      <category>Cricoid Cartilage anatomy &amp; histology</category>
      <category>Obesity</category>
      <title>Comparison of neck-extended and modified ramped positions for locating the cricothyroid membrane in obese anesthetized patients.</title>
      <description>The American journal of emergency medicine; 07/01/2026&lt;br/&gt;(AN 41932263); ISSN: 1532-8171&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41932263</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40079382&amp;site=ehost-live&amp;scope=site</link>
      <author>Wu O; Gao J; Zhang X; Liu W; Zhang H; Khederzadeh S; Lu X; Wu Y</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Signal Transduction</category>
      <category>Immunity, Innate</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity immunology</category>
      <category>Hypertension metabolism</category>
      <category>Hypertension immunology</category>
      <category>Hypertension etiology</category>
      <category>Hypertension physiopathology</category>
      <category>Toll-Like Receptor 5 metabolism</category>
      <category>Toll-Like Receptor 5 immunology</category>
      <title>TLR5's Role in Obesity-related Hypertension: Updated Evidence and Prospects.</title>
      <description>Angiology; 07/01/2026&lt;br/&gt;(AN 40079382); ISSN: 1940-1574&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40079382</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40534432&amp;site=ehost-live&amp;scope=site</link>
      <author>Cai Q; Zhao X; Zhang X; Wang C; Zhou Y; Tian T; Zhou X; Zhang Y; Liu L; Zhang W; Hu A</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Age Factors</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Circadian Rhythm</category>
      <category>Cohort Studies</category>
      <category>Hypertension physiopathology</category>
      <category>Hypertension epidemiology</category>
      <category>Hypertension diagnosis</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Blood Pressure Monitoring, Ambulatory</category>
      <category>Blood Pressure</category>
      <category>Body Weight</category>
      <title>Ambulatory Blood Pressure Characteristics are Modulated by Age and Body Weight in Hypertensives: A Cohort Study of 35,367 Patients.</title>
      <description>Angiology; 07/01/2026&lt;br/&gt;(AN 40534432); ISSN: 1940-1574&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40534432</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41991422&amp;site=ehost-live&amp;scope=site</link>
      <author>Gunasekaran P; Inban P; Agrawal A; Thai A; Aravazhi PS; Tariq H; Prajjwal P; John J</author>
      <category>Weight Loss drug effects</category>
      <category>Glucagon-Like Peptides analogs &amp; derivatives</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Liraglutide therapeutic use</category>
      <category>Incretins therapeutic use</category>
      <category>Gastric Inhibitory Polypeptide therapeutic use</category>
      <category>Humans</category>
      <category>Semaglutide</category>
      <category>Tirzepatide</category>
      <category>Female</category>
      <category>Diabetes Mellitus, Type 2</category>
      <category>Immunoglobulin Fc Fragments</category>
      <category>Recombinant Fusion Proteins</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Approved weight loss drugs for obesity with a thorough emphasis on GLP-1 agonist medications: A systematic review.</title>
      <description>Disease-a-month : DM; 07/01/2026&lt;br/&gt;(AN 41991422); ISSN: 1557-8194&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41991422</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42090706&amp;site=ehost-live&amp;scope=site</link>
      <author>Rogers CB; Gangel M; Schorr M</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adolescent</category>
      <category>Young Adult</category>
      <category>Qualitative Research</category>
      <category>Adult</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Obesity drug therapy</category>
      <category>Obesity psychology</category>
      <category>Social Stigma</category>
      <category>Health Knowledge, Attitudes, Practice</category>
      <category>Weight Loss</category>
      <title>"There Are Healthier Ways": Perspectives of Emerging Adults on Weight Loss Medications.</title>
      <description>Family &amp; community health; 07/01/2026&lt;br/&gt;(AN 42090706); ISSN: 1550-5057&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42090706</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42025578&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang B; Dong X; Sun M; Xie Y; Akakuru OU; Li C; Qin J; Lv H</author>
      <category>Adipocytes metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Oxidative Stress</category>
      <category>Energy Metabolism</category>
      <category>Obesity metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <category>Iron metabolism</category>
      <category>Homeostasis</category>
      <title>Iron Metabolism and Adipose Tissue Homeostasis: Emerging Perspectives for Obesity Intervention.</title>
      <description>Antioxidants &amp; redox signaling; 07/01/2026&lt;br/&gt;(AN 42025578); ISSN: 1557-7716&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42025578</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41991476&amp;site=ehost-live&amp;scope=site</link>
      <author>Yoshinaga T; Matsumura T; Kajihara N; Yagi Y; Takeshita M; Zhou Y; Fukuda K; Kukidome D; Senokuchi T; Sato M; Motoshima H; Kondo T; Nishikawa T; Araki E; Kubota N</author>
      <category>Superoxide Dismutase metabolism</category>
      <category>Superoxide Dismutase genetics</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Endothelial Cells metabolism</category>
      <category>Apolipoproteins E genetics</category>
      <category>Chemokine CCL2 metabolism</category>
      <category>Intercellular Adhesion Molecule-1 metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Mice, Knockout</category>
      <category>Reactive Oxygen Species metabolism</category>
      <category>Atherosclerosis metabolism</category>
      <category>Atherosclerosis etiology</category>
      <category>Atherosclerosis pathology</category>
      <category>Obesity metabolism</category>
      <category>Obesity complications</category>
      <category>Mitochondria metabolism</category>
      <category>Endothelium, Vascular metabolism</category>
      <title>Impact of Endothelium-Derived Mitochondrial Reactive Oxygen Species on Obesity-Associated Atherosclerosis.</title>
      <description>Antioxidants &amp; redox signaling; 07/01/2026&lt;br/&gt;(AN 41991476); ISSN: 1557-7716&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41991476</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41177187&amp;site=ehost-live&amp;scope=site</link>
      <author>Wu KA; Kugelman DN; Shah SN; Ryan SP; Bolognesi MP; Seyler TM; Wellman SS</author>
      <category>Obesity, Morbid complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Prospective Studies</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Gait</category>
      <category>Osteoarthritis, Knee surgery</category>
      <category>Osteoarthritis, Knee complications</category>
      <category>Obesity complications</category>
      <category>Arthroplasty, Replacement, Knee</category>
      <category>Activities of Daily Living</category>
      <title>Impact of Obesity on Daily Activity Following Total Knee Arthroplasty.</title>
      <description>The Journal of arthroplasty; 07/01/2026&lt;br/&gt;(AN 41177187); ISSN: 1532-8406&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41177187</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41934670&amp;site=ehost-live&amp;scope=site</link>
      <author>Oh YW</author>
      <category>Republic of Korea epidemiology</category>
      <category>Humans</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Female</category>
      <category>Nutrition Surveys</category>
      <category>Prevalence</category>
      <category>Young Adult</category>
      <category>Selection Bias</category>
      <category>National Health Programs</category>
      <category>Obesity epidemiology</category>
      <category>Insurance Claim Review statistics &amp; numerical data</category>
      <title>Illustrating Poststratification Methods in Medical Claims Data: A Korean Example.</title>
      <description>Epidemiology (Cambridge, Mass.); 07/01/2026&lt;br/&gt;(AN 41934670); ISSN: 1531-5487&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41934670</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41849231&amp;site=ehost-live&amp;scope=site</link>
      <author>Kim CD; Cook CE; Banack HR</author>
      <category>Canada epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Canadian Longitudinal Study on Aging</category>
      <category>Absorptiometry, Photon</category>
      <category>Longitudinal Studies</category>
      <category>Sensitivity and Specificity</category>
      <category>Predictive Value of Tests</category>
      <category>Aged, 80 and over</category>
      <category>Middle Aged</category>
      <category>Reproducibility of Results</category>
      <category>Obesity diagnosis</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <category>Aging</category>
      <title>Validation of Body Mass Index-For-Age Percentile Curves in Older Adults Using Data From the Canadian Longitudinal Study on Aging.</title>
      <description>Epidemiology (Cambridge, Mass.); 07/01/2026&lt;br/&gt;(AN 41849231); ISSN: 1531-5487&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41849231</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41129713&amp;site=ehost-live&amp;scope=site</link>
      <author>Ahmed J; Abbas Isa H; Qamaruddin A; Shareef A; Almarabheh A; Fadhel L; Alhajeri S</author>
      <category>Bahrain epidemiology</category>
      <category>Tertiary Care Centers statistics &amp; numerical data</category>
      <category>Prenatal Care statistics &amp; numerical data</category>
      <category>Diabetes, Gestational epidemiology</category>
      <category>Fetal Growth Retardation epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Retrospective Studies</category>
      <category>Cross-Sectional Studies</category>
      <category>Gestational Age</category>
      <category>Risk Factors</category>
      <category>Infant, Newborn</category>
      <category>Stillbirth epidemiology</category>
      <category>Pregnancy Complications epidemiology</category>
      <title>Stillbirths in Bahrain: Analysis of patients admitted to a major tertiary hospital during a five-year period.</title>
      <description>Journal of neonatal-perinatal medicine; 07/01/2026&lt;br/&gt;(AN 41129713); ISSN: 1878-4429&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 01 Jul 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41129713</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42201771&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen R; Zeng Y; Li Y; Hung L; Min M; Xu K; Wang J; Liu T; Deng D; Qin C; Ma J; Luo Q; Xiao X</author>
      <category>Animals</category>
      <category>Humans</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>CD36 Antigens metabolism</category>
      <category>CD36 Antigens genetics</category>
      <category>Fatty Liver metabolism</category>
      <category>Fatty Liver chemically induced</category>
      <category>Fatty Liver pathology</category>
      <category>Obesity metabolism</category>
      <category>Liver Cirrhosis metabolism</category>
      <category>Liver Cirrhosis chemically induced</category>
      <category>Liver Cirrhosis pathology</category>
      <category>Carbonic Anhydrases metabolism</category>
      <title>1-Naphthol Drives Liver Steatosis and Fibrosis via the CA3-CD36 Axis Independent of Obesity.</title>
      <description>FASEB journal : official publication of the Federation of American Societies for Experimental Biology; 06/15/2026&lt;br/&gt;(AN 42201771); ISSN: 1530-6860&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 15 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42201771</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42228536&amp;site=ehost-live&amp;scope=site</link>
      <author>Nalbandian M; Lone J; Le Moal E; Kim I; Jeuris K; Li YK; Kraft P; Zhao M; Koleckar K; Zhang Z; Svensson KJ; Blau HM</author>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Glucagon-Like Peptide-1 Receptor metabolism</category>
      <category>Animals</category>
      <category>Semaglutide</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Weight Loss drug effects</category>
      <category>Muscle, Skeletal drug effects</category>
      <category>Muscle, Skeletal physiology</category>
      <category>Muscle, Skeletal pathology</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Hydroxyprostaglandin Dehydrogenases antagonists &amp; inhibitors</category>
      <category>Hydroxyprostaglandin Dehydrogenases metabolism</category>
      <category>Glucagon-Like Peptides pharmacology</category>
      <category>Muscle Strength drug effects</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>15-PGDH inhibition promotes muscle repair and strength recovery during GLP-1 receptor agonist-induced weight loss.</title>
      <description>Proceedings of the National Academy of Sciences of the United States of America; 06/09/2026&lt;br/&gt;(AN 42228536); ISSN: 1091-6490&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 09 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42228536</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42207914&amp;site=ehost-live&amp;scope=site</link>
      <author>Li J; Ma Z; Zhang J; Sun C; Wu H; Li X; Li Z; Wang H; Yang Y; Shang L; Yang Z; Zhu J; Liu J; Manzoor R; Tang L; Li X; Ye X; Ma H</author>
      <category>Obesity metabolism</category>
      <category>Obesity microbiology</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Akkermansia</category>
      <category>Biological Transport</category>
      <category>Mice, Knockout</category>
      <category>Fatty Acid-Binding Proteins metabolism</category>
      <category>Fatty Acid-Binding Proteins genetics</category>
      <category>Fatty Acids metabolism</category>
      <category>Verrucomicrobia metabolism</category>
      <title>Akkermansia muciniphila-derived L-norleucine modulates FABP1-dependent fatty acid transport.</title>
      <description>Proceedings of the National Academy of Sciences of the United States of America; 06/02/2026&lt;br/&gt;(AN 42207914); ISSN: 1091-6490&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 02 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42207914</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42150108&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang Y; Shi J; Huang Z; Yang G; Wang J; Kwok RTK; Lam JWY; Zhao Z; Ding D; Xie H; Zhang J; Tang BZ</author>
      <category>Polyethylene Glycols chemistry</category>
      <category>Animals</category>
      <category>Infrared Rays</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Injections</category>
      <category>Hydrogels chemistry</category>
      <category>Hydrogels pharmacology</category>
      <category>Hydrogels administration &amp; dosage</category>
      <category>Obesity drug therapy</category>
      <category>Obesity therapy</category>
      <category>Obesity diagnostic imaging</category>
      <category>Adipose Tissue drug effects</category>
      <category>Anti-Obesity Agents chemistry</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <category>Anti-Obesity Agents administration &amp; dosage</category>
      <category>Photothermal Therapy</category>
      <title>Injectable NIR-II Photothermal Hydrogels for Image-Guided Adipose Remodeling and Antiobesity Therapy.</title>
      <description>ACS nano; 06/02/2026&lt;br/&gt;(AN 42150108); ISSN: 1936-086X&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 02 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42150108</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41672417&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu H; Luo J; Wang X; Cai H; Wang C; Dai X; Shen W</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Prospective Studies</category>
      <category>Treatment Outcome</category>
      <category>Recovery of Function</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Obesity</category>
      <category>Bursitis therapy</category>
      <category>Bursitis physiopathology</category>
      <category>Shoulder Joint physiopathology</category>
      <category>Body Mass Index</category>
      <category>Adipose Tissue</category>
      <title>Body Fat Percentage But Not BMI Was Related to Clinical Function in Patients With Adhesive Capsulitis After Manipulation Under Anesthesia.</title>
      <description>Clinical orthopaedics and related research; 06/01/2026&lt;br/&gt;(AN 41672417); ISSN: 1528-1132&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41672417</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41989764&amp;site=ehost-live&amp;scope=site</link>
      <author>Lin Y; Song G; Chen Y; Liang C; Ni Z; Gong L; Yan Y</author>
      <category>Adipocytes metabolism</category>
      <category>Adipose Tissue, White metabolism</category>
      <category>Glucose Transporter Type 4 metabolism</category>
      <category>Glucose metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Signal Transduction</category>
      <category>Male</category>
      <category>3T3-L1 Cells</category>
      <category>Mice, Inbred C57BL</category>
      <category>Diet, High-Fat</category>
      <category>Insulin Resistance physiology</category>
      <category>Receptors, G-Protein-Coupled metabolism</category>
      <category>Physical Conditioning, Animal physiology</category>
      <category>Lactic Acid metabolism</category>
      <category>Lactic Acid pharmacology</category>
      <category>Obesity metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <title>Exercise ameliorates adipose tissue insulin resistance by activating the lactate/GPR81 signaling pathway in DIO-IR mice.</title>
      <description>American journal of physiology. Endocrinology and metabolism; 06/01/2026&lt;br/&gt;(AN 41989764); ISSN: 1522-1555&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41989764</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42030244&amp;site=ehost-live&amp;scope=site</link>
      <author>do Carmo JM; Hall JE; Ladnier E; Dai X; Wang Z; Mouton AJ; Omoto ACM; Jorge L; da Silva AA</author>
      <category>Mitochondria, Heart metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Female</category>
      <category>Disease Models, Animal</category>
      <category>Diet, High-Fat</category>
      <category>Mice</category>
      <category>Mice, Transgenic</category>
      <category>Maze Learning</category>
      <category>Behavior, Animal</category>
      <category>Ventricular Function, Left</category>
      <category>Recognition, Psychology</category>
      <category>Mice, Inbred C57BL</category>
      <category>Alzheimer Disease physiopathology</category>
      <category>Alzheimer Disease psychology</category>
      <category>Alzheimer Disease metabolism</category>
      <category>Alzheimer Disease genetics</category>
      <category>Alzheimer Disease complications</category>
      <category>Cognitive Dysfunction physiopathology</category>
      <category>Cognitive Dysfunction etiology</category>
      <category>Cognitive Dysfunction psychology</category>
      <category>Cognitive Dysfunction metabolism</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Cognition</category>
      <title>Parental obesity exacerbates cognitive dysfunction and cardiac vulnerability in offspring of an Alzheimer disease model.</title>
      <description>American journal of physiology. Heart and circulatory physiology; 06/01/2026&lt;br/&gt;(AN 42030244); ISSN: 1522-1539&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42030244</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42095460&amp;site=ehost-live&amp;scope=site</link>
      <author>Laufer XX; Frolova AI; Raghuraman N; Martin SL; England SK; Stout MJ; Garr Barry V</author>
      <category>Triglycerides blood</category>
      <category>Biomarkers blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Prospective Studies</category>
      <category>Body Mass Index</category>
      <category>White People</category>
      <category>Black or African American</category>
      <category>Risk Factors</category>
      <category>Young Adult</category>
      <category>White</category>
      <category>Race Factors</category>
      <category>Gestational Weight Gain ethnology</category>
      <category>Obesity ethnology</category>
      <category>Obesity blood</category>
      <category>Obesity physiopathology</category>
      <category>Lipids blood</category>
      <category>Dyslipidemias ethnology</category>
      <category>Dyslipidemias blood</category>
      <category>Dyslipidemias diagnosis</category>
      <category>Dyslipidemias physiopathology</category>
      <category>Pregnancy Complications ethnology</category>
      <category>Pregnancy Complications blood</category>
      <category>Pregnancy Complications physiopathology</category>
      <title>Prepregnancy obesity, gestational weight gain, and their relationship with maternal lipid levels at delivery across racial and ethnic populations.</title>
      <description>American journal of physiology. Heart and circulatory physiology; 06/01/2026&lt;br/&gt;(AN 42095460); ISSN: 1522-1539&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42095460</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42021709&amp;site=ehost-live&amp;scope=site</link>
      <author>Li X; Cunneely OP; Foote JB; Burns ZR; Fargue S; Assimos DG; Knight J; Wood KD</author>
      <category>Animals</category>
      <category>Disease Models, Animal</category>
      <category>Diet, High-Fat</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Mice</category>
      <category>Hydroxyproline</category>
      <category>Diet, Western</category>
      <category>Oxalates urine</category>
      <category>Oxalates metabolism</category>
      <category>Liver metabolism</category>
      <category>Liver enzymology</category>
      <category>Fatty Liver metabolism</category>
      <category>Fatty Liver etiology</category>
      <category>Obesity metabolism</category>
      <category>Non-alcoholic Fatty Liver Disease metabolism</category>
      <title>Endogenous oxalate synthesis in mouse models of metabolic dysfunction-associated steatotic liver disease.</title>
      <description>American journal of physiology. Renal physiology; 06/01/2026&lt;br/&gt;(AN 42021709); ISSN: 1522-1466&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42021709</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41996976&amp;site=ehost-live&amp;scope=site</link>
      <author>Slaton J; Nahmias J; Aryan N; Lekawa M; O'Leary MP; Smith BR; Nguyen N; Grigorian A</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Retrospective Studies</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Young Adult</category>
      <category>Obesity complications</category>
      <category>Wounds and Injuries surgery</category>
      <category>Wounds and Injuries complications</category>
      <category>Wounds and Injuries mortality</category>
      <category>Respiratory Distress Syndrome epidemiology</category>
      <category>Respiratory Distress Syndrome etiology</category>
      <category>Pneumonia, Ventilator-Associated epidemiology</category>
      <category>Pneumonia, Ventilator-Associated etiology</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications etiology</category>
      <title>Association of Obesity With Respiratory Complications in Trauma Patients Undergoing Emergent Surgery.</title>
      <description>The Journal of surgical research; 06/01/2026&lt;br/&gt;(AN 41996976); ISSN: 1095-8673&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41996976</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41833646&amp;site=ehost-live&amp;scope=site</link>
      <author>Salib A; Hay M; Abrahams T; Muthalaly R; Aldous E; Tu H; Nerlekar N</author>
      <category>Myocardial Infarction epidemiology</category>
      <category>Humans</category>
      <category>Cardiovascular Diseases mortality</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <category>Cardiovascular Diseases prevention &amp; control</category>
      <category>Bariatric Surgery methods</category>
      <category>Obesity surgery</category>
      <category>Obesity complications</category>
      <title>Cardiovascular Impact of Metabolic Surgery Across Patient and Surgery Subgroups: A Systematic Review and Meta-Analysis.</title>
      <description>The American journal of cardiology; 06/01/2026&lt;br/&gt;(AN 41833646); ISSN: 1879-1913&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41833646</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41802610&amp;site=ehost-live&amp;scope=site</link>
      <author>Neira G; Montiel-Duarte C; Becerril S; Valentí V; Moncada R; Catalán V; Gómez-Ambrosi J; Mugueta C; Silva C; Frühbeck G; Rodríguez A</author>
      <category>Hepatocytes metabolism</category>
      <category>Hepatocytes pathology</category>
      <category>Transcription Factors metabolism</category>
      <category>Transcription Factors genetics</category>
      <category>Obesity pathology</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <category>Humans</category>
      <category>YAP-Signaling Proteins</category>
      <category>Male</category>
      <category>Signal Transduction</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Cell Movement</category>
      <category>Adult</category>
      <category>Cell Transdifferentiation</category>
      <category>Cell Line</category>
      <category>Hepatic Stellate Cells metabolism</category>
      <category>Hepatic Stellate Cells pathology</category>
      <category>Transforming Growth Factor beta1 metabolism</category>
      <category>Transforming Growth Factor beta1 genetics</category>
      <category>Liver Cirrhosis pathology</category>
      <category>Liver Cirrhosis metabolism</category>
      <category>Liver Cirrhosis genetics</category>
      <category>AMP-Activated Protein Kinases metabolism</category>
      <category>AMP-Activated Protein Kinases genetics</category>
      <category>Fibronectins metabolism</category>
      <category>Fibronectins genetics</category>
      <category>Adaptor Proteins, Signal Transducing metabolism</category>
      <category>Adaptor Proteins, Signal Transducing genetics</category>
      <title>FNDC4 regulates TGF-β1-induced hepatic stellate cell activation and liver fibrosis via the AMPK/YAP pathway.</title>
      <description>Free radical biology &amp; medicine; 06/01/2026&lt;br/&gt;(AN 41802610); ISSN: 1873-4596&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41802610</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41962594&amp;site=ehost-live&amp;scope=site</link>
      <author>Ott A; Gül AZ; Löber U; Birkner T; Popova E; Winter C; Hadar R</author>
      <category>Obesity metabolism</category>
      <category>Animals</category>
      <category>Female</category>
      <category>Rats</category>
      <category>Rats, Sprague-Dawley</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Hypothalamo-Hypophyseal System metabolism</category>
      <category>Pituitary-Adrenal System metabolism</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Behavior, Animal physiology</category>
      <title>Exposure to a high-fat diet compromises gut health, behavior, and HPA axis function, with partial reversal when limited to adolescence.</title>
      <description>Brain research bulletin; 06/01/2026&lt;br/&gt;(AN 41962594); ISSN: 1873-2747&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41962594</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41932622&amp;site=ehost-live&amp;scope=site</link>
      <author>Nie Y; Guo W; Qiu L; Liu J; Kuang Z; Si J; Zeng Y; Shen X; Liu Y; Wang L</author>
      <category>Neurons metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Female</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Obesity metabolism</category>
      <category>Obesity pathology</category>
      <category>Luteinizing Hormone metabolism</category>
      <category>Hypothalamus metabolism</category>
      <category>Hypothalamus pathology</category>
      <category>Demyelinating Diseases metabolism</category>
      <category>Demyelinating Diseases pathology</category>
      <title>Obesity inhibits hypothalamic activation and luteinizing hormone dynamics through Sox-2-dependent demyelination.</title>
      <description>Neurobiology of disease; 06/01/2026&lt;br/&gt;(AN 41932622); ISSN: 1095-953X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41932622</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41996945&amp;site=ehost-live&amp;scope=site</link>
      <author>Romero-Tapiador S; Tolosana R; Morales A; Lacruz-Pleguezuelos B; Bosch Pastor S; Marcos-Zambrano LJ; Bazán GX; Freixer G; Vera-Rodriguez R; Fierrez J; Ortega-Garcia J; Espinosa-Salinas I; Carrillo de Santa Pau E</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Algorithms</category>
      <category>Weight Loss physiology</category>
      <category>Precision Medicine methods</category>
      <category>Obesity physiopathology</category>
      <category>Obesity therapy</category>
      <category>Overweight physiopathology</category>
      <category>Overweight therapy</category>
      <category>Wearable Electronic Devices</category>
      <category>Artificial Intelligence</category>
      <title>Personalized weight loss management through wearable devices and artificial intelligence.</title>
      <description>Computers in biology and medicine; 06/01/2026&lt;br/&gt;(AN 41996945); ISSN: 1879-0534&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41996945</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41924799&amp;site=ehost-live&amp;scope=site</link>
      <author>Karikis I; Jachimiak JF; Arda Y; Luckhurst CM; Paranjape CN; DeWane MP; Bartek M; Ng-Kamstra JS; Kaafarani HM; Velmahos GC; Hwabejire JO</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Female</category>
      <category>Aged, 80 and over</category>
      <category>Hospital Mortality</category>
      <category>Retrospective Studies</category>
      <category>Risk Factors</category>
      <category>Emergencies</category>
      <category>Risk Assessment</category>
      <category>Sepsis surgery</category>
      <category>Sepsis mortality</category>
      <category>Sepsis complications</category>
      <category>Laparotomy adverse effects</category>
      <category>Laparotomy mortality</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications etiology</category>
      <category>Obesity complications</category>
      <category>Body Mass Index</category>
      <title>The weight of risk: BMI and postoperative outcomes in older adults with sepsis undergoing emergency laparotomy.</title>
      <description>Surgery; 06/01/2026&lt;br/&gt;(AN 41924799); ISSN: 1532-7361&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41924799</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41722850&amp;site=ehost-live&amp;scope=site</link>
      <author>Xuan Y; Xiong X; Wang X; Wang Y; Shen Y; Zhang H; Zhang R; Chen L; Zhang P; Zhang Y; Hu C</author>
      <category>Eating drug effects</category>
      <category>Appetite drug effects</category>
      <category>Energy Metabolism drug effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Diet, High-Fat</category>
      <category>Xanthenes</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Agouti-Related Protein metabolism</category>
      <category>Hypothalamus metabolism</category>
      <category>Hypothalamus drug effects</category>
      <category>GTP-Binding Protein beta Subunits metabolism</category>
      <category>GTP-Binding Protein beta Subunits antagonists &amp; inhibitors</category>
      <category>GTP-Binding Protein gamma Subunits antagonists &amp; inhibitors</category>
      <category>GTP-Binding Protein gamma Subunits metabolism</category>
      <category>Neurons metabolism</category>
      <category>Neurons drug effects</category>
      <title>Targeting Gβγ subunits in hypothalamic AgRP neurons to treat obesity.</title>
      <description>Metabolism: clinical and experimental; 06/01/2026&lt;br/&gt;(AN 41722850); ISSN: 1532-8600&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41722850</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41833661&amp;site=ehost-live&amp;scope=site</link>
      <author>Della Guardia L; Shin AC</author>
      <category>Energy Metabolism physiology</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Thermogenesis</category>
      <category>Lipolysis</category>
      <category>Catecholamines metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <category>Obesity metabolism</category>
      <category>Body Weight physiology</category>
      <title>Adipose tissue catecholamine resistance: a metabolic safeguard that challenges weight control.</title>
      <description>Metabolism: clinical and experimental; 06/01/2026&lt;br/&gt;(AN 41833661); ISSN: 1532-8600&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41833661</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41850421&amp;site=ehost-live&amp;scope=site</link>
      <author>Fu L; Ding R; Xu G; Hu J; Yang P</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <title>Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives.</title>
      <description>Metabolism: clinical and experimental; 06/01/2026&lt;br/&gt;(AN 41850421); ISSN: 1532-8600&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41850421</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41369015&amp;site=ehost-live&amp;scope=site</link>
      <author>Bakar S; Arpa M; Kuruca N; Şentürk Ş</author>
      <category>Overweight blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Cross-Sectional Studies</category>
      <category>Body Mass Index</category>
      <category>Adult</category>
      <category>Young Adult</category>
      <category>Case-Control Studies</category>
      <category>Polycystic Ovary Syndrome blood</category>
      <category>Obesity blood</category>
      <category>Obesity complications</category>
      <category>Bone Morphogenetic Protein 4 blood</category>
      <category>Intercellular Signaling Peptides and Proteins blood</category>
      <category>Bone Morphogenetic Protein 7 blood</category>
      <title>Gremlin-1 is associated with obesity but not polycystic ovary syndrome: Insights from a body mass index-matched analysis of bone morphogenetic protein pathway components, a cross-sectional study.</title>
      <description>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics; 06/01/2026&lt;br/&gt;(AN 41369015); ISSN: 1879-3479&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41369015</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41985657&amp;site=ehost-live&amp;scope=site</link>
      <author>Gray KE; Benson S; Robustelli BL; Perez L; Taylor L; Nelson KM; Hoerster KD</author>
      <category>Humans</category>
      <category>Weight Loss</category>
      <category>Body Mass Index</category>
      <category>United States</category>
      <category>Male</category>
      <category>United States Department of Veterans Affairs</category>
      <category>Female</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Middle Aged</category>
      <category>Exercise</category>
      <category>Health Behavior</category>
      <category>Weight Reduction Programs methods</category>
      <category>Weight Reduction Programs organization &amp; administration</category>
      <category>Obesity therapy</category>
      <category>Spouses psychology</category>
      <category>Veterans</category>
      <title>Protocol for HealthyTogether: A randomized controlled trial testing a virtual, dyadic weight management intervention for a veteran and a support person.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 41985657); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41985657</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41997541&amp;site=ehost-live&amp;scope=site</link>
      <author>Azari H; Combs D; Galindo S; Jafarabadi GS; Chemitiganti R; Park OH; Moustaid-Moussa N; Dhanasekara CS; Albracht-Schulte K</author>
      <category>Inflammation therapy</category>
      <category>Dysbiosis therapy</category>
      <category>Safflower Oil administration &amp; dosage</category>
      <category>Humans</category>
      <category>Double-Blind Method</category>
      <category>Gastrointestinal Microbiome</category>
      <category>Dietary Supplements</category>
      <category>Adult</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Male</category>
      <category>Female</category>
      <category>Body Mass Index</category>
      <category>Middle Aged</category>
      <category>High-Intensity Interval Training methods</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Fatty Acids, Omega-3 administration &amp; dosage</category>
      <category>Fatty Acids, Omega-3 therapeutic use</category>
      <category>Fish Oils administration &amp; dosage</category>
      <title>Combined effectiveness of omega-3 PUFA-rich fish oil supplementation and high-intensity interval training in obesity associated metabolic dysfunction: Protocol for a double-blind, randomized clinical trial.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 41997541); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41997541</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41980660&amp;site=ehost-live&amp;scope=site</link>
      <author>Bernhart JA; Bell A; Wilcox S; Rudisill AC; Etheredge J; Alexander G; Day D; Turner-McGrievy G</author>
      <category>Humans</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Male</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Middle Aged</category>
      <category>Blood Pressure</category>
      <category>Research Design</category>
      <category>Body Weight</category>
      <category>White</category>
      <category>Obesity diet therapy</category>
      <category>Obesity ethnology</category>
      <category>Diet, Vegan methods</category>
      <category>Overweight diet therapy</category>
      <category>Overweight ethnology</category>
      <category>Health Promotion methods</category>
      <category>Restaurants</category>
      <category>Black or African American</category>
      <title>Nutritious eating with soul dissemination and implementation study: Design and methods of a type II hybrid effectiveness trial implemented in vegan restaurants.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 41980660); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41980660</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41997542&amp;site=ehost-live&amp;scope=site</link>
      <author>Valle CG; Nezami BT; Hatley KE; Diamond MA; Polzien K; Wasser HM; O'Shea NG; Tate DF</author>
      <category>Humans</category>
      <category>Young Adult</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Health Behavior</category>
      <category>Weight Loss</category>
      <category>Adolescent</category>
      <category>Goals</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Exercise</category>
      <category>Obesity therapy</category>
      <category>Obesity psychology</category>
      <category>Overweight therapy</category>
      <category>Overweight psychology</category>
      <category>Weight Reduction Programs methods</category>
      <category>Behavior Therapy methods</category>
      <category>Mobile Applications</category>
      <category>Patient Compliance</category>
      <title>Promoting adherence to weight-related behaviors in young adults: Design of the Nudge microrandomized trial.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 41997542); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41997542</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42031230&amp;site=ehost-live&amp;scope=site</link>
      <author>Hagerman C; Choo-Kang D; LaFata E; Rohde P; Butryn M</author>
      <category>Feeding Behavior psychology</category>
      <category>Humans</category>
      <category>Pilot Projects</category>
      <category>Adult</category>
      <category>Motivation</category>
      <category>Male</category>
      <category>Female</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Middle Aged</category>
      <category>Food, Processed</category>
      <category>Obesity psychology</category>
      <category>Obesity therapy</category>
      <category>Overweight psychology</category>
      <category>Overweight therapy</category>
      <category>Cognitive Dissonance</category>
      <category>Fast Foods</category>
      <title>A cognitive dissonance-based intervention to reduce ultra-processed food intake: Protocol for a pilot randomized controlled trial.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 42031230); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42031230</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42009100&amp;site=ehost-live&amp;scope=site</link>
      <author>Klonis N; Duremdes Nava ML; Aguilar M; Viola V; Davila V; Teo S; Bryant MS; Armamento-Villareal R; Qualls C; Villareal DT</author>
      <category>Humans</category>
      <category>Aged</category>
      <category>Double-Blind Method</category>
      <category>Aged, 80 and over</category>
      <category>Frail Elderly</category>
      <category>Male</category>
      <category>Veterans</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Female</category>
      <category>Combined Modality Therapy</category>
      <category>Physical Functional Performance</category>
      <category>Weight Loss</category>
      <category>Healthy Lifestyle</category>
      <category>Metformin therapeutic use</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Exercise Therapy methods</category>
      <category>Frailty therapy</category>
      <title>Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol.</title>
      <description>Contemporary clinical trials; 06/01/2026&lt;br/&gt;(AN 42009100); ISSN: 1559-2030&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42009100</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41482754&amp;site=ehost-live&amp;scope=site</link>
      <author>Nam SY; Jo J</author>
      <category>Overweight complications</category>
      <category>Overweight epidemiology</category>
      <category>Thinness epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Cohort Studies</category>
      <category>Postmenopause</category>
      <category>Follow-Up Studies</category>
      <category>Adult</category>
      <category>Premenopause</category>
      <category>Breast Neoplasms epidemiology</category>
      <category>Breast Neoplasms etiology</category>
      <category>Uterine Neoplasms epidemiology</category>
      <category>Uterine Neoplasms etiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <title>The effect of body mass index change on breast and uterine cancer risk in middle- and older-aged adults.</title>
      <description>International journal of cancer; 06/01/2026&lt;br/&gt;(AN 41482754); ISSN: 1097-0215&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41482754</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42114845&amp;site=ehost-live&amp;scope=site</link>
      <author>Grünewald A; Steidel E; Müntjes C; Hühne T; Degenhardt F; Stehling F; Cetiner M</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Child</category>
      <category>Syndrome</category>
      <category>Receptor, Melanocortin, Type 4 agonists</category>
      <category>alpha-MSH analogs &amp; derivatives</category>
      <category>alpha-MSH therapeutic use</category>
      <category>Hypothalamic Diseases drug therapy</category>
      <category>Hypothalamic Diseases complications</category>
      <category>Obesity drug therapy</category>
      <category>Obesity complications</category>
      <category>Hypoventilation drug therapy</category>
      <category>Hypoventilation complications</category>
      <category>Autonomic Nervous System Diseases drug therapy</category>
      <category>Autonomic Nervous System Diseases complications</category>
      <title>Melanocortin-4 Receptor Agonist Treatment of Hypothalamic Obesity in ROHHAD Syndrome.</title>
      <description>Pediatrics; 06/01/2026&lt;br/&gt;(AN 42114845); ISSN: 1098-4275&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42114845</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41621494&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang R; Goruk S; Chan CB; Field CJ</author>
      <category>Spleen metabolism</category>
      <category>Spleen immunology</category>
      <category>Spleen cytology</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Docosahexaenoic Acids administration &amp; dosage</category>
      <category>Intra-Abdominal Fat metabolism</category>
      <category>Intra-Abdominal Fat immunology</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Female</category>
      <category>Rats, Wistar</category>
      <category>Rats</category>
      <category>Sex Factors</category>
      <category>Eicosapentaenoic Acid</category>
      <category>Fish Oils</category>
      <category>Obesity immunology</category>
      <category>Obesity diet therapy</category>
      <category>Obesity metabolism</category>
      <category>Fatty Acids, Unsaturated administration &amp; dosage</category>
      <category>Fatty Acids, Unsaturated pharmacology</category>
      <category>Adipose Tissue metabolism</category>
      <category>Adipose Tissue immunology</category>
      <category>Inflammation</category>
      <title>Early-life dietary long-chain polyunsaturated fatty acid consumption promotes immune function and reduces systemic and adipose inflammation in a sex-specific manner in obese Wistar rats.</title>
      <description>The Journal of nutritional biochemistry; 06/01/2026&lt;br/&gt;(AN 41621494); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41621494</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41628733&amp;site=ehost-live&amp;scope=site</link>
      <author>Anunciado-Koza RVP; Bilodeau C; Cooke D; Ables GP; Koza RA</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Adipose Tissue, White metabolism</category>
      <category>Adipose Tissue, Brown metabolism</category>
      <category>Obesity metabolism</category>
      <category>Animals</category>
      <category>Cold Temperature</category>
      <category>Mice, Knockout</category>
      <category>Thermogenesis</category>
      <category>Male</category>
      <category>Energy Metabolism</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Uncoupling Protein 1 genetics</category>
      <category>Uncoupling Protein 1 metabolism</category>
      <category>Uncoupling Protein 1 deficiency</category>
      <category>Methionine deficiency</category>
      <category>Methionine administration &amp; dosage</category>
      <title>Enhanced metabolic benefits of dietary methionine restriction in cold resistant hybrid UCP1-deficient mice.</title>
      <description>The Journal of nutritional biochemistry; 06/01/2026&lt;br/&gt;(AN 41628733); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41628733</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42066439&amp;site=ehost-live&amp;scope=site</link>
      <author>Shi N; Wang R; Cao X; Huang Z; Lin F; Xu R; Zhang Q</author>
      <category>Energy Intake drug effects</category>
      <category>Humans</category>
      <category>Body Mass Index</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Phaseolus chemistry</category>
      <category>Plant Extracts pharmacology</category>
      <category>Plant Extracts therapeutic use</category>
      <category>Plant Extracts adverse effects</category>
      <category>Obesity drug therapy</category>
      <category>Overweight drug therapy</category>
      <category>Adiposity drug effects</category>
      <category>Weight Loss drug effects</category>
      <title>White kidney bean extract reduces body weight and adiposity with acceptable safety in adults with overweight and obese: a systematic review and meta-analysis.</title>
      <description>Nutrition research (New York, N.Y.); 06/01/2026&lt;br/&gt;(AN 42066439); ISSN: 1879-0739&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42066439</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42114176&amp;site=ehost-live&amp;scope=site</link>
      <author>Chang D; McTigue DM; Bruno RS</author>
      <category>Liver physiopathology</category>
      <category>Sympathetic Nervous System physiopathology</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Inflammation</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Spinal Cord Injuries complications</category>
      <category>Spinal Cord Injuries physiopathology</category>
      <category>Fatty Liver etiology</category>
      <category>Fatty Liver physiopathology</category>
      <category>Non-alcoholic Fatty Liver Disease etiology</category>
      <category>Metabolic Diseases etiology</category>
      <title>Metabolic dysfunction-associated steatotic liver disease in spinal cord injury and obesity: A narrative review of divergent mechanisms, convergent outcomes.</title>
      <description>Nutrition research (New York, N.Y.); 06/01/2026&lt;br/&gt;(AN 42114176); ISSN: 1879-0739&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42114176</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41747267&amp;site=ehost-live&amp;scope=site</link>
      <author>Kawakita T; Jones SA; Furukawa N; Saade G</author>
      <category>United States epidemiology</category>
      <category>Diabetes, Gestational epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Hypertension, Pregnancy-Induced epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Retrospective Studies</category>
      <category>Adult</category>
      <category>Comorbidity</category>
      <category>Risk Factors</category>
      <category>Prevalence</category>
      <category>Maternal Age</category>
      <category>Pregnancy Complications epidemiology</category>
      <title>Contribution of Comorbidities and Pregnancy Complications to Severe Maternal Morbidity in the United States.</title>
      <description>Obstetrics and gynecology; 06/01/2026&lt;br/&gt;(AN 41747267); ISSN: 1873-233X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41747267</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41747400&amp;site=ehost-live&amp;scope=site</link>
      <author>Jawamis A; Al-Domi H; Sarayreh NA</author>
      <category>Biomarkers blood</category>
      <category>Interleukin-6 blood</category>
      <category>Insulin blood</category>
      <category>Lipopolysaccharides blood</category>
      <category>Blood Glucose metabolism</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Insulin Resistance</category>
      <category>Diet, Ketogenic methods</category>
      <category>Endotoxemia blood</category>
      <category>Endotoxemia diet therapy</category>
      <category>Prediabetic State diet therapy</category>
      <category>Prediabetic State blood</category>
      <category>Prediabetic State complications</category>
      <category>Obesity diet therapy</category>
      <category>Obesity blood</category>
      <category>Obesity complications</category>
      <category>Caloric Restriction methods</category>
      <title>Effects of the ketogenic-caloric restricted diet on metabolic endotoxemia and metabolic health in adults with prediabetes: A randomized controlled trial.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 06/01/2026&lt;br/&gt;(AN 41747400); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41747400</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42222886&amp;site=ehost-live&amp;scope=site</link>
      <author>Ahima RS</author>
      <category>Obesity metabolism</category>
      <category>Obesity pathology</category>
      <category>NF-E2-Related Factor 2 metabolism</category>
      <category>NF-E2-Related Factor 2 genetics</category>
      <category>Animals</category>
      <category>Humans</category>
      <category>Mice</category>
      <category>Palmitic Acid adverse effects</category>
      <category>Palmitic Acid metabolism</category>
      <category>Diet, Western adverse effects</category>
      <category>Enteric Nervous System pathology</category>
      <category>Enteric Nervous System metabolism</category>
      <category>Enteric Nervous System physiopathology</category>
      <category>Ferroptosis</category>
      <title>Connecting a Western diet, palmitic acid, and enteric neuropathy.</title>
      <description>The Journal of clinical investigation; 06/01/2026&lt;br/&gt;(AN 42222886); ISSN: 1558-8238&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42222886</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41424261&amp;site=ehost-live&amp;scope=site</link>
      <author>Tawk K; Dichter A; Park T; Abouzari M; Oliaei S</author>
      <category>Hypertension complications</category>
      <category>Obesity complications</category>
      <category>United States epidemiology</category>
      <category>Sjogren's Syndrome complications</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Middle Aged</category>
      <category>Case-Control Studies</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Databases, Factual</category>
      <category>Logistic Models</category>
      <category>Salivary Gland Calculi etiology</category>
      <category>Salivary Gland Calculi epidemiology</category>
      <title>Identifying Risk Factors for Sialolithiasis.</title>
      <description>The Laryngoscope; 06/01/2026&lt;br/&gt;(AN 41424261); ISSN: 1531-4995&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41424261</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41577258&amp;site=ehost-live&amp;scope=site</link>
      <author>Shah J; Razavi P; Festok M; Ahmed H; Mahrous MA; Kovacs KD; Kiss S</author>
      <category>United States epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity drug therapy</category>
      <category>Vascular Endothelial Growth Factor A antagonists &amp; inhibitors</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Retrospective Studies</category>
      <category>Disease Progression</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Propensity Score</category>
      <category>Incidence</category>
      <category>Adult</category>
      <category>Tirzepatide</category>
      <category>Diabetic Retinopathy epidemiology</category>
      <category>Diabetic Retinopathy prevention &amp; control</category>
      <category>Diabetic Retinopathy diagnosis</category>
      <title>Tirzepatide and Reduced Risk of Diabetic Retinopathy and Related Complications: A Multicenter US Cohort Study.</title>
      <description>Ophthalmology; 06/01/2026&lt;br/&gt;(AN 41577258); ISSN: 1549-4713&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41577258</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=39217115&amp;site=ehost-live&amp;scope=site</link>
      <author>Galhardo A; Moreira P; Ferreira C; Cunha M</author>
      <category>Obesity psychology</category>
      <category>Thinness psychology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Young Adult</category>
      <category>Adolescent</category>
      <category>Aged</category>
      <category>Portugal</category>
      <category>Body Mass Index</category>
      <category>Empathy physiology</category>
      <category>Body Dissatisfaction psychology</category>
      <category>Depression psychology</category>
      <category>Anxiety psychology</category>
      <category>Body Image psychology</category>
      <category>Self Concept</category>
      <category>Peer Group</category>
      <category>Famous Persons</category>
      <category>Personal Satisfaction</category>
      <title>The Relationship Between Body Image Dissatisfaction, Psychopathological Symptoms, Social Comparisons With Peers and Celebrities, and Self-Compassion in Men.</title>
      <description>Psychological reports; 06/01/2026&lt;br/&gt;(AN 39217115); ISSN: 1558-691X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_39217115</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41984511&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu K; Sun W; Ma G; Chen F; Liu T</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Disability-Adjusted Life Years</category>
      <category>Risk Factors</category>
      <category>Aged</category>
      <category>Global Health</category>
      <category>Aged, 80 and over</category>
      <category>Alzheimer Disease epidemiology</category>
      <category>Alzheimer Disease mortality</category>
      <category>Global Burden of Disease trends</category>
      <category>Dementia epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <title>Global burden, trends, and projections of Alzheimer's disease and other dementias attributable to high body mass index from 1990 to 2040: A comprehensive analysis of the Global Burden of Disease Study 2021.</title>
      <description>Journal of Alzheimer's disease : JAD; 06/01/2026&lt;br/&gt;(AN 41984511); ISSN: 1875-8908&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41984511</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41087546&amp;site=ehost-live&amp;scope=site</link>
      <author>Tran XN; Lee YL; Lin YC; Chang TY; Chang LT; Ho KF; Chuang KJ; Chung KF; Chang JH; Chuang HC</author>
      <category>Humans</category>
      <category>Child</category>
      <category>Male</category>
      <category>Case-Control Studies</category>
      <category>Female</category>
      <category>Child, Preschool</category>
      <category>Humidity</category>
      <category>Adolescent</category>
      <category>Risk Factors</category>
      <category>Odds Ratio</category>
      <category>Logistic Models</category>
      <category>Temperature</category>
      <category>Asthma complications</category>
      <category>Asthma therapy</category>
      <category>Obesity complications</category>
      <category>Pediatric Obesity complications</category>
      <category>Hospitalization</category>
      <category>Meteorological Concepts</category>
      <title>Associations of meteorological factors and obesity on pediatric asthma hospitalization.</title>
      <description>Pediatric research; 06/01/2026&lt;br/&gt;(AN 41087546); ISSN: 1530-0447&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41087546</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41104919&amp;site=ehost-live&amp;scope=site</link>
      <author>Hersh DS; Anuar A; Bennett KA; Clifford CM; Elbabaa SK; Emery SP; Goodnight WH; Hirose S; Jampa A; Lillegard JB; Lim FY; Luks FI; Miller JL; Moehrlen U; Moldenhauer JS; Schenone MH; Shaaban AF; Tsao K; Zaretsky MV; Crombleholme TM</author>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Registries</category>
      <category>Prospective Studies</category>
      <category>Infant, Newborn</category>
      <category>Meningomyelocele surgery</category>
      <category>Fetal Diseases surgery</category>
      <category>Body Mass Index</category>
      <title>Fetal Myelomeningocele Closure in the Setting of Maternal Body Mass Index 35 to 40.</title>
      <description>Neurosurgery; 06/01/2026&lt;br/&gt;(AN 41104919); ISSN: 1524-4040&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41104919</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41317030&amp;site=ehost-live&amp;scope=site</link>
      <author>Petcka NL; Smith SR; Fer D; Stetler J; Oyefule O; Fay K; Hechenbleikner E; Davis SS Jr; Yost C; Mou D</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Surveys and Questionnaires</category>
      <category>Bariatric Surgery psychology</category>
      <category>Feeding Behavior psychology</category>
      <category>Obesity surgery</category>
      <category>Obesity psychology</category>
      <category>Food Insecurity</category>
      <category>Patient Reported Outcome Measures</category>
      <category>Stress, Psychological</category>
      <category>Psychological Distress</category>
      <title>An Explorative Cross-Sectional Study Using Patient-Reported Outcome Measures to Assess How Food Insecurity Impacts Eating-Related Behavior, Distress, and Symptoms for Patients Considering Metabolic and Bariatric Surgery.</title>
      <description>The American surgeon; 06/01/2026&lt;br/&gt;(AN 41317030); ISSN: 1555-9823&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41317030</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41381036&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhu C; Liu W</author>
      <category>Blood Glucose metabolism</category>
      <category>Humans</category>
      <category>Body Mass Index</category>
      <category>alpha-2-HS-Glycoprotein metabolism</category>
      <category>alpha-2-HS-Glycoprotein analysis</category>
      <category>Obesity surgery</category>
      <category>Obesity blood</category>
      <category>Obesity metabolism</category>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity, Morbid blood</category>
      <category>Bariatric Surgery</category>
      <title>Role of Bariatric Surgery in Modulating Fetuin-A and Metabolic Outcomes: A Systematic Review and Meta-Analysis.</title>
      <description>The American surgeon; 06/01/2026&lt;br/&gt;(AN 41381036); ISSN: 1555-9823&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41381036</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42223753&amp;site=ehost-live&amp;scope=site</link>
      <author>Rao RS; Hogan G; Rao A; Sweeny A; Mehta M</author>
      <category>Glycated Hemoglobin analysis</category>
      <category>Blood Glucose analysis</category>
      <category>Insulin therapeutic use</category>
      <category>Humans</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Male</category>
      <category>Treatment Outcome</category>
      <category>Middle Aged</category>
      <category>Continuous Glucose Monitoring</category>
      <category>Quality of Life</category>
      <category>Follow-Up Studies</category>
      <category>Diabetes Mellitus, Type 1 complications</category>
      <category>Diabetes Mellitus, Type 1 surgery</category>
      <category>Diabetes Mellitus, Type 1 drug therapy</category>
      <category>Diabetes Mellitus, Type 1 blood</category>
      <category>Gastrectomy methods</category>
      <category>Gastrectomy adverse effects</category>
      <category>Duodenum surgery</category>
      <category>Obesity surgery</category>
      <category>Obesity complications</category>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity, Morbid complications</category>
      <title>Five-year outcomes of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) in adults with type 1 diabetes mellitus.</title>
      <description>Endocrine; 06/01/2026&lt;br/&gt;(AN 42223753); ISSN: 1559-0100&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42223753</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41874564&amp;site=ehost-live&amp;scope=site</link>
      <author>Pénisson S; Weischer M; Li L; Zhang Y; Grant H; Yuan RL; Arnold KM; Mülazımoğlu M; Wang Y; Kawamoto S; Fouladi DF; Shayesteh S; Blanco A; Ghandili S; Zinreich E; Graves JS; Rahmanuddin S; Kern SE; Wu PH; Hooper JE; Yuille A; Fishman EK; Chu L; Tomasetti C</author>
      <category>Kidney pathology</category>
      <category>Liver pathology</category>
      <category>Pancreas pathology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Body Mass Index</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Organ Size</category>
      <category>Middle Aged</category>
      <category>Risk Factors</category>
      <category>Aged</category>
      <category>Obesity complications</category>
      <category>Obesity pathology</category>
      <category>Neoplasms pathology</category>
      <category>Neoplasms etiology</category>
      <category>Hyperplasia pathology</category>
      <title>Hyperplasia Functions as a Link between Obesity and Cancer.</title>
      <description>Cancer research; 06/01/2026&lt;br/&gt;(AN 41874564); ISSN: 1538-7445&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41874564</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40700548&amp;site=ehost-live&amp;scope=site</link>
      <author>Xu S; Li J; Qiu J; Zhang Y; Yang S; Liu J</author>
      <category>Glucagon-Like Peptide 1 blood</category>
      <category>Humans</category>
      <category>Blood Glucose</category>
      <category>Glycated Hemoglobin</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Treatment Outcome</category>
      <category>Sleep Apnea, Obstructive drug therapy</category>
      <category>Sleep Apnea, Obstructive complications</category>
      <category>Sleep Apnea, Obstructive blood</category>
      <category>Obesity complications</category>
      <category>Obesity drug therapy</category>
      <category>Obesity blood</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Diabetes Mellitus, Type 2 blood</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Obese or Diabetic Patients With Obstructive Sleep Apnea Syndrome: A Meta-Analysis.</title>
      <description>Nutrition reviews; 06/01/2026&lt;br/&gt;(AN 40700548); ISSN: 1753-4887&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40700548</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40587385&amp;site=ehost-live&amp;scope=site</link>
      <author>Yang X; Liu W; Zhuo Y; Luo T; Wu; Hua L</author>
      <category>Obesity prevention &amp; control</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Life Style</category>
      <category>Feeding Behavior</category>
      <category>Intermittent Fasting</category>
      <category>Fasting physiology</category>
      <category>Fasting adverse effects</category>
      <category>Reproduction physiology</category>
      <title>Intermittent Fasting in Female Reproduction: A Double-Edged Sword.</title>
      <description>Nutrition reviews; 06/01/2026&lt;br/&gt;(AN 40587385); ISSN: 1753-4887&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40587385</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42186269&amp;site=ehost-live&amp;scope=site</link>
      <author>Ludy MJ; Moore GE; Mattes RD; Westerterp-Plantenga MS</author>
      <category>Obesity diet therapy</category>
      <category>Energy Intake drug effects</category>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Thermogenesis drug effects</category>
      <category>Capsicum chemistry</category>
      <category>Energy Metabolism drug effects</category>
      <category>Capsaicin pharmacology</category>
      <category>Capsaicin administration &amp; dosage</category>
      <title>Attenuation of Adaptive Thermogenesis by a Culinary Dose of Red Pepper During 24-Hour Negative Energy Balance.</title>
      <description>Nutrition reviews; 06/01/2026&lt;br/&gt;(AN 42186269); ISSN: 1753-4887&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42186269</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42017239&amp;site=ehost-live&amp;scope=site</link>
      <author>Flack JM; Buhnerkempe MG; Lopez A; Byrd JB</author>
      <category>Aldosterone metabolism</category>
      <category>Aldosterone blood</category>
      <category>Hypertension physiopathology</category>
      <category>Adipocytes metabolism</category>
      <category>Intra-Abdominal Fat metabolism</category>
      <category>Humans</category>
      <category>Hyperaldosteronism etiology</category>
      <category>Hyperaldosteronism metabolism</category>
      <category>Hyperaldosteronism physiopathology</category>
      <category>Hyperaldosteronism epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Obesity epidemiology</category>
      <title>Link of Obesity With Primary Aldosteronism: Causal or Not?</title>
      <description>Hypertension (Dallas, Tex. : 1979); 06/01/2026&lt;br/&gt;(AN 42017239); ISSN: 1524-4563&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42017239</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41705339&amp;site=ehost-live&amp;scope=site</link>
      <author>Vernail VL; Mehay DL; Kimbark KD; Tanner JA; Bingaman SS; Silberman Y; Arnold AC</author>
      <category>Blood Pressure drug effects</category>
      <category>Blood Pressure physiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Hypertension metabolism</category>
      <category>Hypertension physiopathology</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Diet, High-Fat</category>
      <category>Disease Models, Animal</category>
      <category>Mice, Inbred C57BL</category>
      <category>Arcuate Nucleus of Hypothalamus drug effects</category>
      <category>Arcuate Nucleus of Hypothalamus metabolism</category>
      <category>Angiotensin I pharmacology</category>
      <category>Peptide Fragments pharmacology</category>
      <category>Pro-Opiomelanocortin metabolism</category>
      <category>Neurons drug effects</category>
      <category>Neurons metabolism</category>
      <title>Angiotensin-(1-7) Activates Proopiomelanocortin Neurons in the Arcuate Nucleus.</title>
      <description>Hypertension (Dallas, Tex. : 1979); 06/01/2026&lt;br/&gt;(AN 41705339); ISSN: 1524-4563&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41705339</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41701539&amp;site=ehost-live&amp;scope=site</link>
      <author>Garcia JN; Cottam MA; Rodriguez AS; Agha AFH; Caslin HL; Winn NC; Hasty AH</author>
      <category>Adipose Tissue metabolism</category>
      <category>Adipose Tissue immunology</category>
      <category>CD27 Ligand metabolism</category>
      <category>CD27 Ligand genetics</category>
      <category>Tumor Necrosis Factor Receptor Superfamily, Member 7 metabolism</category>
      <category>Tumor Necrosis Factor Receptor Superfamily, Member 7 genetics</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Mice, Knockout</category>
      <category>Obesity metabolism</category>
      <category>Obesity immunology</category>
      <category>Weight Loss immunology</category>
      <category>Memory T Cells immunology</category>
      <category>Memory T Cells metabolism</category>
      <category>Weight Gain immunology</category>
      <category>T-Lymphocytes immunology</category>
      <category>T-Lymphocytes metabolism</category>
      <category>Immunologic Memory</category>
      <title>Interrupting T-Cell Memory Ameliorates Exaggerated Metabolic Response to Weight Cycling.</title>
      <description>Diabetes; 06/01/2026&lt;br/&gt;(AN 41701539); ISSN: 1939-327X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41701539</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41911360&amp;site=ehost-live&amp;scope=site</link>
      <author>Englund A; Lange AH; Hagemann CA; Kizilkaya HS; Rosenkilde MM; Hartmann B; Holst JJ; Dela F; Lund AB; Gasbjerg LS; Knop FK</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Double-Blind Method</category>
      <category>Cross-Over Studies</category>
      <category>Middle Aged</category>
      <category>Blood Proteins</category>
      <category>Obesity drug therapy</category>
      <category>Obesity blood</category>
      <category>Obesity metabolism</category>
      <category>Postprandial Period drug effects</category>
      <category>Eating drug effects</category>
      <category>Blood Glucose drug effects</category>
      <category>Blood Glucose metabolism</category>
      <category>Antimicrobial Peptides pharmacology</category>
      <category>Antimicrobial Peptides therapeutic use</category>
      <category>Antimicrobial Cationic Peptides pharmacology</category>
      <title>LEAP2 Reduces Ad Libitum Food Intake and Attenuates Postprandial Glucose Excursions in Men With Obesity.</title>
      <description>Diabetes; 06/01/2026&lt;br/&gt;(AN 41911360); ISSN: 1939-327X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41911360</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41813242&amp;site=ehost-live&amp;scope=site</link>
      <author>Chun SH; Gong HS</author>
      <category>Obesity epidemiology</category>
      <category>Republic of Korea epidemiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Cross-Sectional Studies</category>
      <category>Retrospective Studies</category>
      <category>Muscle, Skeletal</category>
      <category>Risk Factors</category>
      <category>Carpal Tunnel Syndrome epidemiology</category>
      <category>Sarcopenia epidemiology</category>
      <category>Sarcopenia complications</category>
      <category>Sarcopenia diagnosis</category>
      <category>Sarcopenia physiopathology</category>
      <category>Body Mass Index</category>
      <title>Beyond Body Mass Index: Appendicular Lean Mass Index-Defined Sarcopenia and Carpal Tunnel Syndrome-A Cross-Sectional Analysis.</title>
      <description>Muscle &amp; nerve; 06/01/2026&lt;br/&gt;(AN 41813242); ISSN: 1097-4598&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41813242</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41862384&amp;site=ehost-live&amp;scope=site</link>
      <author>Sebastian SA; Ayyalu T; Bimal T; Patel B; Kittleson MM; Carbone S; Yehya A</author>
      <category>Obesity complications</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Humans</category>
      <category>Treatment Outcome</category>
      <category>Heart Failure drug therapy</category>
      <category>Heart Failure physiopathology</category>
      <category>Heart Failure etiology</category>
      <category>Stroke Volume drug effects</category>
      <category>Tirzepatide therapeutic use</category>
      <category>Tirzepatide adverse effects</category>
      <title>Efficacy and safety of Tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis.</title>
      <description>Disease-a-month : DM; 06/01/2026&lt;br/&gt;(AN 41862384); ISSN: 1557-8194&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41862384</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41091899&amp;site=ehost-live&amp;scope=site</link>
      <author>Jacobson S; Margolese N; Margolese HC</author>
      <category>Humans</category>
      <category>Antipsychotic Agents adverse effects</category>
      <category>Weight Gain drug effects</category>
      <category>Mental Disorders drug therapy</category>
      <category>Obesity chemically induced</category>
      <category>Obesity drug therapy</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>GLP-1 Receptor Agonists as a Novel Solution for Antipsychotic-Induced Weight Gain in Severe and Persistent Mental Illness.</title>
      <description>Canadian journal of psychiatry. Revue canadienne de psychiatrie; 06/01/2026&lt;br/&gt;(AN 41091899); ISSN: 1497-0015&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41091899</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41989028&amp;site=ehost-live&amp;scope=site</link>
      <author>Chandrasekaran S</author>
      <category>Humans</category>
      <category>Pregnancy</category>
      <category>Female</category>
      <category>Insulin Resistance</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>Diabetes, Gestational metabolism</category>
      <category>Diabetes, Gestational epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity epidemiology</category>
      <category>Pregnancy in Obesity metabolism</category>
      <title>Obesity and Diabetes: A Complex Connection.</title>
      <description>Clinical obstetrics and gynecology; 06/01/2026&lt;br/&gt;(AN 41989028); ISSN: 1532-5520&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41989028</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41981828&amp;site=ehost-live&amp;scope=site</link>
      <author>Wu Y; Liu Q; Li X; Ai Y; Zhao S; Ji X; Li M; Xiu J; Zhang J; Yin Z; Bai L</author>
      <category>Animals</category>
      <category>Rats, Sprague-Dawley</category>
      <category>Male</category>
      <category>Magnetic Resonance Imaging</category>
      <category>Rats</category>
      <category>Disease Models, Animal</category>
      <category>Gait</category>
      <category>Time Factors</category>
      <category>Biomechanical Phenomena</category>
      <category>Rotator Cuff</category>
      <category>Rotator Cuff Injuries surgery</category>
      <category>Rotator Cuff Injuries physiopathology</category>
      <category>Rotator Cuff Injuries diagnostic imaging</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Wound Healing</category>
      <title>Obesity Amplifies the Detrimental Effects of Delayed Repair on Tendon-to-Bone Healing After Rotator Cuff Injury in a Rat Model.</title>
      <description>The American journal of sports medicine; 06/01/2026&lt;br/&gt;(AN 41981828); ISSN: 1552-3365&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41981828</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41770540&amp;site=ehost-live&amp;scope=site</link>
      <author>Hochreiner EM; Takla T; Majewski M; Mele M; Mulligan LJ</author>
      <category>Hypertension physiopathology</category>
      <category>Hypertension epidemiology</category>
      <category>Humans</category>
      <category>Pregnancy</category>
      <category>Female</category>
      <category>Hemodynamics</category>
      <category>Cardiovascular Diseases physiopathology</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Pregnancy Complications, Cardiovascular physiopathology</category>
      <category>Pregnancy Complications, Cardiovascular epidemiology</category>
      <title>Impact of cardiovascular disease in the obstetric population.</title>
      <description>Advances in physiology education; 06/01/2026&lt;br/&gt;(AN 41770540); ISSN: 1522-1229&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41770540</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41335494&amp;site=ehost-live&amp;scope=site</link>
      <author>Schumacher LM; Bass SB; Ard J; Rubin DJ; Herring SJ; Rao AD; Jones RM; Sarwer DB</author>
      <category>Humans</category>
      <category>Patient Participation</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Obesity therapy</category>
      <category>Decision Making, Shared</category>
      <title>The New Obesity Treatment Landscape: Challenges and Opportunities to Promote Shared Decision-Making in People With Obesity and Type 2 Diabetes.</title>
      <description>Diabetes care; 06/01/2026&lt;br/&gt;(AN 41335494); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41335494</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41296499&amp;site=ehost-live&amp;scope=site</link>
      <author>Arslanian S; Gies I; Goldman B; Karlsson T; Kelly AS; Skalshøi Kjær M; Körner A; Noureddin M; Wabitsch M; Harder-Lauridsen NM; Weghuber D</author>
      <category>Blood Glucose metabolism</category>
      <category>Blood Glucose drug effects</category>
      <category>Humans</category>
      <category>Adolescent</category>
      <category>Female</category>
      <category>Male</category>
      <category>Child</category>
      <category>Cardiometabolic Risk Factors</category>
      <category>Risk Factors</category>
      <category>Insulin Resistance physiology</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Obesity drug therapy</category>
      <title>Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study.</title>
      <description>Diabetes care; 06/01/2026&lt;br/&gt;(AN 41296499); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41296499</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42012390&amp;site=ehost-live&amp;scope=site</link>
      <author>Curto A; Konieczna J; Colom A; Abete I; de Hoogh K; Hoek G; Salas-Salvadó J; Martín-Sánchez JV; Estruch R; Vidal J; Toledo E; García-Gavilán JF; de Paz JA; Casas R; Goñi-Ruiz N; Vázquez-Lorente H; Fitó M; Martínez JA; Romaguera D</author>
      <category>Particulate Matter adverse effects</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Aged</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Body Composition physiology</category>
      <category>Air Pollution adverse effects</category>
      <category>Metabolic Syndrome physiopathology</category>
      <category>Metabolic Syndrome epidemiology</category>
      <category>Obesity physiopathology</category>
      <category>Obesity epidemiology</category>
      <category>Overweight physiopathology</category>
      <category>Overweight epidemiology</category>
      <title>Long-term Air Pollution and Overall and Regional Body Composition in Older Adults With Overweight or Obesity and Metabolic Syndrome.</title>
      <description>Diabetes care; 06/01/2026&lt;br/&gt;(AN 42012390); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42012390</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41834311&amp;site=ehost-live&amp;scope=site</link>
      <author>Kikuchi A; Yoshimoto H; Monma T; Ozawa S; Tsuchida M; Takeda F</author>
      <category>Japan epidemiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Prevalence</category>
      <category>Risk Factors</category>
      <category>Metabolic Syndrome epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Alcohol Drinking epidemiology</category>
      <category>Alcohol Drinking adverse effects</category>
      <title>Association Between Alcohol Drinking Patterns and Multiple Metabolic Syndrome Components in Non-Obese and Obese Individuals.</title>
      <description>Neuropsychopharmacology reports; 06/01/2026&lt;br/&gt;(AN 41834311); ISSN: 2574-173X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41834311</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41927174&amp;site=ehost-live&amp;scope=site</link>
      <author>Abdel-Aal NM; Elsayyad MM; Ahmed SS; Basha MA; Kamel FH</author>
      <category>Biomarkers blood</category>
      <category>Glycated Hemoglobin metabolism</category>
      <category>Glycated Hemoglobin analysis</category>
      <category>C-Reactive Protein metabolism</category>
      <category>C-Reactive Protein analysis</category>
      <category>Lipids blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Quality of Life</category>
      <category>Skinfold Thickness</category>
      <category>Waist-Hip Ratio</category>
      <category>Caloric Restriction</category>
      <category>Resistance Training methods</category>
      <category>Obesity therapy</category>
      <category>Obesity blood</category>
      <category>Exercise Therapy methods</category>
      <category>Virtual Reality</category>
      <category>Adipose Tissue</category>
      <title>Virtual reality exercises versus high volume resistance training on body fat and blood biomarkers in obese adult females: A randomized controlled study.</title>
      <description>Journal of bodywork and movement therapies; 06/01/2026&lt;br/&gt;(AN 41927174); ISSN: 1532-9283&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41927174</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41825476&amp;site=ehost-live&amp;scope=site</link>
      <author>Markovic ES; Ward H; Khanuja K; McLaren R Jr</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Body Mass Index</category>
      <category>Infant, Newborn</category>
      <category>Cohort Studies</category>
      <category>Logistic Models</category>
      <category>Infant, Large for Gestational Age</category>
      <category>Pregnancy in Obesity</category>
      <category>Obesity epidemiology</category>
      <category>Obesity complications</category>
      <category>Pregnancy Outcome epidemiology</category>
      <category>Pregnancy in Diabetics epidemiology</category>
      <category>Pregnancy Complications epidemiology</category>
      <category>Gestational Weight Gain</category>
      <title>Association of Prepregnancy Obesity and Excessive Gestational Weight Gain with Perinatal Outcomes among Patients with Pregestational Diabetes.</title>
      <description>American journal of perinatology; 06/01/2026&lt;br/&gt;(AN 41825476); ISSN: 1098-8785&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41825476</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42049055&amp;site=ehost-live&amp;scope=site</link>
      <author>McWhorter KL; Wells G; Bowers K; Summer S; Dolan L; Catalano P; Szczesniak RD; Altaye M; Rosenn B; Khoury JC; Ehrlich S</author>
      <category>Glycated Hemoglobin analysis</category>
      <category>Blood Glucose analysis</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Infant, Newborn</category>
      <category>Male</category>
      <category>Developmental Origins of Health and Disease</category>
      <category>Hyperglycemia complications</category>
      <category>Obesity epidemiology</category>
      <category>Obesity etiology</category>
      <category>Overweight epidemiology</category>
      <category>Overweight etiology</category>
      <category>Pregnancy in Diabetics blood</category>
      <category>Birth Weight</category>
      <category>Prenatal Exposure Delayed Effects</category>
      <category>Diabetes Mellitus, Type 1</category>
      <title>Maternal Hyperglycemia and Adult Offspring Overweight and Obesity: Is Birthweight a Mediator?</title>
      <description>American journal of perinatology; 06/01/2026&lt;br/&gt;(AN 42049055); ISSN: 1098-8785&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42049055</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41954863&amp;site=ehost-live&amp;scope=site</link>
      <author>Bassatne A; Rizo I</author>
      <category>Islet Amyloid Polypeptide therapeutic use</category>
      <category>Humans</category>
      <category>Weight Loss</category>
      <category>Obesity drug therapy</category>
      <category>Obesity therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Incretins therapeutic use</category>
      <title>Future Directions in the Medical Treatment of Obesity: A Narrative Review.</title>
      <description>Advances in therapy; 06/01/2026&lt;br/&gt;(AN 41954863); ISSN: 1865-8652&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41954863</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41965443&amp;site=ehost-live&amp;scope=site</link>
      <author>Gibble TH; Leith A; Harrison L; Gerber C; Raikar SK; Ashok G; Artime E</author>
      <category>Tirzepatide therapeutic use</category>
      <category>Humans</category>
      <category>Female</category>
      <category>United States</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Weight Reduction Programs</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Overweight drug therapy</category>
      <category>Quality of Life</category>
      <title>Health-Related Quality of Life and Work-Related Outcomes in People with Obesity or Overweight Treated with Tirzepatide or Other Obesity Medications: United States Results from the Adelphi Real World Obesity Disease Specific Programme™.</title>
      <description>Advances in therapy; 06/01/2026&lt;br/&gt;(AN 41965443); ISSN: 1865-8652&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41965443</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41072556&amp;site=ehost-live&amp;scope=site</link>
      <author>Lee S; Singh K; Clark SC; Goh GS</author>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications prevention &amp; control</category>
      <category>Obesity drug therapy</category>
      <category>Obesity complications</category>
      <category>Reoperation statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Treatment Outcome</category>
      <category>Female</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Arthroplasty, Replacement, Knee adverse effects</category>
      <category>Arthroplasty, Replacement, Hip adverse effects</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>The Impact of Glucagon-Like Peptide-1 Receptor Agonist Use on Clinical Outcomes After Total Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis of 346,899 Patients.</title>
      <description>The Journal of arthroplasty; 06/01/2026&lt;br/&gt;(AN 41072556); ISSN: 1532-8406&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41072556</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40920206&amp;site=ehost-live&amp;scope=site</link>
      <author>Chilingarashvili G; Pasnoor DS; Bajjuri S; Parekh R; Manjappachar N; Gummadi J; Nanjundappa A; Desai R</author>
      <category>Length of Stay statistics &amp; numerical data</category>
      <category>United States epidemiology</category>
      <category>Respiratory Insufficiency epidemiology</category>
      <category>Respiratory Insufficiency etiology</category>
      <category>Respiration, Artificial statistics &amp; numerical data</category>
      <category>Hospitalization statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Retrospective Studies</category>
      <category>Hospital Mortality</category>
      <category>Aged, 80 and over</category>
      <category>Risk Factors</category>
      <category>Shock, Septic mortality</category>
      <category>Shock, Septic complications</category>
      <category>Shock, Septic epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Obesity, Metabolically Benign complications</category>
      <category>Obesity, Metabolically Benign epidemiology</category>
      <title>Impact of Metabolically Healthy and Unhealthy Obesity on Outcomes of Sepsis Complicated by Septic Shock in Elderly Patients.</title>
      <description>Journal of intensive care medicine; 06/01/2026&lt;br/&gt;(AN 40920206); ISSN: 1525-1489&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40920206</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40993984&amp;site=ehost-live&amp;scope=site</link>
      <author>Schneider ML; Tewksbury C</author>
      <category>Micronutrients deficiency</category>
      <category>Humans</category>
      <category>Bias</category>
      <category>Prevalence</category>
      <category>Body Composition</category>
      <category>Weight Loss</category>
      <category>Obesity complications</category>
      <category>Malnutrition diagnosis</category>
      <category>Malnutrition epidemiology</category>
      <category>Nutrition Assessment</category>
      <category>Weight Prejudice</category>
      <title>Addressing bias to facilitate accurate nutrition assessment in obesity.</title>
      <description>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition; 06/01/2026&lt;br/&gt;(AN 40993984); ISSN: 1941-2452&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40993984</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41459811&amp;site=ehost-live&amp;scope=site</link>
      <author>Kayhan Kocak FO; Altın Z; Kızıltaş A</author>
      <category>Frailty epidemiology</category>
      <category>Humans</category>
      <category>Cross-Sectional Studies</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Female</category>
      <category>Retrospective Studies</category>
      <category>Aged, 80 and over</category>
      <category>Nutrition Assessment</category>
      <category>Prevalence</category>
      <category>Accidental Falls</category>
      <category>Sarcopenia epidemiology</category>
      <category>Sarcopenia diagnosis</category>
      <category>Sarcopenia complications</category>
      <category>Malnutrition diagnosis</category>
      <category>Malnutrition epidemiology</category>
      <category>Malnutrition complications</category>
      <category>Obesity epidemiology</category>
      <category>Obesity diagnosis</category>
      <category>Obesity complications</category>
      <category>Geriatric Assessment methods</category>
      <category>Body Mass Index</category>
      <title>Malnutrition by GLIM and its overlap with sarcopenic obesity in older adults with elevated body mass index: A retrospective cross-sectional study.</title>
      <description>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition; 06/01/2026&lt;br/&gt;(AN 41459811); ISSN: 1941-2452&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41459811</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42001256&amp;site=ehost-live&amp;scope=site</link>
      <author>Barlas EA; Akın S; Doğan N; Şahin GG; İpekten F</author>
      <category>Humans</category>
      <category>Retrospective Studies</category>
      <category>Aged</category>
      <category>Male</category>
      <category>Female</category>
      <category>Geriatric Assessment</category>
      <category>Middle Aged</category>
      <category>Aged, 80 and over</category>
      <category>Risk Factors</category>
      <category>Body Mass Index</category>
      <category>Proportional Hazards Models</category>
      <category>Kaplan-Meier Estimate</category>
      <category>Independent Living</category>
      <category>Sarcopenia mortality</category>
      <category>Sarcopenia complications</category>
      <category>Obesity mortality</category>
      <category>Obesity complications</category>
      <title>Comparative five-year mortality risk in older adults with sarcopenia and sarcopenic obesity: A retrospective cohort analysis.</title>
      <description>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition; 06/01/2026&lt;br/&gt;(AN 42001256); ISSN: 1941-2452&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42001256</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41632466&amp;site=ehost-live&amp;scope=site</link>
      <author>Wong GWS; Guo C; French CM; Bell JJ; Ross LJ</author>
      <category>Humans</category>
      <category>Retrospective Studies</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Weight Loss</category>
      <category>Adult</category>
      <category>Elective Surgical Procedures</category>
      <category>Body Mass Index</category>
      <category>Operative Time</category>
      <category>Aged</category>
      <category>Treatment Outcome</category>
      <category>Obesity diet therapy</category>
      <category>Obesity rehabilitation</category>
      <category>Obesity surgery</category>
      <category>Preoperative Care methods</category>
      <category>Caloric Restriction methods</category>
      <category>Laparoscopy</category>
      <category>Nutritionists</category>
      <title>Dietitian-led very low-calorie diet for preoperative rehabilitation in patients with obesity awaiting non-bariatric elective laparoscopic surgery: A retrospective study.</title>
      <description>Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition; 06/01/2026&lt;br/&gt;(AN 41632466); ISSN: 1941-2452&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41632466</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41160911&amp;site=ehost-live&amp;scope=site</link>
      <author>Wilkins FL; Moore WS; Jackson JR; McVay MA</author>
      <category>Glucagon-Like Peptide 1 therapeutic use</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Dietary Supplements</category>
      <category>Obesity drug therapy</category>
      <category>Obesity therapy</category>
      <category>Weight Loss</category>
      <title>Correlates of Healthcare Patients' Interest in and Use of Medication and Non-Evidence-Based Approaches to Weight Loss.</title>
      <description>American journal of health promotion : AJHP; 06/01/2026&lt;br/&gt;(AN 41160911); ISSN: 2168-6602&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41160911</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40417931&amp;site=ehost-live&amp;scope=site</link>
      <author>Azran C; Kais H; Porat D; Dahan A</author>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity surgery</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Biological Availability</category>
      <category>Gastric Bypass methods</category>
      <category>Gastric Bypass trends</category>
      <category>Gastric Bypass adverse effects</category>
      <category>Lamotrigine blood</category>
      <category>Lamotrigine pharmacokinetics</category>
      <category>Anticonvulsants blood</category>
      <category>Anticonvulsants pharmacokinetics</category>
      <category>Anticonvulsants therapeutic use</category>
      <title>Varying Lamotrigine Concentrations in Patients Following One Anastomosis Gastric Bypass Surgery: A Case Series.</title>
      <description>Journal of pharmacy practice; 06/01/2026&lt;br/&gt;(AN 40417931); ISSN: 1531-1937&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40417931</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40906565&amp;site=ehost-live&amp;scope=site</link>
      <author>Kettner J; Donnelly E; Maes ML</author>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Lactation drug effects</category>
      <category>Obesity drug therapy</category>
      <category>Humans</category>
      <category>Pregnancy</category>
      <category>Female</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Hypoglycemic Agents pharmacology</category>
      <category>Hypoglycemic Agents adverse effects</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <category>Reproductive Health</category>
      <title>Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications.</title>
      <description>Journal of pharmacy practice; 06/01/2026&lt;br/&gt;(AN 40906565); ISSN: 1531-1937&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40906565</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42219677&amp;site=ehost-live&amp;scope=site</link>
      <author>Nandankar N; Negrón AL; Ganesh H; Youssef N; Farooq S; Al-Samerria S; Levine JE; Radovick S</author>
      <category>Obesity metabolism</category>
      <category>Hypothalamus metabolism</category>
      <category>Animals</category>
      <category>Female</category>
      <category>Mice, Knockout</category>
      <category>Mice</category>
      <category>Kisspeptins metabolism</category>
      <category>Kisspeptins genetics</category>
      <category>Kisspeptins physiology</category>
      <category>Homeostasis physiology</category>
      <category>Neurons metabolism</category>
      <category>Energy Metabolism physiology</category>
      <category>Energy Metabolism genetics</category>
      <category>Ovary metabolism</category>
      <title>KNDy kisspeptin is required for metabolic homeostasis in female mice in an ovarian hormone-independent manner.</title>
      <description>Journal of neuroendocrinology; 06/01/2026&lt;br/&gt;(AN 42219677); ISSN: 1365-2826&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42219677</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41699896&amp;site=ehost-live&amp;scope=site</link>
      <author>Robb C; Strafella R; Ayar J; Desai R; Reno A; Grunfeld N; Drugge E; Dandolu V</author>
      <category>United States epidemiology</category>
      <category>Hospitalization statistics &amp; numerical data</category>
      <category>Obesity ethnology</category>
      <category>Obesity epidemiology</category>
      <category>Black or African American statistics &amp; numerical data</category>
      <category>White People statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Retrospective Studies</category>
      <category>Cross-Sectional Studies</category>
      <category>Pregnancy</category>
      <category>Comorbidity</category>
      <category>Young Adult</category>
      <category>Morbidity</category>
      <category>White</category>
      <category>Polycystic Ovary Syndrome ethnology</category>
      <category>Polycystic Ovary Syndrome epidemiology</category>
      <category>Pregnancy Complications ethnology</category>
      <category>Pregnancy Complications epidemiology</category>
      <category>Healthcare Disparities ethnology</category>
      <category>Racial Groups statistics &amp; numerical data</category>
      <category>Health Status Disparities</category>
      <title>Racial Disparities in Severe Maternal Morbidity Among Patients with Polycystic Ovarian Syndrome.</title>
      <description>Journal of women's health (2002); 06/01/2026&lt;br/&gt;(AN 41699896); ISSN: 1931-843X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41699896</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42047631&amp;site=ehost-live&amp;scope=site</link>
      <author>Katzmarzyk PT; Drews K; Ard JD; McLaughlin TL; Harris MN; Lee A; Foster GD; Lee HJ; Dunn TC; Martin CK; Greenway FL; Cardel MI</author>
      <category>Glycated Hemoglobin metabolism</category>
      <category>Glycated Hemoglobin analysis</category>
      <category>Blood Glucose metabolism</category>
      <category>Blood Glucose analysis</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Continuous Glucose Monitoring</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Waist Circumference</category>
      <category>Weight Loss</category>
      <category>Aged</category>
      <category>Treatment Outcome</category>
      <category>Patient Satisfaction</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Diabetes Mellitus, Type 2 blood</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Obesity blood</category>
      <category>Overweight therapy</category>
      <category>Overweight complications</category>
      <category>Overweight blood</category>
      <category>Weight Reduction Programs methods</category>
      <title>Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial.</title>
      <description>Obesity (Silver Spring, Md.); 06/01/2026&lt;br/&gt;(AN 42047631); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42047631</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42120922&amp;site=ehost-live&amp;scope=site</link>
      <author>Lewis KH; Zhang F; LeCates RF; Argetsinger S; Albert S; Iyer GS; Connolly JG; Wharam JF; Arterburn DE; Ross-Degnan D; Toh S</author>
      <category>Liraglutide therapeutic use</category>
      <category>Liraglutide economics</category>
      <category>Naltrexone therapeutic use</category>
      <category>Naltrexone economics</category>
      <category>Phentermine therapeutic use</category>
      <category>Phentermine economics</category>
      <category>Bupropion therapeutic use</category>
      <category>Bupropion economics</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Topiramate</category>
      <category>Emergency Room Visits</category>
      <category>Obesity drug therapy</category>
      <category>Obesity economics</category>
      <category>Anti-Obesity Agents economics</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Health Care Costs</category>
      <title>Health Care Costs and Use of Patients Prescribed Four Different Obesity Medications.</title>
      <description>Obesity (Silver Spring, Md.); 06/01/2026&lt;br/&gt;(AN 42120922); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42120922</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41401218&amp;site=ehost-live&amp;scope=site</link>
      <author>Abud GF; Ortiz GU; Venturini ACR; Travieso SG; Fogagnolo C; Viliod MCL; Esteves GP; Silva BM; da Silva ASR; de Freitas EC</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Cross-Sectional Studies</category>
      <category>Pilot Projects</category>
      <category>Aged</category>
      <category>Prevalence</category>
      <category>Middle Aged</category>
      <category>Hand Strength</category>
      <category>Body Mass Index</category>
      <category>Body Composition</category>
      <category>Waist Circumference</category>
      <category>Logistic Models</category>
      <category>Sarcopenia epidemiology</category>
      <category>Sarcopenia physiopathology</category>
      <category>Sarcopenia complications</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Obesity physiopathology</category>
      <category>Adipose Tissue</category>
      <title>Association between body fat and the prevalence of sarcopenia in older women with obesity: a pilot cross-sectional study.</title>
      <description>Menopause (New York, N.Y.); 06/01/2026&lt;br/&gt;(AN 41401218); ISSN: 1530-0374&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41401218</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42166306&amp;site=ehost-live&amp;scope=site</link>
      <author>Baalmann A; Michel J; Avedissian SN; Pow A; Farris K</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Retrospective Studies</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Cohort Studies</category>
      <category>Aged</category>
      <category>Medication Adherence</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Glucagon-Like Peptides administration &amp; dosage</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Anti-Obesity Agents administration &amp; dosage</category>
      <category>Delivery of Health Care, Integrated</category>
      <title>Real-world use of semaglutide for obesity treatment: A cohort study in an integrated health care delivery system.</title>
      <description>Journal of managed care &amp; specialty pharmacy; 06/01/2026&lt;br/&gt;(AN 42166306); ISSN: 2376-1032&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42166306</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42166309&amp;site=ehost-live&amp;scope=site</link>
      <author>Ramachandran S; Urick B; Thomas T</author>
      <category>Humans</category>
      <category>Cost-Benefit Analysis</category>
      <category>United States</category>
      <category>Obesity drug therapy</category>
      <category>Obesity economics</category>
      <category>Anti-Obesity Agents economics</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Weight Loss drug effects</category>
      <title>ICER report demonstrates both the value and challenges in financing of weight loss medications.</title>
      <description>Journal of managed care &amp; specialty pharmacy; 06/01/2026&lt;br/&gt;(AN 42166309); ISSN: 2376-1032&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42166309</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41182078&amp;site=ehost-live&amp;scope=site</link>
      <author>Román-Calleja BM; Ruiz-Margain A; Duarte-Rojo A; Flores-Silva F; Martinez-Cabrera CF; Gutiérrez-Rosas LE; Valencia-Peña BA; Cantú-Brito C; Chalasani N; Aguilar-Salinas CA; Macías-Rodríguez RU</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Treatment Outcome</category>
      <category>Vascular Stiffness</category>
      <category>Ultrasonography, Doppler, Transcranial</category>
      <category>Body Composition</category>
      <category>Cerebrovascular Circulation</category>
      <category>Neuropsychological Tests</category>
      <category>Caloric Restriction</category>
      <category>Hemodynamics</category>
      <category>Resistance Training</category>
      <category>Obesity complications</category>
      <category>Obesity therapy</category>
      <category>Exercise Therapy methods</category>
      <category>Fatty Liver therapy</category>
      <category>Fatty Liver psychology</category>
      <category>Fatty Liver complications</category>
      <category>Non-alcoholic Fatty Liver Disease therapy</category>
      <category>Non-alcoholic Fatty Liver Disease psychology</category>
      <category>Cognition</category>
      <category>Exercise</category>
      <title>Physical exercise improves neurocognition in patients with metabolic dysfunction-associated steatotic liver disease.</title>
      <description>Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society; 06/01/2026&lt;br/&gt;(AN 41182078); ISSN: 1527-6473&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41182078</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41804758&amp;site=ehost-live&amp;scope=site</link>
      <author>Akturk HK; Mason E; Cengiz D; Karakus KE; Garg SK</author>
      <category>Hypoglycemia chemically induced</category>
      <category>Obesity complications</category>
      <category>Overweight complications</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Blood Glucose</category>
      <category>Drug Therapy, Combination</category>
      <category>Diabetes Mellitus, Type 1 drug therapy</category>
      <category>Diabetes Mellitus, Type 1 complications</category>
      <category>Hypoglycemic Agents adverse effects</category>
      <category>Semaglutide adverse effects</category>
      <category>Tirzepatide adverse effects</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists adverse effects</category>
      <title>Patient-Reported Adverse Events with Adjunctive Tirzepatide or Semaglutide Treatment in Adults with Type 1 Diabetes.</title>
      <description>Diabetes technology &amp; therapeutics; 06/01/2026&lt;br/&gt;(AN 41804758); ISSN: 1557-8593&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41804758</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41379348&amp;site=ehost-live&amp;scope=site</link>
      <author>Tranby B; Sia I; Clark M; Novotny P; Lohr A; Suarez Pardo L; Patten C; Iteghete S; Zeratsky K; Rieck T; Molina L; Porraz Capetillo G; Ahmed Y; Dirie H; Wieland M</author>
      <category>Somalia ethnology</category>
      <category>Minnesota epidemiology</category>
      <category>United States epidemiology</category>
      <category>Diet, Healthy ethnology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Adolescent</category>
      <category>Exercise</category>
      <category>Middle Aged</category>
      <category>Young Adult</category>
      <category>Aged</category>
      <category>Aged, 80 and over</category>
      <category>Heart Disease Risk Factors</category>
      <category>Quality of Life</category>
      <category>Emigrants and Immigrants psychology</category>
      <category>Emigrants and Immigrants statistics &amp; numerical data</category>
      <category>Health Behavior ethnology</category>
      <category>Obesity ethnology</category>
      <category>Hispanic or Latino psychology</category>
      <category>Hispanic or Latino statistics &amp; numerical data</category>
      <category>Cardiovascular Diseases ethnology</category>
      <category>Self Efficacy</category>
      <title>Self-Efficacy Is Associated with Health Behaviors Related To Obesity and Cardiovascular Risk Among Hispanic/Latinx and Somali Immigrants To the United States.</title>
      <description>Journal of immigrant and minority health; 06/01/2026&lt;br/&gt;(AN 41379348); ISSN: 1557-1920&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41379348</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42165284&amp;site=ehost-live&amp;scope=site</link>
      <author>Jiang Y; Mao Y; Li L; Wang N; Zhu Z; Ding Y</author>
      <category>Randomized Controlled Trials as Topic statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Body Mass Index</category>
      <category>Diabetes, Gestational prevention &amp; control</category>
      <category>Diabetes, Gestational etiology</category>
      <category>Overweight therapy</category>
      <category>Overweight complications</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Weight Loss physiology</category>
      <category>Weight Reduction Programs methods</category>
      <category>Weight Reduction Programs standards</category>
      <category>Weight Reduction Programs statistics &amp; numerical data</category>
      <title>Effectiveness of Pre-Pregnancy Weight Loss Interventions on the Risk of Gestational Diabetes Mellitus in Overweight or Obese Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</title>
      <description>Worldviews on evidence-based nursing; 06/01/2026&lt;br/&gt;(AN 42165284); ISSN: 1741-6787&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42165284</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41887959&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu C; Lu G; Tian P; Liu J; Liu Y; Li M; Liu J; Zhang Z; Zhang P</author>
      <category>Weight Loss physiology</category>
      <category>Humans</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Female</category>
      <category>Male</category>
      <category>Bariatric Surgery methods</category>
      <category>Bariatric Surgery statistics &amp; numerical data</category>
      <category>Sarcopenia surgery</category>
      <category>Sarcopenia complications</category>
      <category>Obesity surgery</category>
      <category>Obesity complications</category>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity, Morbid complications</category>
      <title>Analysis of the efficacy of metabolic and bariatric surgery on sarcopenic obesity: a systematic review and meta-analysis.</title>
      <description>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery; 06/01/2026&lt;br/&gt;(AN 41887959); ISSN: 1878-7533&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41887959</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41887957&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu C; Tian P; Li M; Liu Y; Liu J; Zhang Z; Zhang P</author>
      <category>Weight Loss drug effects</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications prevention &amp; control</category>
      <category>Obesity surgery</category>
      <category>Humans</category>
      <category>Treatment Outcome</category>
      <category>Bariatric Surgery methods</category>
      <category>Bariatric Surgery adverse effects</category>
      <category>Preoperative Care methods</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Efficacy of preoperative GLP-1 receptor agonists on the perioperative outcomes of bariatric surgery: a systematic review and meta-analysis.</title>
      <description>Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery; 06/01/2026&lt;br/&gt;(AN 41887957); ISSN: 1878-7533&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41887957</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42224300&amp;site=ehost-live&amp;scope=site</link>
      <author>Hironao KY; Fujino S; Johta Y; Odongo K; Ashida H; Yamashita Y</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Cytokines metabolism</category>
      <category>I-kappa B Kinase metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Microglia drug effects</category>
      <category>Microglia metabolism</category>
      <category>Microglia pathology</category>
      <category>Obesity prevention &amp; control</category>
      <category>Obesity metabolism</category>
      <category>Obesity etiology</category>
      <category>Obesity chemically induced</category>
      <category>Hydroxybenzoates pharmacology</category>
      <category>Hydroxybenzoates therapeutic use</category>
      <category>NF-kappa B metabolism</category>
      <category>NF-kappa B antagonists &amp; inhibitors</category>
      <category>Inflammation chemically induced</category>
      <category>Inflammation metabolism</category>
      <category>Fatty Acids adverse effects</category>
      <category>Signal Transduction drug effects</category>
      <title>Protocatechuic acid prevents obesity caused by long-chain saturated fatty acid-induced inflammation in mouse microglia via inhibition of the NF-κB pathway.</title>
      <description>PloS one; 06/01/2026&lt;br/&gt;(AN 42224300); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42224300</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=39528779&amp;site=ehost-live&amp;scope=site</link>
      <author>Hoobler R; Puklin LS; Harrigan M; Cartmel B; Li FY; Sanft T; Ferrucci LM; Irwin ML; Playdon MC</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Life Style</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Adult</category>
      <category>Weight Reduction Programs</category>
      <category>Obesity</category>
      <category>Breast Neoplasms mortality</category>
      <category>Breast Neoplasms therapy</category>
      <category>Cancer Survivors statistics &amp; numerical data</category>
      <category>Weight Loss</category>
      <category>Exercise</category>
      <title>Baseline predictors associated with successful weight loss among breast cancer survivors in the Lifestyle, Exercise, and Nutrition (LEAN) study.</title>
      <description>Journal of cancer survivorship : research and practice; 06/01/2026&lt;br/&gt;(AN 39528779); ISSN: 1932-2267&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_39528779</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41800902&amp;site=ehost-live&amp;scope=site</link>
      <author>Sandberg J</author>
      <category>Weight Loss physiology</category>
      <category>Bariatric Surgery methods</category>
      <category>Humans</category>
      <category>Dyspnea etiology</category>
      <category>Dyspnea physiopathology</category>
      <category>Dyspnea epidemiology</category>
      <category>Dyspnea therapy</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Obesity therapy</category>
      <category>Obesity epidemiology</category>
      <category>Overweight complications</category>
      <category>Overweight physiopathology</category>
      <category>Overweight epidemiology</category>
      <title>Impact of increasing overweight and obesity on breathlessness: a review.</title>
      <description>Current opinion in supportive and palliative care; 06/01/2026&lt;br/&gt;(AN 41800902); ISSN: 1751-4266&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41800902</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41834458&amp;site=ehost-live&amp;scope=site</link>
      <author>Fairfield H; Marinac CR; Hamidi H; Knox K; Nestor B; Marques-Mourlet C; Diaz G; Wong CV; Mishra AK; Schimelman A; Qiang YW; Karam M; Farrell M; Jachimowicz E; Stohn JP; Birmann BM; Cornelius P; Reagan MR</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Disease Progression</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Mice, SCID</category>
      <category>Female</category>
      <category>Multiple Myeloma pathology</category>
      <category>Multiple Myeloma etiology</category>
      <category>Obesity complications</category>
      <category>Obesity pathology</category>
      <category>Disease Models, Animal</category>
      <title>Obesity Accelerates Multiple Myeloma Progression in Certain Mouse Models and in Humans.</title>
      <description>Cancer prevention research (Philadelphia, Pa.); 06/01/2026&lt;br/&gt;(AN 41834458); ISSN: 1940-6215&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41834458</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40071546&amp;site=ehost-live&amp;scope=site</link>
      <author>Richter A; Altemeier A; Becher C; Güllmann M; Plaass C; Ettinger S</author>
      <category>Bone Transplantation methods</category>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Registries</category>
      <category>Adult</category>
      <category>Germany</category>
      <category>Treatment Outcome</category>
      <category>Middle Aged</category>
      <category>Prospective Studies</category>
      <category>Young Adult</category>
      <category>Aged</category>
      <category>Adolescent</category>
      <category>Follow-Up Studies</category>
      <category>Talus surgery</category>
      <category>Cartilage, Articular surgery</category>
      <category>Cartilage, Articular injuries</category>
      <category>Body Mass Index</category>
      <title>Influence of the BMI (&amp;lt;30 kg/m2 vs. ≥30 kg/m2) on the Surgical Outcome of Osteochondral Lesions of the Talus: Prospective Data from the German Cartilage Registry (KnorpelRegister DGOU).</title>
      <description>Cartilage; 06/01/2026&lt;br/&gt;(AN 40071546); ISSN: 1947-6043&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40071546</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42226483&amp;site=ehost-live&amp;scope=site</link>
      <author>Li X; Wang W; Zhang Y; Ding P; Li X</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Heart Failure etiology</category>
      <category>Heart Failure physiopathology</category>
      <category>Heart Failure metabolism</category>
      <category>Leptin metabolism</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Obesity metabolism</category>
      <title>Leptin in Obesity-Related Heart Failure: Pathophysiological Mechanisms and Therapeutic Implications.</title>
      <description>Comprehensive Physiology; 06/01/2026&lt;br/&gt;(AN 42226483); ISSN: 2040-4603&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 01 Jun 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42226483</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42165391&amp;site=ehost-live&amp;scope=site</link>
      <author>Matsumura S; Fujiwara M; Horie S; Marutani M; Nousou E; Iki N; Yamato Y; Otonashi Y; Sasaki T; Fujitani M; Fujikawa T</author>
      <category>Hypothalamus metabolism</category>
      <category>Obesity metabolism</category>
      <category>Mitochondria metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Female</category>
      <category>Mice, Knockout</category>
      <category>Mice, Inbred C57BL</category>
      <category>Energy Metabolism</category>
      <category>Eating</category>
      <category>Soybean Oil</category>
      <category>Receptor, Melanocortin, Type 4 metabolism</category>
      <category>Receptor, Melanocortin, Type 4 genetics</category>
      <category>Neurons metabolism</category>
      <category>GTP Phosphohydrolases metabolism</category>
      <category>GTP Phosphohydrolases genetics</category>
      <category>Body Weight physiology</category>
      <category>Dietary Fats metabolism</category>
      <title>OPA1 in MC4R Neurons Regulates Dietary Fat Intake and Body Weight in Mice.</title>
      <description>FASEB journal : official publication of the Federation of American Societies for Experimental Biology; 05/31/2026&lt;br/&gt;(AN 42165391); ISSN: 1530-6860&lt;br/&gt;MEDLINE</description>
      <pubDate>Sun, 31 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42165391</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42216338&amp;site=ehost-live&amp;scope=site</link>
      <author>Tian Y; Tian W; Zhang P; Yu N; Liu C; Liu X; Lu H</author>
      <category>China epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>Stroke epidemiology</category>
      <category>Stroke mortality</category>
      <category>Stroke etiology</category>
      <category>Global Burden of Disease trends</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <category>Cost of Illness</category>
      <title>Stroke burden attributable to high body mass index in China from 1990 to 2021 and projections to 2036 based on global burden of disease data.</title>
      <description>Medicine; 05/29/2026&lt;br/&gt;(AN 42216338); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 29 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42216338</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42213691&amp;site=ehost-live&amp;scope=site</link>
      <author>Nam SY; Jo J</author>
      <category>Republic of Korea epidemiology</category>
      <category>Humans</category>
      <category>Middle Aged</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Age Factors</category>
      <category>Sex Factors</category>
      <category>Aged</category>
      <category>Proportional Hazards Models</category>
      <category>Stomach Neoplasms epidemiology</category>
      <category>Stomach Neoplasms etiology</category>
      <category>Smoking adverse effects</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <category>Menopause</category>
      <title>Body mass index change trajectories and gastric cancer risk: Effect modification by sex, age, smoking, and menopausal status in Korean adults aged ≥40 years.</title>
      <description>PloS one; 05/29/2026&lt;br/&gt;(AN 42213691); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 29 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42213691</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42209772&amp;site=ehost-live&amp;scope=site</link>
      <author>Mete Kalayci F; Özalp Kizilay D; Ataseven E; Kantar M; Özkiziltan U; Bolat E; Suner Karakülah A; Gökşen D; Darcan Ş; Özen S</author>
      <category>Craniopharyngioma complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Child</category>
      <category>Male</category>
      <category>Retrospective Studies</category>
      <category>Child, Preschool</category>
      <category>Adolescent</category>
      <category>Hypothalamic Neoplasms complications</category>
      <category>Hypothalamic Neoplasms surgery</category>
      <category>Obesity etiology</category>
      <category>Pediatric Obesity etiology</category>
      <category>Pediatric Obesity epidemiology</category>
      <category>Hypothalamic Diseases</category>
      <title>Factors associated with acquired hypothalamic obesity in children with hypothalamic tumors: a comparative single-center study.</title>
      <description>Endocrine; 05/28/2026&lt;br/&gt;(AN 42209772); ISSN: 1559-0100&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 28 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42209772</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42207404&amp;site=ehost-live&amp;scope=site</link>
      <author>Alanazi M; Al-Kuraishy HM; Mohamed AA; Abass SA; Shokr MM; Alruwaili M; Batiha GE</author>
      <category>Dysbiosis drug therapy</category>
      <category>Energy Metabolism drug effects</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Insulin Resistance</category>
      <category>Obesity drug therapy</category>
      <category>Obesity microbiology</category>
      <category>Dipeptidyl-Peptidase IV Inhibitors pharmacology</category>
      <category>Dipeptidyl-Peptidase IV Inhibitors therapeutic use</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Dipeptidyl Peptidase 4 metabolism</category>
      <title>Targeting Gut Microbiota by DPP-4 Inhibitors in Obesity: Mechanistic Insights and Therapeutic Implications.</title>
      <description>Current nutrition reports; 05/28/2026&lt;br/&gt;(AN 42207404); ISSN: 2161-3311&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 28 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42207404</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42127269&amp;site=ehost-live&amp;scope=site</link>
      <author>Hao Z; Ge J; Sun Y; Yang D; Guo K; Wang Y; Tu T; Zhang M; Huang H; Luo H; Zhang W; Su X</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Bacteria isolation &amp; purification</category>
      <category>Bacteria classification</category>
      <category>Bacteria genetics</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Humans</category>
      <category>Mice, Inbred C57BL</category>
      <category>Administration, Oral</category>
      <category>Dietary Fiber administration &amp; dosage</category>
      <category>Dietary Fiber metabolism</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Obesity diet therapy</category>
      <category>Obesity etiology</category>
      <category>Endo-1,4-beta Xylanases administration &amp; dosage</category>
      <category>Endo-1,4-beta Xylanases metabolism</category>
      <category>Metabolic Diseases microbiology</category>
      <category>Metabolic Diseases metabolism</category>
      <category>Metabolic Diseases drug therapy</category>
      <category>Metabolic Diseases diet therapy</category>
      <title>Ameliorating High-Fat Diet-Induced Obesity and Metabolic Disorders in Mice by Simultaneous Oral Administration of a Xylanase and Wheat Bran.</title>
      <description>Journal of agricultural and food chemistry; 05/27/2026&lt;br/&gt;(AN 42127269); ISSN: 1520-5118&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 27 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42127269</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42189938&amp;site=ehost-live&amp;scope=site</link>
      <author>Hashiuchi E; Inaba Y; Sugimoto H; Kimura K; Watanabe H; Kajino M; Asahara SI; Kobayashi M; Kikuchi O; Hayashi Y; Horike SI; Daikoku T; Mieda M; Sakurai T; Sakai M; Matsumoto M; Kitamura T; Sato M; Ravnskjaer K; Kasuga M; Tanida M; Kuroda S; Inoue H</author>
      <category>Nitric Oxide metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Obese</category>
      <category>Signal Transduction</category>
      <category>Mice, Inbred C57BL</category>
      <category>Vagus Nerve metabolism</category>
      <category>Vagus Nerve physiopathology</category>
      <category>Insulin metabolism</category>
      <category>Insulin blood</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <category>Obesity physiopathology</category>
      <category>Nitric Oxide Synthase Type I metabolism</category>
      <category>Nitric Oxide Synthase Type I genetics</category>
      <category>Insulin Secretion</category>
      <title>Vagal activation inhibits insulin release through neuronal nitric oxide synthase in obese male mice.</title>
      <description>Science signaling; 05/26/2026&lt;br/&gt;(AN 42189938); ISSN: 1937-9145&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 26 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42189938</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42189448&amp;site=ehost-live&amp;scope=site</link>
      <author>Landry MJ; Parker JJ</author>
      <category>Child</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Life Style</category>
      <category>Parenting</category>
      <category>Paternal Behavior</category>
      <category>Risk Factors</category>
      <category>Fathers psychology</category>
      <category>Pediatric Obesity prevention &amp; control</category>
      <category>Pediatric Obesity genetics</category>
      <category>Pediatric Obesity psychology</category>
      <category>Pediatric Obesity epidemiology</category>
      <category>Developmental Origins of Health and Disease</category>
      <category>Father-Child Relations</category>
      <category>Obesity</category>
      <title>The Role of Fathers in the Intergenerational Transmission of Obesity.</title>
      <description>Current obesity reports; 05/26/2026&lt;br/&gt;(AN 42189448); ISSN: 2162-4968&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 26 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42189448</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42183945&amp;site=ehost-live&amp;scope=site</link>
      <author>Piao X; Hang Y; Bai L; Wu M; Liu X; Yu J</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Immunity, Innate</category>
      <category>Cell Plasticity</category>
      <category>Epigenesis, Genetic</category>
      <category>Metabolic Reprogramming</category>
      <category>Obesity immunology</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Asthma metabolism</category>
      <category>Asthma etiology</category>
      <category>Asthma immunology</category>
      <category>Lymphocytes immunology</category>
      <category>Lymphocytes metabolism</category>
      <title>Metabolic Reprogramming and ILC2 Plasticity in Obesity-related Asthma.</title>
      <description>Clinical reviews in allergy &amp; immunology; 05/25/2026&lt;br/&gt;(AN 42183945); ISSN: 1559-0267&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 25 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42183945</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42183911&amp;site=ehost-live&amp;scope=site</link>
      <author>Peary A; Vaidya N; Jakicic J; Chao AM</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Obesity therapy</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Obesity Management methods</category>
      <category>Life Style</category>
      <title>To Reenvision and Redefine: Considering the Role of Lifestyle Interventions in the New Era of Second-Generation Obesity Management Medications.</title>
      <description>Current atherosclerosis reports; 05/25/2026&lt;br/&gt;(AN 42183911); ISSN: 1534-6242&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 25 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42183911</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42183965&amp;site=ehost-live&amp;scope=site</link>
      <author>García G; Candal-Pedreira C; Rey-Brandariz J; Cid LL; Pérez-Ríos M</author>
      <category>Cardiovascular Diseases mortality</category>
      <category>Neoplasms mortality</category>
      <category>Humans</category>
      <category>Body Mass Index</category>
      <category>Cause of Death</category>
      <category>Obesity mortality</category>
      <category>Obesity complications</category>
      <category>Overweight mortality</category>
      <title>How Have Researchers Estimated the Impact of Excess Weight on Mortality? A Systematic Review.</title>
      <description>Current obesity reports; 05/25/2026&lt;br/&gt;(AN 42183965); ISSN: 2162-4968&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 25 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42183965</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42177687&amp;site=ehost-live&amp;scope=site</link>
      <author>Ahmed H; Kärkkäinen O; Babu AF; Meuronen T; Koistinen V; Leclercq S; Amadieu C; Leyrolle Q; Neyrinck A; Rodriguez J; Csader S; Schwab U; Thissen JP; Starkel P; De Timary P; Layé S; Delzenne N; Hanhineva K</author>
      <category>Obesity metabolism</category>
      <category>Obesity therapy</category>
      <category>Obesity blood</category>
      <category>Metabolomics methods</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Feces chemistry</category>
      <category>Exercise physiology</category>
      <category>Plasma metabolism</category>
      <category>Metabolome</category>
      <title>Comparison of fecal and plasma metabolite correlations following nutrition or exercise interventions.</title>
      <description>Metabolomics : Official journal of the Metabolomic Society; 05/24/2026&lt;br/&gt;(AN 42177687); ISSN: 1573-3890&lt;br/&gt;MEDLINE</description>
      <pubDate>Sun, 24 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42177687</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42177698&amp;site=ehost-live&amp;scope=site</link>
      <author>Farooq S; Rana S; Siddiqui AJ; Iqbal A; Musharraf SG</author>
      <category>Metabolomics methods</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Case-Control Studies</category>
      <category>Adult</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Middle Aged</category>
      <category>Body Mass Index</category>
      <category>Gas Chromatography-Mass Spectrometry</category>
      <category>Genome-Wide Association Study</category>
      <category>Genotype</category>
      <category>Obesity genetics</category>
      <category>Obesity metabolism</category>
      <category>Membrane Proteins genetics</category>
      <category>Membrane Proteins metabolism</category>
      <category>Metabolome genetics</category>
      <title>Effect of TMEM18 rs7561317 on metabolome in context of obesity.</title>
      <description>Metabolomics : Official journal of the Metabolomic Society; 05/24/2026&lt;br/&gt;(AN 42177698); ISSN: 1573-3890&lt;br/&gt;MEDLINE</description>
      <pubDate>Sun, 24 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42177698</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42021739&amp;site=ehost-live&amp;scope=site</link>
      <author>Huang K; Huang Y; Zhang Y; Zhang Y; Hatch NW; Freed JK; Cai H</author>
      <category>Animals</category>
      <category>Mice, Knockout</category>
      <category>Mice</category>
      <category>Diet, High-Fat</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Obesity genetics</category>
      <category>Obesity enzymology</category>
      <category>Obesity metabolism</category>
      <category>Obesity pathology</category>
      <category>Obesity physiopathology</category>
      <category>NADPH Oxidase 1 genetics</category>
      <category>NADPH Oxidase 1 metabolism</category>
      <category>NADPH Oxidase 1 deficiency</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Muscle, Skeletal pathology</category>
      <category>Muscle, Skeletal enzymology</category>
      <category>Mitochondria, Muscle metabolism</category>
      <category>Mitochondria, Muscle pathology</category>
      <category>Mitochondria, Muscle enzymology</category>
      <category>Endothelial Cells enzymology</category>
      <category>Endothelium, Vascular enzymology</category>
      <title>Endothelial NOX1 Drives Obesity via Skeletal Muscle Mitochondrial Dysfunction.</title>
      <description>Circulation research; 05/22/2026&lt;br/&gt;(AN 42021739); ISSN: 1524-4571&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 22 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42021739</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42175433&amp;site=ehost-live&amp;scope=site</link>
      <author>Li J; Zhou L</author>
      <category>Humans</category>
      <category>Cross-Sectional Studies</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Nutrition Surveys</category>
      <category>Risk Factors</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Depression epidemiology</category>
      <category>Depression etiology</category>
      <category>Obesity psychology</category>
      <category>Obesity epidemiology</category>
      <category>Body Fat Distribution</category>
      <title>J-shaped association between body roundness index and depression: A large-scale cross-sectional study.</title>
      <description>Medicine; 05/22/2026&lt;br/&gt;(AN 42175433); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 22 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42175433</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42175452&amp;site=ehost-live&amp;scope=site</link>
      <author>Alayed K; Alshehri NA; Alsaedi GT; Binsalamh LF; Aldhalaan MA; Almutairi MA; Alobaid RA; Munahhi RS; Alrashidi RA; Alruwaili SA</author>
      <category>United States epidemiology</category>
      <category>Biomarkers blood</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Nutrition Surveys</category>
      <category>Insulin Resistance</category>
      <category>Body Mass Index</category>
      <category>Waist Circumference</category>
      <category>Triglycerides blood</category>
      <category>Blood Glucose analysis</category>
      <category>Obesity blood</category>
      <category>Obesity epidemiology</category>
      <category>Obesity diagnosis</category>
      <title>Triglyceride-glucose indices distinguish clinical from preclinical obesity in US adults: A cross-sectional study.</title>
      <description>Medicine; 05/22/2026&lt;br/&gt;(AN 42175452); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 22 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42175452</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42175494&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen X; Xiang C; Xia L; Li Q; Chen C</author>
      <category>Waist Circumference genetics</category>
      <category>Humans</category>
      <category>Mendelian Randomization Analysis</category>
      <category>Body Mass Index</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adiposity genetics</category>
      <category>Obesity genetics</category>
      <category>Obesity complications</category>
      <title>Unraveling the causal web of 4 adiposity indices and 92 multi-system outcomes: A body-wide Mendelian randomization study.</title>
      <description>Medicine; 05/22/2026&lt;br/&gt;(AN 42175494); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 22 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42175494</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42166447&amp;site=ehost-live&amp;scope=site</link>
      <author>Nakamura M; Yamazaki C; Hiromura K; Goto A; Hamazaki K</author>
      <category>Japan epidemiology</category>
      <category>Humans</category>
      <category>Middle Aged</category>
      <category>Male</category>
      <category>Female</category>
      <category>Retrospective Studies</category>
      <category>Aged</category>
      <category>Glomerular Filtration Rate</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>Kidney Function Tests</category>
      <category>East Asian People</category>
      <category>Kidney physiopathology</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Thinness physiopathology</category>
      <category>Thinness epidemiology</category>
      <category>Thinness complications</category>
      <category>Renal Insufficiency, Chronic epidemiology</category>
      <category>Renal Insufficiency, Chronic physiopathology</category>
      <category>Body Mass Index</category>
      <title>Analysis of the relationship between body mass index and kidney function decline in a middle-aged Japanese population: A population-based retrospective cohort study.</title>
      <description>PloS one; 05/21/2026&lt;br/&gt;(AN 42166447); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 21 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42166447</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42162527&amp;site=ehost-live&amp;scope=site</link>
      <author>Sul HH; Ahmad S; Danpanichkul P; Mantovani A; Souza M; Petrov MS</author>
      <category>Humans</category>
      <category>Magnetic Resonance Imaging</category>
      <category>Body Mass Index</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Diabetes Mellitus, Type 2 diagnostic imaging</category>
      <category>Pancreas diagnostic imaging</category>
      <category>Pancreas pathology</category>
      <category>Obesity complications</category>
      <category>Adipose Tissue diagnostic imaging</category>
      <title>Burden of Intrapancreatic Fat Deposition in Type 2 Diabetes and the Role of Obesity: A Systematic Review and Meta-Analysis.</title>
      <description>Current obesity reports; 05/21/2026&lt;br/&gt;(AN 42162527); ISSN: 2162-4968&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 21 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42162527</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41996653&amp;site=ehost-live&amp;scope=site</link>
      <category>United States epidemiology</category>
      <category>Overweight complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Prospective Studies</category>
      <category>Risk Factors</category>
      <category>Body Mass Index</category>
      <category>Aged</category>
      <category>Waist Circumference</category>
      <category>National Cancer Institute (U.S.)</category>
      <category>Cohort Studies</category>
      <category>Proportional Hazards Models</category>
      <category>Body Height</category>
      <category>Adult</category>
      <category>Urinary Bladder Neoplasms epidemiology</category>
      <category>Urinary Bladder Neoplasms etiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Body Size</category>
      <title>Body Size and Bladder Cancer Risk: A Pooled Analysis of Prospective Studies From the National Cancer Institute Cohort Consortium.</title>
      <description>Journal of clinical oncology : official journal of the American Society of Clinical Oncology; 05/20/2026&lt;br/&gt;(AN 41996653); ISSN: 1527-7755&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 20 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41996653</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41925581&amp;site=ehost-live&amp;scope=site</link>
      <author>Muniyappa R; Chukir T; Desai D; Weintraub MA; Corrigan MD; Gianchandani R; Rothberg AE</author>
      <category>Endocrinology standards</category>
      <category>Endocrinology organization &amp; administration</category>
      <category>Humans</category>
      <category>Body Mass Index</category>
      <category>Adiposity</category>
      <category>Obesity diagnosis</category>
      <category>Obesity classification</category>
      <category>Obesity therapy</category>
      <title>Defining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41925581); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41925581</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41466357&amp;site=ehost-live&amp;scope=site</link>
      <author>Chacko SR; Sharma SS; Ahmadian S; Saini J; Fell V; Peersen AF; Atkinson EJ; Gruber L; Van Gompel JJ; Simha V; Young WF Jr; Bancos I</author>
      <category>Hypertension epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Hydrocortisone metabolism</category>
      <category>Hydrocortisone blood</category>
      <category>Hyperlipidemias epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Prospective Studies</category>
      <category>Adult</category>
      <category>Comorbidity</category>
      <category>Remission Induction</category>
      <category>Treatment Outcome</category>
      <category>Cushing Syndrome surgery</category>
      <category>Cushing Syndrome epidemiology</category>
      <category>Cushing Syndrome complications</category>
      <category>Diabetes Mellitus epidemiology</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <title>Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41466357); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41466357</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41527361&amp;site=ehost-live&amp;scope=site</link>
      <author>Ayonrinde OT; Mori TA; Adams LA; Beilin LJ; Olynyk JK; Hart R</author>
      <category>Obesity epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adolescent</category>
      <category>Insulin Resistance</category>
      <category>Cardiometabolic Risk Factors</category>
      <category>Adult</category>
      <category>Longitudinal Studies</category>
      <category>Retrospective Studies</category>
      <category>Young Adult</category>
      <category>Polycystic Ovary Syndrome complications</category>
      <category>Polycystic Ovary Syndrome epidemiology</category>
      <category>Polycystic Ovary Syndrome metabolism</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <category>Cardiovascular Diseases etiology</category>
      <title>MASLD coexisting with PCOS increases cardiometabolic risk.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41527361); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41527361</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41507035&amp;site=ehost-live&amp;scope=site</link>
      <author>Pané A; Videla L; Viaplana J; Ibarzabal A; Molero J; Moize V; Lopez-Ruiz S; de Hollanda A; Ortega E; Barroeta I; Alcolea D; Camacho V; Vidal J; Chiva-Blanch G; Fortea J; Jiménez A</author>
      <category>Weight Loss physiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Prospective Studies</category>
      <category>Longitudinal Studies</category>
      <category>Middle Aged</category>
      <category>Case-Control Studies</category>
      <category>Leptin blood</category>
      <category>Leptin cerebrospinal fluid</category>
      <category>Obesity surgery</category>
      <category>Obesity blood</category>
      <category>Obesity cerebrospinal fluid</category>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity, Morbid blood</category>
      <category>Obesity, Morbid cerebrospinal fluid</category>
      <category>Bariatric Surgery</category>
      <title>Cerebrospinal fluid and plasma leptin dynamics following bariatric surgery in women.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41507035); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41507035</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41428372&amp;site=ehost-live&amp;scope=site</link>
      <author>Bogner B; Jung M; Reisert M; Maushagen J; Rospleszcz S; Nolde JM; Schlett CL; Bamberg F; Kammerlander A; Weiss J; Taron J</author>
      <category>United Kingdom epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Biological Specimen Banks</category>
      <category>Phenotype</category>
      <category>Aged</category>
      <category>Prospective Studies</category>
      <category>Magnetic Resonance Imaging</category>
      <category>Follow-Up Studies</category>
      <category>Risk Factors</category>
      <category>UK Biobank</category>
      <category>Metabolic Syndrome epidemiology</category>
      <category>Metabolic Syndrome complications</category>
      <category>Metabolic Syndrome pathology</category>
      <category>Metabolic Syndrome metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity pathology</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Cardiovascular Diseases mortality</category>
      <category>Cardiovascular Diseases pathology</category>
      <category>Cardiovascular Diseases metabolism</category>
      <category>Heart diagnostic imaging</category>
      <title>Associations of Metabolic Phenotypes with Cardiac Structure and Clinical Outcomes: Insights from the UK Biobank.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41428372); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41428372</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41402995&amp;site=ehost-live&amp;scope=site</link>
      <author>Belan M; Giguère-Johnson M; Carranza-Mamane B; Pesant MH; AinMelk Y; Langlois MF; Lavoie H; Greenblatt EM; Laredo S; Sagle M; Waddell G; Jean-Denis F; Baillargeon JP</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Pregnancy</category>
      <category>Young Adult</category>
      <category>Adolescent</category>
      <category>Pregnancy Rate</category>
      <category>Live Birth</category>
      <category>Reproductive Techniques, Assisted</category>
      <category>Polycystic Ovary Syndrome therapy</category>
      <category>Polycystic Ovary Syndrome complications</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Infertility, Female therapy</category>
      <category>Infertility, Female etiology</category>
      <category>Overweight therapy</category>
      <category>Overweight complications</category>
      <category>Life Style</category>
      <title>Lifestyle intervention before and during fertility treatment in women with obesity or with overweight and PCOS-a RCT.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41402995); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41402995</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41568975&amp;site=ehost-live&amp;scope=site</link>
      <author>Nordestgaard LT; Luo J; Emanuelsson F; Leyden G; Sanderson E; Davey Smith G; Christoffersen M; Afzal S; Benn M; Nordestgaard BG; Tybjærg-Hansen A; Frikke-Schmidt R</author>
      <category>Hypertension complications</category>
      <category>Hypertension epidemiology</category>
      <category>United Kingdom epidemiology</category>
      <category>Humans</category>
      <category>Mendelian Randomization Analysis</category>
      <category>Risk Factors</category>
      <category>Prospective Studies</category>
      <category>Male</category>
      <category>Female</category>
      <category>Aged</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Dementia, Vascular epidemiology</category>
      <category>Dementia, Vascular etiology</category>
      <category>Dementia, Vascular genetics</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Body Mass Index</category>
      <title>High Body Mass Index as a Causal Risk Factor for Vascular-Related Dementia: A Mendelian Randomization Study.</title>
      <description>The Journal of clinical endocrinology and metabolism; 05/19/2026&lt;br/&gt;(AN 41568975); ISSN: 1945-7197&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41568975</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42084042&amp;site=ehost-live&amp;scope=site</link>
      <author>Xiao L; Li R; Zhu X; Liu Z; Zhang R; Han G; Zhao T; Zhang Z; Geng J</author>
      <category>Nanoparticles chemistry</category>
      <category>Boron Compounds chemistry</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Photoacoustic Techniques methods</category>
      <category>Obesity diagnostic imaging</category>
      <category>Obesity metabolism</category>
      <category>Adipose Tissue diagnostic imaging</category>
      <category>Adipose Tissue metabolism</category>
      <category>Fluorescent Dyes chemistry</category>
      <category>Fluorescent Dyes pharmacology</category>
      <category>Hypoxia</category>
      <title>Hypoxia-Activated Probe for Targeted Photoacoustic Imaging and Photothermal Modulation of Adipose Tissue in Obesity.</title>
      <description>Analytical chemistry; 05/19/2026&lt;br/&gt;(AN 42084042); ISSN: 1520-6882&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42084042</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42154764&amp;site=ehost-live&amp;scope=site</link>
      <author>Yonekura Y; Tanno K; Higashiyama A; Okuda N; Nagahata T; Okayama A</author>
      <category>Japan epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>East Asian People</category>
      <category>Obesity economics</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Health Expenditures statistics &amp; numerical data</category>
      <category>Diabetes Mellitus economics</category>
      <category>Diabetes Mellitus therapy</category>
      <category>Diabetes Mellitus epidemiology</category>
      <title>Association between obesity and medical expenditures among Japanese adults treated for diabetes: A secondary analysis.</title>
      <description>PloS one; 05/19/2026&lt;br/&gt;(AN 42154764); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 19 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42154764</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42149945&amp;site=ehost-live&amp;scope=site</link>
      <author>Del Razo-Olvera FM; Arias-Marroquín AT; Martínez-Fajardo M; Dávila-Olmedo WE; Cruz Bautista I; Galán-Ramírez GA; Juárez-Martínez L; Gómez-Velasco DV; Guillén-Pineda LE; López Estrada A; Otero-Otero R; Elías-López D; Martagón-Rosado AJ; Aguilar-Salinas C; Soto-Mota A</author>
      <category>Obesity blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Leptin blood</category>
      <category>Postprandial Period physiology</category>
      <category>Adiponectin blood</category>
      <category>Dietary Carbohydrates administration &amp; dosage</category>
      <category>Dietary Fats administration &amp; dosage</category>
      <category>Meals</category>
      <category>Diet, High-Fat</category>
      <title>Postprandial response of leptin and adiponectin to standardized high-carbohydrate and high-fat meals in adults: A cross-sectional study.</title>
      <description>PloS one; 05/18/2026&lt;br/&gt;(AN 42149945); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 18 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42149945</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41740915&amp;site=ehost-live&amp;scope=site</link>
      <author>Mi Y; Guo J; Liu Y; Zhao J</author>
      <category>Overweight physiopathology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Young Adult</category>
      <category>Brain Mapping</category>
      <category>Body Mass Index</category>
      <category>Obesity physiopathology</category>
      <category>Brain physiopathology</category>
      <category>Electroencephalography</category>
      <title>Brain dynamics imbalance in obesity: Evidence from EEG microstate.</title>
      <description>Physiology &amp; behavior; 05/15/2026&lt;br/&gt;(AN 41740915); ISSN: 1873-507X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41740915</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41759565&amp;site=ehost-live&amp;scope=site</link>
      <author>Gadelmawla AF; Hammad N; Atta K; Diaa A; Abouzkaly F; Soni K; Kelkar R; Agrawal SP; Ahmed R; Jain H; Passey S; Aronow WS</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Obesity drug therapy</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>CagriSema Versus Semaglutide Monotherapy or Placebo for Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with GRADE Assessment.</title>
      <description>The American journal of cardiology; 05/15/2026&lt;br/&gt;(AN 41759565); ISSN: 1879-1913&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41759565</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42152301&amp;site=ehost-live&amp;scope=site</link>
      <author>Luan S; Nan J; Kong L; Li Q; Zheng X; Shang N</author>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>Chronic Disease epidemiology</category>
      <category>Obesity genetics</category>
      <category>Obesity epidemiology</category>
      <category>Ischemic Stroke genetics</category>
      <category>Ischemic Stroke epidemiology</category>
      <category>Humans</category>
      <category>Mendelian Randomization Analysis</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Genome-Wide Association Study</category>
      <category>Male</category>
      <category>Female</category>
      <category>Neuralgia, Postherpetic genetics</category>
      <category>Neuralgia, Postherpetic epidemiology</category>
      <category>Herpes Zoster genetics</category>
      <category>Herpes Zoster epidemiology</category>
      <title>Association between chronic diseases, herpes zoster and postherpetic neuralgia: A two-sample Mendelian randomization study.</title>
      <description>Medicine; 05/15/2026&lt;br/&gt;(AN 42152301); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42152301</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42152321&amp;site=ehost-live&amp;scope=site</link>
      <author>Chandika RM; Elfaki FA; Khalafalla HE; Khan M; Khalid OH; Hejri YM; Bani IA</author>
      <category>Saudi Arabia epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Overweight epidemiology</category>
      <category>Thinness epidemiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Cross-Sectional Studies</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Body Mass Index</category>
      <category>Prevalence</category>
      <category>Young Adult</category>
      <category>Tuberculosis epidemiology</category>
      <category>Diet statistics &amp; numerical data</category>
      <category>Nutritional Status</category>
      <category>Feeding Behavior</category>
      <title>Assessment of dietary patterns and nutritional status among tuberculosis patients in Saudi Arabia.</title>
      <description>Medicine; 05/15/2026&lt;br/&gt;(AN 42152321); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42152321</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42152373&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen J; Zuo J; Zhao J; Zhu X; Li X; Zhan P; Chen P; Nie Z; Fu Y; Wang H; Fu S</author>
      <category>Humans</category>
      <category>Body Mass Index</category>
      <category>Mendelian Randomization Analysis</category>
      <category>Inflammation</category>
      <category>Bayes Theorem</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>C-Reactive Protein metabolism</category>
      <category>C-Reactive Protein analysis</category>
      <category>Urinary Bladder Neoplasms etiology</category>
      <category>Urinary Bladder Neoplasms genetics</category>
      <category>Urinary Bladder Neoplasms blood</category>
      <category>Urinary Bladder Neoplasms epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity blood</category>
      <title>From fat to tumor: Exploring the inflammatory bridge via CRP in obesity-related bladder cancer.</title>
      <description>Medicine; 05/15/2026&lt;br/&gt;(AN 42152373); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42152373</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42036909&amp;site=ehost-live&amp;scope=site</link>
      <author>Kaur H; Kaushik D; Rasane P; Oz F; Proestos C; Kumar M</author>
      <category>Energy Metabolism drug effects</category>
      <category>Leptin metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Obesity metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <title>Molecular and Cellular Mechanisms of Anti-Obesity Agents: An Integrative Review.</title>
      <description>FASEB journal : official publication of the Federation of American Societies for Experimental Biology; 05/15/2026&lt;br/&gt;(AN 42036909); ISSN: 1530-6860&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42036909</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42065856&amp;site=ehost-live&amp;scope=site</link>
      <author>Gao Z; Li L; Luo X; Fu G; Mao R; Qu Y; Sun J; Zhao H; Zhang C</author>
      <category>Inflammation metabolism</category>
      <category>Inflammation pathology</category>
      <category>Endoribonucleases metabolism</category>
      <category>Cytokines metabolism</category>
      <category>Obesity complications</category>
      <category>Palmitic Acid adverse effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Gene Expression Profiling</category>
      <category>Gene Knockdown Techniques</category>
      <category>Spermatogenesis</category>
      <category>Mice, Inbred C57BL</category>
      <category>Sperm Count</category>
      <category>Endoplasmic Reticulum Stress</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Sertoli Cells metabolism</category>
      <category>NF-kappa B metabolism</category>
      <category>TNF Receptor-Associated Factor 2 metabolism</category>
      <category>Protein Serine-Threonine Kinases metabolism</category>
      <category>Signal Transduction</category>
      <title>High-Fat Diet Induces Inflammatory Injury in Mice Sertoli Cells via the IRE1α/TRAF2 Axis to Activate the NF-κB Signaling Pathway.</title>
      <description>FASEB journal : official publication of the Federation of American Societies for Experimental Biology; 05/15/2026&lt;br/&gt;(AN 42065856); ISSN: 1530-6860&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 15 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42065856</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42153149&amp;site=ehost-live&amp;scope=site</link>
      <author>Gao J; Wang Y</author>
      <category>China epidemiology</category>
      <category>Overweight epidemiology</category>
      <category>Overweight complications</category>
      <category>Thinness epidemiology</category>
      <category>Thinness complications</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Retrospective Studies</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>Body Mass Index</category>
      <category>Incidence</category>
      <category>Prevalence</category>
      <category>Young Adult</category>
      <category>Pre-Eclampsia epidemiology</category>
      <category>Pre-Eclampsia etiology</category>
      <category>Obesity epidemiology</category>
      <category>Obesity complications</category>
      <category>Gestational Weight Gain</category>
      <title>Pre-pregnancy obesity, not gestational weight gain, is a high-risk factor for pre-eclampsia: a retrospective study in Bengbu, China.</title>
      <description>PeerJ; 05/14/2026&lt;br/&gt;(AN 42153149); ISSN: 2167-8359&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 14 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42153149</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42118793&amp;site=ehost-live&amp;scope=site</link>
      <author>Kawashima M; Aoki T; Hamada H; Watanabe C; Oyanagi E; Kono T; Yamagata T; West NP; Yano H</author>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Fatty Acids, Volatile metabolism</category>
      <category>Feces microbiology</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Mice, Obese</category>
      <category>Fecal Microbiota Transplantation methods</category>
      <category>Inulin pharmacology</category>
      <category>Inulin administration &amp; dosage</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Obesity therapy</category>
      <category>Obesity etiology</category>
      <category>Obesity microbiology</category>
      <category>Obesity metabolism</category>
      <category>Physical Conditioning, Animal</category>
      <title>Continuous high-fat high-sugar diet overrides the therapeutic potential of fecal microbiota transplantation from exercised and/or inulin-conditioned donors in obese mice.</title>
      <description>PloS one; 05/12/2026&lt;br/&gt;(AN 42118793); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 12 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42118793</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42115518&amp;site=ehost-live&amp;scope=site</link>
      <author>Mayol D; Tecce N; Amatrudo F; Russo G; Aprano S; De Luca V; Iaccarino G; Illario M; Colao A; Moscatelli F; Vetrani C</author>
      <category>Obesity therapy</category>
      <category>Overweight therapy</category>
      <category>Humans</category>
      <category>Exercise</category>
      <category>Mobile Applications</category>
      <category>Body Composition</category>
      <category>Cardiometabolic Risk Factors</category>
      <category>Wearable Electronic Devices</category>
      <category>Diet</category>
      <category>Adult</category>
      <category>Cardiovascular Diseases prevention &amp; control</category>
      <category>Life Style</category>
      <category>Digital Technology</category>
      <title>Digital Solutions for the Control of Lifestyle Parameters in Individuals With High Cardiometabolic Risk: a Scoping Review.</title>
      <description>Current nutrition reports; 05/12/2026&lt;br/&gt;(AN 42115518); ISSN: 2161-3311&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 12 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42115518</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42115484&amp;site=ehost-live&amp;scope=site</link>
      <author>Yadav A; Manandhar S; Kloster A; Aradhyula V; Maddipati KR; Moukarbel GV; Kennedy DJ; Khouri SJ; Gupta R</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Aged</category>
      <category>Prospective Studies</category>
      <category>Middle Aged</category>
      <category>Echocardiography</category>
      <category>Cohort Studies</category>
      <category>Oxylipins blood</category>
      <category>Heart Failure blood</category>
      <category>Heart Failure physiopathology</category>
      <category>Heart Failure complications</category>
      <category>Heart Failure metabolism</category>
      <category>Obesity blood</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Stroke Volume physiology</category>
      <title>Obesity is associated with distinct oxylipins in heart failure with preserved ejection fraction.</title>
      <description>Metabolomics : Official journal of the Metabolomic Society; 05/11/2026&lt;br/&gt;(AN 42115484); ISSN: 1573-3890&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 11 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42115484</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42116300&amp;site=ehost-live&amp;scope=site</link>
      <author>Ibrahim IAE</author>
      <category>Saudi Arabia epidemiology</category>
      <category>Rural Population statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Cross-Sectional Studies</category>
      <category>Aged</category>
      <category>Prevalence</category>
      <category>Middle Aged</category>
      <category>Comorbidity</category>
      <category>Risk Factors</category>
      <category>Sex Factors</category>
      <category>Aged, 80 and over</category>
      <category>Exercise</category>
      <category>Obesity epidemiology</category>
      <title>Prevalence and predictors of obesity and related comorbidities among older adults in Bisha Province: A cross-sectional study.</title>
      <description>Medicine; 05/08/2026&lt;br/&gt;(AN 42116300); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42116300</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42116346&amp;site=ehost-live&amp;scope=site</link>
      <author>Chen J; Song C; Chen C; You M; Chen B</author>
      <category>Humans</category>
      <category>Mendelian Randomization Analysis</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Body Mass Index</category>
      <category>Waist-Hip Ratio</category>
      <category>Genome-Wide Association Study</category>
      <category>Risk Factors</category>
      <category>Male</category>
      <category>Genetic Predisposition to Disease</category>
      <category>Female</category>
      <category>Urolithiasis genetics</category>
      <category>Urolithiasis etiology</category>
      <category>Urolithiasis epidemiology</category>
      <category>Obesity genetics</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <title>Causal effects of obesity on urolithiasis and the mediating role of inflammatory factors: A two-sample Mendelian randomization study.</title>
      <description>Medicine; 05/08/2026&lt;br/&gt;(AN 42116346); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42116346</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42101776&amp;site=ehost-live&amp;scope=site</link>
      <author>Angarita-Plánchez ME; Sánchez-Rodríguez P; Múnera-Rodríguez AM; Leiva-Castro C; Benítez-Márquez JM; Reina-Pérez I; Palomares F; López-Enríquez S</author>
      <category>Adipose Tissue metabolism</category>
      <category>Biomarkers metabolism</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Insulin-Secreting Cells metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Insulin Resistance</category>
      <category>Signal Transduction</category>
      <category>Autophagy physiology</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Diabetes Mellitus, Type 2 physiopathology</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <title>Autophagy in Obesity and Type 2 Diabetes: Beyond the Protective Paradigm.</title>
      <description>Current obesity reports; 05/08/2026&lt;br/&gt;(AN 42101776); ISSN: 2162-4968&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42101776</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42090498&amp;site=ehost-live&amp;scope=site</link>
      <author>Duan X; Davis LM; Patel S; Bidault G; Long L; Jenkins B; Yi Y; Pushpa P; Wesseling JR; Koulman A; Vidal-Puig A; Fazakerley DJ; Savage DB</author>
      <category>Liver metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <category>Glucose metabolism</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Insulin metabolism</category>
      <category>Triglycerides metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Obesity metabolism</category>
      <category>Obesity diet therapy</category>
      <category>Insulin Resistance</category>
      <category>Caloric Restriction</category>
      <title>Integrated analysis of insulin resistance reveals metabolic remodeling following diet switch-triggered calorie reduction.</title>
      <description>Science advances; 05/08/2026&lt;br/&gt;(AN 42090498); ISSN: 2375-2548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42090498</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42100877&amp;site=ehost-live&amp;scope=site</link>
      <author>Wisessaowapak C; Skorobogatko Y; Kim H; Feng X; Son S; Fu H; Zhang S; Lertvilai P; Chang L; Hoang A; Chen H; Bedsted S; Valentine J; Huh JY; Zhao P; Reilly SM; Watcharasit P; Ahmadian M; Saltiel AR</author>
      <category>Aminoimidazole Carboxamide analogs &amp; derivatives</category>
      <category>Aminoimidazole Carboxamide pharmacology</category>
      <category>Fasting metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Energy Metabolism</category>
      <category>Signal Transduction</category>
      <category>Mice, Inbred C57BL</category>
      <category>Insulin Resistance</category>
      <category>Mice, Knockout</category>
      <category>Aminopyridines</category>
      <category>Ribonucleotides</category>
      <category>Protein Serine-Threonine Kinases metabolism</category>
      <category>Protein Serine-Threonine Kinases genetics</category>
      <category>Protein Serine-Threonine Kinases antagonists &amp; inhibitors</category>
      <category>AMP-Activated Protein Kinases metabolism</category>
      <category>Adipocytes metabolism</category>
      <category>Adipocytes drug effects</category>
      <category>Obesity metabolism</category>
      <title>A nutrient-responsive AMPK/TBK1 circuit restricts adipocyte catabolism.</title>
      <description>JCI insight; 05/08/2026&lt;br/&gt;(AN 42100877); ISSN: 2379-3708&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42100877</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41875890&amp;site=ehost-live&amp;scope=site</link>
      <author>Ji L; Jiang H; Cheng Z; Li X; Pang S; Zhang Y; Qiu W; Ma Q; Liu Z; Wang Y; Deng H; Du H; Han-Zhang H; Qian L</author>
      <category>Weight Loss drug effects</category>
      <category>Overweight drug therapy</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Double-Blind Method</category>
      <category>Middle Aged</category>
      <category>Body Mass Index</category>
      <category>Adult</category>
      <category>China</category>
      <category>Treatment Outcome</category>
      <category>East Asian People</category>
      <category>Peptides</category>
      <category>Obesity drug therapy</category>
      <category>Anti-Obesity Agents administration &amp; dosage</category>
      <category>Anti-Obesity Agents adverse effects</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Mazdutide 9 mg in Chinese adults with a body mass index ≥30 kg/m2 but without diabetes: A phase 2 randomized controlled trial.</title>
      <description>Med (New York, N.Y.); 05/08/2026&lt;br/&gt;(AN 41875890); ISSN: 2666-6340&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 08 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41875890</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41802488&amp;site=ehost-live&amp;scope=site</link>
      <author>McLeod A; Rullmann M; Hinderberger P; Böttcher Y; Müller I; Hankir MK; Becker GA; Blüher M; Regenthal R; Hilbert A; Sabri O; Hesse S</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Polymorphism, Single Nucleotide</category>
      <category>Positron-Emission Tomography</category>
      <category>Middle Aged</category>
      <category>Genotype</category>
      <category>Brain-Derived Neurotrophic Factor genetics</category>
      <category>Serotonin Plasma Membrane Transport Proteins metabolism</category>
      <category>Prefrontal Cortex metabolism</category>
      <category>Prefrontal Cortex diagnostic imaging</category>
      <category>Feeding Behavior physiology</category>
      <category>Obesity genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity diagnostic imaging</category>
      <title>BDNF Val66Met polymorphism is linked to elevated levels of serotonin-transporter in the medial prefrontal cortex but not to altered eating behavior.</title>
      <description>Neuroscience; 05/07/2026&lt;br/&gt;(AN 41802488); ISSN: 1873-7544&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 07 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41802488</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41504714&amp;site=ehost-live&amp;scope=site</link>
      <author>van der Linden BWA; Viehl CA; Noor N; Adair T; Vaccarella S; Carmeli C</author>
      <category>Switzerland epidemiology</category>
      <category>Cause of Death trends</category>
      <category>Mortality trends</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Prevalence</category>
      <category>Cardiovascular Diseases mortality</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Neoplasms mortality</category>
      <category>Neoplasms etiology</category>
      <category>Obesity mortality</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <title>Trends in obesity-related cardiovascular and cancer mortality in Switzerland 1995-2019: an analysis of multiple causes of death.</title>
      <description>American journal of epidemiology; 05/07/2026&lt;br/&gt;(AN 41504714); ISSN: 1476-6256&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 07 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41504714</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41980777&amp;site=ehost-live&amp;scope=site</link>
      <author>Cudic M; Tubbs JD; Ge T; Smoller JW</author>
      <category>Major Depressive Disorder genetics</category>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>United Kingdom epidemiology</category>
      <category>Coronary Artery Disease genetics</category>
      <category>Obesity genetics</category>
      <category>Asthma genetics</category>
      <category>Atrial Fibrillation genetics</category>
      <category>Hypercholesterolemia genetics</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>Odds Ratio</category>
      <category>Genome-Wide Association Study</category>
      <category>Multifactorial Inheritance genetics</category>
      <category>Genetic Predisposition to Disease</category>
      <title>Putting polygenic scores in context: How intersectional factors affect relative and absolute genetic risk.</title>
      <description>American journal of human genetics; 05/07/2026&lt;br/&gt;(AN 41980777); ISSN: 1537-6605&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 07 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41980777</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42095976&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang G; Yang X; Wang K; Li X; Dai Z; Qiao S</author>
      <category>HIV-1 pathogenicity</category>
      <category>Hemoglobins metabolism</category>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Viral Load</category>
      <category>CD4 Lymphocyte Count</category>
      <category>Hematocrit</category>
      <category>Prevalence</category>
      <category>Risk Factors</category>
      <category>AIDS Dementia Complex virology</category>
      <category>AIDS Dementia Complex epidemiology</category>
      <category>AIDS Dementia Complex psychology</category>
      <category>HIV Infections complications</category>
      <category>HIV Infections virology</category>
      <category>Substance-Related Disorders complications</category>
      <category>Substance-Related Disorders virology</category>
      <title>Clinical and behavioral predictors of HIV-associated neurocognitive disorder among people with HIV who use substances: a secondary analysis of the HOPE trial.</title>
      <description>Journal of neurovirology; 05/07/2026&lt;br/&gt;(AN 42095976); ISSN: 1538-2443&lt;br/&gt;MEDLINE</description>
      <pubDate>Thu, 07 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42095976</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42035234&amp;site=ehost-live&amp;scope=site</link>
      <author>Pereira S</author>
      <category>Obesity metabolism</category>
      <category>Receptors, Leptin metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Signal Transduction</category>
      <category>Leptin metabolism</category>
      <category>Leptin physiology</category>
      <category>Cardiovascular Diseases metabolism</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Cardiovascular System metabolism</category>
      <title>Leptin and cardiovascular health.</title>
      <description>Endocrinology; 05/06/2026&lt;br/&gt;(AN 42035234); ISSN: 1945-7170&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 06 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42035234</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42046378&amp;site=ehost-live&amp;scope=site</link>
      <author>Shen HX; Shi L; Li YX; Zhang XY; Zhao CQ; Ma H; Lu YM</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Triglycerides metabolism</category>
      <category>Lipid Metabolism drug effects</category>
      <category>Fruit chemistry</category>
      <category>Sirtuin 1 metabolism</category>
      <category>Sirtuin 1 genetics</category>
      <category>Sterol Regulatory Element Binding Protein 1 metabolism</category>
      <category>Sterol Regulatory Element Binding Protein 1 genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Animals</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Hep G2 Cells</category>
      <category>Pomegranate chemistry</category>
      <category>Polysaccharides chemistry</category>
      <category>Polysaccharides administration &amp; dosage</category>
      <category>Prebiotics analysis</category>
      <category>Prebiotics administration &amp; dosage</category>
      <category>Plant Extracts administration &amp; dosage</category>
      <category>Plant Extracts chemistry</category>
      <category>Hypolipidemic Agents administration &amp; dosage</category>
      <category>Hypolipidemic Agents chemistry</category>
      <title>A Neutral Triple-Helix Pomegranate (Punica granatum) Peel Polysaccharide with Lipid-Lowering and Prebiotic Activities.</title>
      <description>Journal of agricultural and food chemistry; 05/06/2026&lt;br/&gt;(AN 42046378); ISSN: 1520-5118&lt;br/&gt;MEDLINE</description>
      <pubDate>Wed, 06 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42046378</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42066046&amp;site=ehost-live&amp;scope=site</link>
      <author>Peng Y; Shi X; Wang Y; Jia L; Li T; Cai Z; Li H; Zhang J; Wang Y</author>
      <category>AMP-Activated Protein Kinases metabolism</category>
      <category>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha metabolism</category>
      <category>Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <category>Cell Nucleus metabolism</category>
      <category>Adipose Tissue metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Signal Transduction</category>
      <category>Phosphorylation</category>
      <category>Mice, Knockout</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Thermogenesis physiology</category>
      <category>Cold Temperature</category>
      <title>Cellular Feimin promotes cold-induced thermogenesis.</title>
      <description>Proceedings of the National Academy of Sciences of the United States of America; 05/05/2026&lt;br/&gt;(AN 42066046); ISSN: 1091-6490&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 05 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42066046</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41844147&amp;site=ehost-live&amp;scope=site</link>
      <author>Kim MS; Chen Q; Sui Y; Yang X; Wang S; Weng LC; Cho SMJ; Koyama S; Zhu X; Yu K; Chen X; Zhang R; Yin W; Liao S; Liu Z; Alkuraya FS; Natarajan P; Ellinor PT; Fahed AC; Wang M</author>
      <category>Humans</category>
      <category>Genome-Wide Association Study</category>
      <category>Risk Factors</category>
      <category>Genetic Predisposition to Disease</category>
      <category>Female</category>
      <category>Male</category>
      <category>Genetic Risk Score</category>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>Obesity genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity epidemiology</category>
      <category>Multifactorial Inheritance genetics</category>
      <title>Metabolic polygenic risk scores for prediction of obesity, type 2 diabetes, and related morbidities.</title>
      <description>Cell metabolism; 05/05/2026&lt;br/&gt;(AN 41844147); ISSN: 1932-7420&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 05 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41844147</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42025169&amp;site=ehost-live&amp;scope=site</link>
      <author>Tsang AH; Heeley N; Alcaino C; Hwang E; Lam BY; Rahman T; Darwish T; Nuzzaci D; Kay RG; Sarkar A; Wang R; Basha N; Punnoose A; Kirwan P; Ma M; Yeo GS; Merkle FT; Gribble FM; Reinmann F; Williams KW; Blouet C</author>
      <category>Hypothalamus metabolism</category>
      <category>Pro-Opiomelanocortin metabolism</category>
      <category>Obesity metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Mice, Knockout</category>
      <category>Leucine metabolism</category>
      <category>Neurons metabolism</category>
      <category>Neurons drug effects</category>
      <category>Weight Loss drug effects</category>
      <category>Dietary Proteins pharmacology</category>
      <category>Dietary Proteins metabolism</category>
      <category>Calcium Channels, T-Type metabolism</category>
      <category>Calcium Channels, T-Type genetics</category>
      <category>Satiety Response drug effects</category>
      <title>Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary protein.</title>
      <description>Cell metabolism; 05/05/2026&lt;br/&gt;(AN 42025169); ISSN: 1932-7420&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 05 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42025169</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41812649&amp;site=ehost-live&amp;scope=site</link>
      <author>Tiash S; Patel SA; Russo M; Suresh A; Pang B; Pai YL; Jia W; Field RL; Pietka T; Abumrad NA; Smith GI; Samovski D; Klein S; Brestoff JR; Crewe C</author>
      <category>Obesity metabolism</category>
      <category>Obesity immunology</category>
      <category>Obesity pathology</category>
      <category>Adipose Tissue metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Mice, Inbred C57BL</category>
      <category>Male</category>
      <category>Signal Transduction</category>
      <category>Extracellular Vesicles metabolism</category>
      <category>Adipocytes metabolism</category>
      <category>Macrophages metabolism</category>
      <title>Immune cells regulate circulating adipocyte extracellular vesicle levels in response to metabolic shifts.</title>
      <description>Cell metabolism; 05/05/2026&lt;br/&gt;(AN 41812649); ISSN: 1932-7420&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 05 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41812649</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42085441&amp;site=ehost-live&amp;scope=site</link>
      <author>WalyEldeen AA; Mohamed G; Taha SN; Gameel AM; Talat LY; Hassan H; Ibrahim SA</author>
      <category>Biomarkers, Tumor blood</category>
      <category>Biomarkers, Tumor metabolism</category>
      <category>Fibronectins metabolism</category>
      <category>Fibronectins blood</category>
      <category>von Willebrand Factor metabolism</category>
      <category>Syndecan-2 metabolism</category>
      <category>Syndecan-2 blood</category>
      <category>Obesity complications</category>
      <category>Obesity blood</category>
      <category>Triple Negative Breast Neoplasms blood</category>
      <category>Triple Negative Breast Neoplasms pathology</category>
      <category>Triple Negative Breast Neoplasms metabolism</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Neoadjuvant Therapy</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Blood Proteins</category>
      <category>Galectins</category>
      <category>Extracellular Vesicles metabolism</category>
      <category>Proteomics methods</category>
      <category>Breast Neoplasms blood</category>
      <category>Breast Neoplasms pathology</category>
      <category>Breast Neoplasms metabolism</category>
      <title>Plasma small-extracellular vesicles' proteomic signature in neoadjuvant chemotherapy-naïve breast cancer patients.</title>
      <description>PloS one; 05/05/2026&lt;br/&gt;(AN 42085441); ISSN: 1932-6203&lt;br/&gt;MEDLINE</description>
      <pubDate>Tue, 05 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42085441</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42011518&amp;site=ehost-live&amp;scope=site</link>
      <author>Rajendiran R; Pathak S; Kumar A; Bhaumik S; Amit S; Pydi SP; Jayandharan GR</author>
      <category>MicroRNAs genetics</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Blood Glucose metabolism</category>
      <category>Insulin metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Mice, Obese</category>
      <category>Mice, Inbred C57BL</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Fibroblast Growth Factors genetics</category>
      <category>Fibroblast Growth Factors metabolism</category>
      <category>Genetic Therapy methods</category>
      <category>Dependovirus genetics</category>
      <category>Obesity therapy</category>
      <category>Genetic Vectors genetics</category>
      <title>Combination Gene Therapy with AAV-Based Vectors Ameliorates the Phenotype of Type 2 Diabetes in Diet-Induced Obese and db/db Mice.</title>
      <description>Molecular pharmaceutics; 05/04/2026&lt;br/&gt;(AN 42011518); ISSN: 1543-8392&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 04 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42011518</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42081471&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang J; Li H; Shi W; Ren X; Liu Y; Mao L; Wang D; Zhang T; Zhang Z; Zheng H; Yang X; Yao M; Chen Z</author>
      <category>Biomarkers metabolism</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Computational Biology</category>
      <category>Machine Learning</category>
      <category>Molecular Docking Simulation</category>
      <category>Male</category>
      <category>Gastrointestinal Microbiome physiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <category>Obesity microbiology</category>
      <category>Sarcopenia metabolism</category>
      <category>Sarcopenia genetics</category>
      <category>Sarcopenia epidemiology</category>
      <title>Co-morbid biomarkers for sarcopenic obesity associated with gut microbiota metabolites: From burden to treatment.</title>
      <description>PLoS computational biology; 05/04/2026&lt;br/&gt;(AN 42081471); ISSN: 1553-7358&lt;br/&gt;MEDLINE</description>
      <pubDate>Mon, 04 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42081471</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42068433&amp;site=ehost-live&amp;scope=site</link>
      <author>Denney DE; Marmura MJ</author>
      <category>Weight Loss physiology</category>
      <category>Exercise physiology</category>
      <category>Humans</category>
      <category>Migraine Disorders therapy</category>
      <category>Migraine Disorders metabolism</category>
      <category>Migraine Disorders complications</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Metabolic Syndrome therapy</category>
      <category>Metabolic Syndrome complications</category>
      <title>Metabolic Dysfunction and Metabolic Management in Episodic Migraine.</title>
      <description>Current pain and headache reports; 05/02/2026&lt;br/&gt;(AN 42068433); ISSN: 1534-3081&lt;br/&gt;MEDLINE</description>
      <pubDate>Sat, 02 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42068433</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41687777&amp;site=ehost-live&amp;scope=site</link>
      <author>Luo P; Liu S; Wang H; Zhang B; Han T; Jin Z</author>
      <category>Humans</category>
      <category>Cross-Sectional Studies</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Body Mass Index</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Nutrition Surveys</category>
      <category>Arthritis, Rheumatoid epidemiology</category>
      <category>Arthritis, Rheumatoid etiology</category>
      <category>Osteoarthritis epidemiology</category>
      <category>Osteoarthritis etiology</category>
      <category>Obesity epidemiology</category>
      <category>Obesity complications</category>
      <category>Body Size</category>
      <title>Association between adult body size index and osteoarthritis/rheumatoid arthritis: a cross-sectional study.</title>
      <description>The American journal of the medical sciences; 05/01/2026&lt;br/&gt;(AN 41687777); ISSN: 1538-2990&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41687777</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41869837&amp;site=ehost-live&amp;scope=site</link>
      <author>Kyere-Davies G; Hill KB; Mullen GP; Varshney RR; Das S; Martinez A; Farriester JW; Kinter M; Mitchell CM; Short KR; Isganaitis EM; Fields DA; Rudolph MC</author>
      <category>Animals</category>
      <category>Female</category>
      <category>Mice</category>
      <category>Oxidation-Reduction</category>
      <category>Pregnancy</category>
      <category>Mice, Inbred C57BL</category>
      <category>Lactation metabolism</category>
      <category>Lactation physiology</category>
      <category>Fatty Acids metabolism</category>
      <category>Mammary Glands, Animal metabolism</category>
      <category>Physical Conditioning, Animal physiology</category>
      <category>Lipid Metabolism physiology</category>
      <category>Milk metabolism</category>
      <category>Milk chemistry</category>
      <category>Obesity metabolism</category>
      <category>Pregnancy in Obesity metabolism</category>
      <title>Maternal exercise during lactation remodels obesity-associated mammary metabolism and milk fatty acids, enhancing offspring lipid oxidation.</title>
      <description>American journal of physiology. Endocrinology and metabolism; 05/01/2026&lt;br/&gt;(AN 41869837); ISSN: 1522-1555&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41869837</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41873824&amp;site=ehost-live&amp;scope=site</link>
      <author>Morano C; Centofanti L; Dei Cas M; Zanzi R; De Pinto G; Bignotto M; Zermiani P; Bianco E; Samartin F; Penati S; Pes I; Goggi I; Senesi P; Serrao G; Bucciarelli L; Bravi F; Russo A; Trinchera M; Battezzati PM; Ferraroni M; Folli F; Paroni R</author>
      <category>Overweight blood</category>
      <category>Sphingomyelins blood</category>
      <category>Ceramides blood</category>
      <category>Fasting blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Sphingolipids blood</category>
      <category>Blood Glucose metabolism</category>
      <category>Obesity blood</category>
      <category>Obesity metabolism</category>
      <category>Body Mass Index</category>
      <title>The interaction between glucose levels and body mass index on the regulation of the circulating sphingolipidome in humans.</title>
      <description>American journal of physiology. Endocrinology and metabolism; 05/01/2026&lt;br/&gt;(AN 41873824); ISSN: 1522-1555&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41873824</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41800787&amp;site=ehost-live&amp;scope=site</link>
      <author>Yang B; Ha J; Sherman AS</author>
      <category>Insulin-Secreting Cells metabolism</category>
      <category>Sulfonylurea Receptors genetics</category>
      <category>Blood Glucose metabolism</category>
      <category>Humans</category>
      <category>Disease Progression</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Longitudinal Studies</category>
      <category>Diabetes Mellitus, Type 2 genetics</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Hyperinsulinism metabolism</category>
      <category>Hyperinsulinism genetics</category>
      <category>Insulin metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity complications</category>
      <category>Obesity genetics</category>
      <category>Insulin Resistance</category>
      <category>Models, Theoretical</category>
      <category>Models, Biological</category>
      <title>Is high insulin protective or detrimental? Mathematical modeling reveals the base of the iceberg.</title>
      <description>American journal of physiology. Endocrinology and metabolism; 05/01/2026&lt;br/&gt;(AN 41800787); ISSN: 1522-1555&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41800787</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41926630&amp;site=ehost-live&amp;scope=site</link>
      <author>Estafanos S; West D; Koussiouris A; Moore DR; Gillen JB</author>
      <category>Blood Glucose metabolism</category>
      <category>Blood Glucose analysis</category>
      <category>Insulin metabolism</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Oxidation-Reduction</category>
      <category>Breath Tests</category>
      <category>Glucose Tolerance Test</category>
      <category>Aged</category>
      <category>Young Adult</category>
      <category>Postprandial Period</category>
      <category>Adolescent</category>
      <category>Sex Characteristics</category>
      <category>Sex Factors</category>
      <category>Carbon Isotopes</category>
      <category>Body Mass Index</category>
      <category>Insulin Resistance</category>
      <category>Obesity metabolism</category>
      <category>Glucose metabolism</category>
      <title>Sex differences in exogenous glucose oxidation are attenuated by obesity: insights from a [U-13C6]glucose home breath test.</title>
      <description>American journal of physiology. Endocrinology and metabolism; 05/01/2026&lt;br/&gt;(AN 41926630); ISSN: 1522-1555&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41926630</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41921473&amp;site=ehost-live&amp;scope=site</link>
      <author>Dutta P; Ganduboina R; Sinha A; Hosseinzadeh S; Shariat M; Palagati K; Muderrisoglu C; Mukherjee I</author>
      <category>United States epidemiology</category>
      <category>Cholecystectomy, Laparoscopic adverse effects</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Retrospective Studies</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Hospital Mortality</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Obesity complications</category>
      <category>Robotic Surgical Procedures adverse effects</category>
      <category>Robotic Surgical Procedures statistics &amp; numerical data</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications etiology</category>
      <category>Gallbladder Diseases surgery</category>
      <category>Gallbladder Diseases complications</category>
      <category>Cholecystectomy adverse effects</category>
      <category>Cholecystectomy methods</category>
      <title>In-Hospital Outcomes of Robotic-Assisted Cholecystectomy in Obese versus Normal-Weight Patients: A National Inpatient Sample Analysis.</title>
      <description>The Journal of surgical research; 05/01/2026&lt;br/&gt;(AN 41921473); ISSN: 1095-8673&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41921473</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41651392&amp;site=ehost-live&amp;scope=site</link>
      <author>Amato AL; Gualtieri P; Cirillo M; La Placa G; Frank G; Cianci R; Di Renzo L</author>
      <category>Humans</category>
      <category>Food Addiction therapy</category>
      <category>Food Addiction psychology</category>
      <category>Food Addiction complications</category>
      <category>Food Addiction physiopathology</category>
      <category>Obesity therapy</category>
      <category>Obesity psychology</category>
      <category>Feeding and Eating Disorders therapy</category>
      <category>Feeding and Eating Disorders psychology</category>
      <title>The impact of food addiction on the treatment of eating disorders and obesity: A systematic review.</title>
      <description>Physiology &amp; behavior; 05/01/2026&lt;br/&gt;(AN 41651392); ISSN: 1873-507X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41651392</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41722634&amp;site=ehost-live&amp;scope=site</link>
      <author>Kyriakoulis I; Sunil Kumar S; Palaiodimos L; Kokkinidis DG</author>
      <category>Humans</category>
      <category>Computed Tomography Angiography methods</category>
      <category>Coronary Artery Disease diagnostic imaging</category>
      <category>Coronary Artery Disease complications</category>
      <category>Coronary Artery Disease epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Coronary Angiography methods</category>
      <category>Body Mass Index</category>
      <title>Noninvasive Imaging Modalities for the Evaluation of Coronary Artery Disease Among Patients With High Body Mass Index: A Focus on Coronary Computed Tomography Angiography (CCTA).</title>
      <description>The American journal of cardiology; 05/01/2026&lt;br/&gt;(AN 41722634); ISSN: 1879-1913&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41722634</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41679408&amp;site=ehost-live&amp;scope=site</link>
      <author>Sharma S; Giri G; Desai A; Ruiz J; Gomez V; Goswami R</author>
      <category>Humans</category>
      <category>Bariatric Surgery</category>
      <category>Quality of Life</category>
      <category>Heart Failure complications</category>
      <category>Heart Failure therapy</category>
      <category>Heart Failure epidemiology</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Disease Management</category>
      <title>Managing Obesity in Heart Failure Patients: Current Evidence and Strategies.</title>
      <description>The American journal of cardiology; 05/01/2026&lt;br/&gt;(AN 41679408); ISSN: 1879-1913&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41679408</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41763500&amp;site=ehost-live&amp;scope=site</link>
      <author>Gironès-Garreta A; Gómez-Roncal S; García-Aranda A; Calvo E; Arola-Arnal A; Aragonès G; Mulero M</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>ARNTL Transcription Factors genetics</category>
      <category>ARNTL Transcription Factors metabolism</category>
      <category>Antioxidants metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Female</category>
      <category>Rats</category>
      <category>Oxidation-Reduction</category>
      <category>Homeostasis</category>
      <category>Oxidative Stress</category>
      <category>Circadian Rhythm</category>
      <category>Sex Factors</category>
      <category>Lipid Metabolism</category>
      <category>NF-E2-Related Factor 2 metabolism</category>
      <category>NF-E2-Related Factor 2 genetics</category>
      <category>Melatonin metabolism</category>
      <category>Melatonin genetics</category>
      <category>Obesity metabolism</category>
      <category>Obesity etiology</category>
      <category>Obesity pathology</category>
      <category>Obesity genetics</category>
      <category>Liver metabolism</category>
      <category>Liver pathology</category>
      <category>Photoperiod</category>
      <title>Sex and photoperiod shape hepatic redox homeostasis in diet-induced obesity in association with a melatonin-NRF2-circadian regulatory axis.</title>
      <description>Free radical biology &amp; medicine; 05/01/2026&lt;br/&gt;(AN 41763500); ISSN: 1873-4596&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41763500</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41989288&amp;site=ehost-live&amp;scope=site</link>
      <author>VanWinkle CK; Howard R; Sow MK; Finks J; Shao JM; Obeid N; Jackson HT</author>
      <category>Cholecystectomy methods</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Treatment Outcome</category>
      <category>Registries</category>
      <category>Retrospective Studies</category>
      <category>Cholecystectomy, Laparoscopic trends</category>
      <category>Cholecystectomy, Laparoscopic statistics &amp; numerical data</category>
      <category>Cholecystectomy, Laparoscopic adverse effects</category>
      <category>Robotic Surgical Procedures trends</category>
      <category>Robotic Surgical Procedures statistics &amp; numerical data</category>
      <category>Obesity complications</category>
      <category>Body Mass Index</category>
      <title>Trends in Use and Outcomes of Laparoscopic vs Robotic Cholecystectomy Based on BMI: A Statewide Analysis.</title>
      <description>Journal of the American College of Surgeons; 05/01/2026&lt;br/&gt;(AN 41989288); ISSN: 1879-1190&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41989288</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41770554&amp;site=ehost-live&amp;scope=site</link>
      <author>Alexander GC; Xiao X; Dilek S; Lewis S; Deng Q; Kim M; Bolanle D; Saldanha IJ; Mehta HB</author>
      <category>Liraglutide therapeutic use</category>
      <category>Glucagon-Like Peptides analogs &amp; derivatives</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Exenatide therapeutic use</category>
      <category>Humans</category>
      <category>Glycated Hemoglobin</category>
      <category>Adult</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Body Mass Index</category>
      <category>Treatment Effect Heterogeneity</category>
      <category>Immunoglobulin Fc Fragments</category>
      <category>Recombinant Fusion Proteins</category>
      <category>Weight Loss drug effects</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Obesity drug therapy</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis.</title>
      <description>JAMA internal medicine; 05/01/2026&lt;br/&gt;(AN 41770554); ISSN: 2168-6114&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41770554</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41974004&amp;site=ehost-live&amp;scope=site</link>
      <author>Escudero C; Havranek K; Martinez Cruz M; Batch B</author>
      <category>Glycated Hemoglobin analysis</category>
      <category>Humans</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Hypoglycemic Agents adverse effects</category>
      <category>Obesity drug therapy</category>
      <category>Endocrinology trends</category>
      <title>Endocrinology: What You May Have Missed in 2025.</title>
      <description>Annals of internal medicine; 05/01/2026&lt;br/&gt;(AN 41974004); ISSN: 1539-3704&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41974004</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41655957&amp;site=ehost-live&amp;scope=site</link>
      <author>So J; Wann J; Kim K; Taleb S; Kim HG; Kumari M; Banks AS; Dong XC; Roh HC</author>
      <category>Animals</category>
      <category>Mice</category>
      <category>Diet, High-Fat</category>
      <category>Male</category>
      <category>Hypertrophy</category>
      <category>Mice, Inbred C57BL</category>
      <category>3T3-L1 Cells</category>
      <category>Mice, Knockout</category>
      <category>Insulin Resistance</category>
      <category>Serum Response Factor metabolism</category>
      <category>Serum Response Factor genetics</category>
      <category>Serum Response Factor physiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity pathology</category>
      <category>Obesity genetics</category>
      <category>Adipocytes metabolism</category>
      <category>Adipocytes pathology</category>
      <category>Actin Cytoskeleton metabolism</category>
      <title>Serum Response Factor (SRF) promotes actin cytoskeletal organization in adipocytes to support adaptive hypertrophic expansion and tissue remodeling during obesity in mice.</title>
      <description>Metabolism: clinical and experimental; 05/01/2026&lt;br/&gt;(AN 41655957); ISSN: 1532-8600&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41655957</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41654010&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhu R; Guo J; Huttunen-Lenz M; Stratton G; Swindell N; Macdonald IA; Handjieva-Darlenska T; Handjiev S; Navas-Carretero S; Poppitt SD; Silvestre M; Schlicht W; Fogelholm M; Martinez JA; Raben A; Brand-Miller J</author>
      <category>Obesity therapy</category>
      <category>Obesity metabolism</category>
      <category>Overweight therapy</category>
      <category>Blood Glucose metabolism</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Weight Loss</category>
      <category>Remission Induction</category>
      <category>Prediabetic State metabolism</category>
      <category>Prediabetic State therapy</category>
      <category>Insulin Resistance physiology</category>
      <category>Diabetes Mellitus, Type 2 prevention &amp; control</category>
      <category>Diabetes Mellitus, Type 2 metabolism</category>
      <category>Liver metabolism</category>
      <category>Life Style</category>
      <title>Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial.</title>
      <description>Metabolism: clinical and experimental; 05/01/2026&lt;br/&gt;(AN 41654010); ISSN: 1532-8600&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41654010</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41328701&amp;site=ehost-live&amp;scope=site</link>
      <author>López Carpintero N; Giráldez-García C; Carmona Camacho R</author>
      <category>Pregnancy Trimesters blood</category>
      <category>Obesity epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Leukocyte Count</category>
      <category>Young Adult</category>
      <category>Leukocytosis etiology</category>
      <category>Leukocytosis epidemiology</category>
      <category>Leukocytosis blood</category>
      <category>Pregnancy Complications epidemiology</category>
      <category>Pregnancy Complications etiology</category>
      <category>Pregnancy Complications blood</category>
      <category>Smoking adverse effects</category>
      <category>Smoking epidemiology</category>
      <category>Tobacco Use adverse effects</category>
      <category>Tobacco Use epidemiology</category>
      <title>Leukocytosis and tobacco use during pregnancy.</title>
      <description>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics; 05/01/2026&lt;br/&gt;(AN 41328701); ISSN: 1879-3479&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41328701</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41739005&amp;site=ehost-live&amp;scope=site</link>
      <author>Tavaglione F; Vaz J; Jamialahmadi O; Díaz LA; Ajmera V; Contrano D; Madamba E; Singh S; Bettencourt R; Richards L; Hagström H; Loomba R</author>
      <category>Biomarkers blood</category>
      <category>California epidemiology</category>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Predictive Value of Tests</category>
      <category>Elasticity Imaging Techniques</category>
      <category>Prospective Studies</category>
      <category>Magnetic Resonance Imaging</category>
      <category>Aged</category>
      <category>Reproducibility of Results</category>
      <category>Glycerophospholipids blood</category>
      <category>Fatty Liver blood</category>
      <category>Fatty Liver diagnosis</category>
      <category>Fatty Liver, Alcoholic blood</category>
      <category>Fatty Liver, Alcoholic diagnosis</category>
      <category>Liver Diseases, Alcoholic blood</category>
      <category>Liver Diseases, Alcoholic diagnosis</category>
      <title>The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol Use.</title>
      <description>Gastroenterology; 05/01/2026&lt;br/&gt;(AN 41739005); ISSN: 1528-0012&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41739005</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41345374&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhang X; Zhao L; Campbell PT; Chen Y; Fang A; Liu Z; Li X; Yang W; Fan J; Petrick JL; McGlynn KA; Lai M; Zhang X</author>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>United Kingdom epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Alcohol Drinking adverse effects</category>
      <category>Alcohol Drinking epidemiology</category>
      <category>Smoking adverse effects</category>
      <category>Smoking epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Middle Aged</category>
      <category>Genetic Predisposition to Disease</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Liver Neoplasms epidemiology</category>
      <category>Liver Neoplasms genetics</category>
      <category>Liver Neoplasms etiology</category>
      <category>Liver Cirrhosis epidemiology</category>
      <category>Liver Cirrhosis genetics</category>
      <category>Liver Cirrhosis etiology</category>
      <category>Fatty Liver genetics</category>
      <category>Fatty Liver epidemiology</category>
      <category>Gene-Environment Interaction</category>
      <title>The impact of genetic and environmental risk factors on adverse liver outcomes.</title>
      <description>International journal of cancer; 05/01/2026&lt;br/&gt;(AN 41345374); ISSN: 1097-0215&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41345374</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41071281&amp;site=ehost-live&amp;scope=site</link>
      <author>Manasyan A; Wolfe EM; Stoneburner J; Roohani I; Stanton EW; Kim MI; Travieso R</author>
      <category>Reoperation statistics &amp; numerical data</category>
      <category>Patient Readmission statistics &amp; numerical data</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Retrospective Studies</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Treatment Outcome</category>
      <category>Middle Aged</category>
      <category>Transgender Persons</category>
      <category>Young Adult</category>
      <category>Gender-Affirming Surgery methods</category>
      <category>Gender-Affirming Surgery adverse effects</category>
      <category>Gender-Affirming Surgery statistics &amp; numerical data</category>
      <category>Gender Dysphoria surgery</category>
      <category>Vagina surgery</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications etiology</category>
      <category>Obesity complications</category>
      <category>Body Mass Index</category>
      <title>Body Mass Index as a Predictor of Surgical Outcomes in Gender-Affirming Vaginoplasty: A Nationwide Analysis.</title>
      <description>Plastic and reconstructive surgery; 05/01/2026&lt;br/&gt;(AN 41071281); ISSN: 1529-4242&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41071281</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42049175&amp;site=ehost-live&amp;scope=site</link>
      <author>Günalan E; Tartıcı G; Aladağ E; Çonak Ö</author>
      <category>Humans</category>
      <category>Bibliometrics</category>
      <category>Artificial Intelligence</category>
      <category>Obesity</category>
      <category>Malnutrition</category>
      <title>Artificial Intelligence Applications across the Spectrum of Malnutrition: From Undernutrition to Obesity.</title>
      <description>The Journal of nutrition; 05/01/2026&lt;br/&gt;(AN 42049175); ISSN: 1541-6100&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42049175</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41765137&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhu X; Welsh JA; McCullough ML; Sylvetsky AC; Hartman TJ; Patel AV; Deubler EL; Ferranti EP; Um CY</author>
      <category>Obesity complications</category>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Aged</category>
      <category>Prospective Studies</category>
      <category>Middle Aged</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Cohort Studies</category>
      <category>Adult</category>
      <category>Aspartame adverse effects</category>
      <category>Aspartame administration &amp; dosage</category>
      <category>Neoplasms epidemiology</category>
      <category>Neoplasms etiology</category>
      <category>Sweetening Agents adverse effects</category>
      <category>Sweetening Agents administration &amp; dosage</category>
      <title>Association between Aspartame Consumption and Cancer Risk: Evidence from a Large Prospective Cohort.</title>
      <description>The Journal of nutrition; 05/01/2026&lt;br/&gt;(AN 41765137); ISSN: 1541-6100&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41765137</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41485711&amp;site=ehost-live&amp;scope=site</link>
      <author>Kim S; Eber MR; Salerno AG; Boudyguina E; Asmis R</author>
      <category>Obesity metabolism</category>
      <category>Obesity etiology</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Female</category>
      <category>Mice, Knockout</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Macrophage Activation</category>
      <category>Monoamine Oxidase metabolism</category>
      <category>Monoamine Oxidase genetics</category>
      <category>Diet, High-Fat adverse effects</category>
      <category>Glucose Intolerance prevention &amp; control</category>
      <category>Glucose Intolerance metabolism</category>
      <category>Macrophages metabolism</category>
      <category>Insulin Resistance</category>
      <category>Weight Gain</category>
      <title>Myeloid monoamine oxidase A protects against glucose intolerance, insulin resistance and weight gain in high-fat diet-fed mice by preventing the hyperactivation of macrophages.</title>
      <description>The Journal of nutritional biochemistry; 05/01/2026&lt;br/&gt;(AN 41485711); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41485711</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41534602&amp;site=ehost-live&amp;scope=site</link>
      <author>Chan PC; Jhuang CH; Chang HY; Hsieh PS</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Adipose Tissue, Brown metabolism</category>
      <category>Uncoupling Protein 1 metabolism</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Lipolysis</category>
      <category>Mice, Inbred C57BL</category>
      <category>Energy Metabolism</category>
      <category>Mice, Knockout</category>
      <category>Obesity metabolism</category>
      <category>Obesity prevention &amp; control</category>
      <category>Obesity etiology</category>
      <category>Carnitine O-Palmitoyltransferase metabolism</category>
      <category>Carnitine O-Palmitoyltransferase genetics</category>
      <category>Serum Amyloid A Protein metabolism</category>
      <category>Serum Amyloid A Protein genetics</category>
      <category>Adipocytes, Brown metabolism</category>
      <category>Thermogenesis</category>
      <title>Brown adipocyte-derived SAA3-CPT1A axis regulates diet-induced thermogenesis and protects against obesity.</title>
      <description>The Journal of nutritional biochemistry; 05/01/2026&lt;br/&gt;(AN 41534602); ISSN: 1873-4847&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41534602</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41880685&amp;site=ehost-live&amp;scope=site</link>
      <author>Li X; Qin Y; Zhang B</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Weight Gain drug effects</category>
      <category>Animals</category>
      <category>Mice, Inbred C57BL</category>
      <category>Mice</category>
      <category>3T3-L1 Cells</category>
      <category>Male</category>
      <category>Betaine pharmacology</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Adipogenesis drug effects</category>
      <category>Obesity drug therapy</category>
      <category>Obesity microbiology</category>
      <category>Adipocytes drug effects</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <title>Betaine inhibited adipogenesis in 3T3-L1 preadipocytes and alleviated obesity-related disorders in high-fat diet-fed C57BL/6 mice by modulating gut microbiota composition.</title>
      <description>Nutrition research (New York, N.Y.); 05/01/2026&lt;br/&gt;(AN 41880685); ISSN: 1879-0739&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41880685</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41967401&amp;site=ehost-live&amp;scope=site</link>
      <author>Magriplis E; Kotopoulou S; Kouvari M; Myrintzou N; Smiliotopoulos T; Tsitsou S; Papakonstandinou E; Panagopoulou MV; Panagiotakos DB; Zampelas A</author>
      <category>Greece epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Biomarkers blood</category>
      <category>Overweight complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Prevalence</category>
      <category>Nutrition Surveys</category>
      <category>Young Adult</category>
      <category>Cross-Sectional Studies</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Logistic Models</category>
      <category>Non-alcoholic Fatty Liver Disease epidemiology</category>
      <category>Non-alcoholic Fatty Liver Disease prevention &amp; control</category>
      <category>Fatty Liver epidemiology</category>
      <category>Diet, Mediterranean</category>
      <title>Higher Mediterranean diet adherence is associated with lower odds of metabolic dysfunction-associated steatotic liver disease in Greek adults: A noninvasive population-based assessment.</title>
      <description>Nutrition research (New York, N.Y.); 05/01/2026&lt;br/&gt;(AN 41967401); ISSN: 1879-0739&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41967401</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41038339&amp;site=ehost-live&amp;scope=site</link>
      <author>Klopfenstein N; Salina A; Blackman A; Aronoff D; Breyer RM; Serezani CH</author>
      <category>Skin immunology</category>
      <category>Skin microbiology</category>
      <category>Skin pathology</category>
      <category>Methicillin-Resistant Staphylococcus aureus immunology</category>
      <category>Signal Transduction immunology</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Disease Models, Animal</category>
      <category>Mice, Inbred C57BL</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Receptors, Interleukin-8B metabolism</category>
      <category>Obesity complications</category>
      <category>Obesity immunology</category>
      <category>Dinoprostone metabolism</category>
      <category>Receptors, Prostaglandin E, EP3 Subtype metabolism</category>
      <category>Staphylococcal Skin Infections immunology</category>
      <category>Staphylococcal Skin Infections microbiology</category>
      <category>Staphylococcal Skin Infections pathology</category>
      <category>Staphylococcal Skin Infections drug therapy</category>
      <title>PGE2/EP3/CXCR2 Axis Dictates Amplified Inflammatory Response during Skin Infection in Mice with Obesity.</title>
      <description>The Journal of investigative dermatology; 05/01/2026&lt;br/&gt;(AN 41038339); ISSN: 1523-1747&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41038339</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41604852&amp;site=ehost-live&amp;scope=site</link>
      <author>Mwala NN; Borkent JW; van der Meij BS; de van der Schueren MAE</author>
      <category>Netherlands epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Risk Factors</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Body Mass Index</category>
      <category>Quality of Life</category>
      <category>Cohort Studies</category>
      <category>Stress, Psychological</category>
      <category>Aged</category>
      <category>Prevalence</category>
      <category>Overweight epidemiology</category>
      <category>Overweight physiopathology</category>
      <category>Obesity epidemiology</category>
      <category>Obesity physiopathology</category>
      <category>Weight Loss</category>
      <title>Unintentional weight loss: Most risk factors do not differ between individuals with a healthy weight and those with overweight or obesity.</title>
      <description>Nutrition (Burbank, Los Angeles County, Calif.); 05/01/2026&lt;br/&gt;(AN 41604852); ISSN: 1873-1244&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41604852</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42057471&amp;site=ehost-live&amp;scope=site</link>
      <author>Jung M; Wang X; Jeon SY; Graff RE; Deng Z; L'Espérance K; Li M; Langston ME; Chung BI</author>
      <category>United States epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Case-Control Studies</category>
      <category>Risk Factors</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Metabolic Syndrome epidemiology</category>
      <category>Metabolic Syndrome complications</category>
      <category>Kidney Neoplasms epidemiology</category>
      <category>Kidney Neoplasms etiology</category>
      <title>Metabolic syndrome and risk of kidney cancer in the United States.</title>
      <description>Cancer; 05/01/2026&lt;br/&gt;(AN 42057471); ISSN: 1097-0142&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42057471</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42159080&amp;site=ehost-live&amp;scope=site</link>
      <author>Junaid M; Zeming H; Zhu Y</author>
      <category>Endocrine System metabolism</category>
      <category>Humans</category>
      <category>Animals</category>
      <category>Energy Metabolism</category>
      <category>Signal Transduction</category>
      <category>Homeostasis</category>
      <category>Leptin metabolism</category>
      <category>Leptin immunology</category>
      <category>Obesity metabolism</category>
      <category>Obesity immunology</category>
      <category>Gastrointestinal Microbiome</category>
      <title>The Leptin Renaissance: Orchestrating the Next Endocrine Paradigm.</title>
      <description>Journal of cellular biochemistry; 05/01/2026&lt;br/&gt;(AN 42159080); ISSN: 1097-4644&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42159080</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41520725&amp;site=ehost-live&amp;scope=site</link>
      <author>Morris KA; Pacyga DC; Schantz SL; Strakovsky RS</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Adult</category>
      <category>Prospective Studies</category>
      <category>Body Mass Index</category>
      <category>Longitudinal Studies</category>
      <category>Illinois</category>
      <category>Young Adult</category>
      <category>Gestational Age</category>
      <category>Obesity physiopathology</category>
      <category>Diet standards</category>
      <category>Diet, Healthy statistics &amp; numerical data</category>
      <category>Gestational Weight Gain</category>
      <category>Maternal Nutritional Physiological Phenomena</category>
      <category>Pregnancy Complications</category>
      <title>Improvement in Maternal Diet Quality Across Pregnancy Is Associated With Lower Gestational Weight Gain in Women With Obesity From the Illinois Kids Development Study.</title>
      <description>Journal of the Academy of Nutrition and Dietetics; 05/01/2026&lt;br/&gt;(AN 41520725); ISSN: 2212-2672&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41520725</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42070887&amp;site=ehost-live&amp;scope=site</link>
      <author>Zeitoun T; Chen ZH; Burgner D; MacKechnie G; Huntington P; Mansell T; Longmore D; Mandhane PJ; Simons E; Turvey SE; Subbarao P; Moraes TJ; Sellen DW; Miliku K</author>
      <category>Canada epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Child</category>
      <category>Animals</category>
      <category>Child, Preschool</category>
      <category>Male</category>
      <category>Prospective Studies</category>
      <category>Cross-Sectional Studies</category>
      <category>Body Mass Index</category>
      <category>Longitudinal Studies</category>
      <category>Diet</category>
      <category>Cohort Studies</category>
      <category>Milk chemistry</category>
      <category>Dietary Fats administration &amp; dosage</category>
      <category>Dietary Fats analysis</category>
      <category>Pediatric Obesity epidemiology</category>
      <category>Pediatric Obesity prevention &amp; control</category>
      <category>Pediatric Obesity etiology</category>
      <category>Obesity epidemiology</category>
      <category>Adiposity</category>
      <title>Milk fat intake, adiposity, and obesity in Canadian children: findings from the prospective Canadian CHILD Cohort Study.</title>
      <description>The American journal of clinical nutrition; 05/01/2026&lt;br/&gt;(AN 42070887); ISSN: 1938-3207&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42070887</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41740726&amp;site=ehost-live&amp;scope=site</link>
      <author>Roberts AK; Panyard DJ; Hislop B; Ward CP; Snyder MP; Gardner CD; Haddad F</author>
      <category>Adipose Tissue metabolism</category>
      <category>Obesity diet therapy</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Body Composition</category>
      <category>Absorptiometry, Photon</category>
      <category>Biomarkers</category>
      <category>Diet, Carbohydrate-Restricted</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Weight Loss</category>
      <category>Diet, Reducing</category>
      <title>Diet-based weight-loss intervention is not associated with a meaningful change in lean soft tissue.</title>
      <description>The American journal of clinical nutrition; 05/01/2026&lt;br/&gt;(AN 41740726); ISSN: 1938-3207&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41740726</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41812769&amp;site=ehost-live&amp;scope=site</link>
      <author>Carollo L; Lawson EA; Stanley TL; Wang J; Bhattacharya R; Bishop DJ; Carmichael O; Esser KA; Febbraio MA; Fielding RA; Fourman LT; Goodpaster BH; Goodyear LJ; Guseh JS; Haines MS; Hawley JA; Heymsfield SB; Lindholm ME; Long JZ; Snyder MP; Whitham M; Grinspoon SK</author>
      <category>Humans</category>
      <category>Congresses as Topic</category>
      <category>Muscle, Skeletal physiology</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Exercise physiology</category>
      <category>Obesity metabolism</category>
      <title>Muscle movement and metabolism: exercise and skeletal muscle as mediators of health-a report from the 26th Annual Harvard Nutrition Obesity Symposium, 2025.</title>
      <description>The American journal of clinical nutrition; 05/01/2026&lt;br/&gt;(AN 41812769); ISSN: 1938-3207&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41812769</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41825530&amp;site=ehost-live&amp;scope=site</link>
      <author>Vázquez-Lorente H; Manzanares-Errazu JM; Babio N; Ruiz-Canela M; Corella D; Hernando J; Martínez JA; Alonso-Gómez ÁM; Wärnberg J; Vioque J; Romaguera D; López-Miranda J; Estruch R; Tinahones FJ; Urbano-Fernández V; Serra-Majem L; Cano-Ibáñez N; Tur JA; Sánchez VM; Pintó X; Delgado-Rodríguez M; Matía-Martín P; Vidal J; Vázquez C; Ros E; Fernández-Aranda F; Toledo E; Gutiérrez-Carrasquilla L; Sorlí JV; Zomeño MD; Garcia-Rios A; Oncina-Canovas A; Cueto-Galán R; Zulet MA; Prohens L; Casas R; Durán-Luque M; Tojal-Sierra L; Simón-Frapolli V; Vázquez-Ruiz Z; Fernández-Carrión R; Castañer O; Rodriguez-Mancheño AL; Asencio A; García-Arellano A; Fitó M; Daimiel L; Salas-Salvadó J</author>
      <category>Humans</category>
      <category>Aged</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Prospective Studies</category>
      <category>Diet</category>
      <category>Choline administration &amp; dosage</category>
      <category>Choline pharmacology</category>
      <category>Betaine administration &amp; dosage</category>
      <category>Betaine pharmacology</category>
      <category>Cognition drug effects</category>
      <category>Metabolic Syndrome complications</category>
      <category>Obesity</category>
      <category>Overweight</category>
      <title>Dietary Choline and Betaine Intake and 2-year Changes in Cognitive Function in Older Adults With Overweight or Obesity and Metabolic Syndrome: A Prospective Cohort Analysis.</title>
      <description>The American journal of clinical nutrition; 05/01/2026&lt;br/&gt;(AN 41825530); ISSN: 1938-3207&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41825530</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41862002&amp;site=ehost-live&amp;scope=site</link>
      <author>Ren J; Sun X; Zhang Z; Zhang Y; Xiong S; Tao X; Sun K; Zhang C; Yin B; Zhang X; Peiris D; Zhang P; Ma Y</author>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Heart Disease Risk Factors</category>
      <category>Overweight</category>
      <category>Risk Factors</category>
      <category>Digital Health</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Cardiovascular Diseases prevention &amp; control</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Body Mass Index</category>
      <title>Baseline body mass index modifies the effects of digital health interventions compared with usual care on cardiovascular disease risk in people with type 2 diabetes: a secondary analysis of the SMARTDiabetes trial.</title>
      <description>The American journal of clinical nutrition; 05/01/2026&lt;br/&gt;(AN 41862002); ISSN: 1938-3207&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41862002</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42135613&amp;site=ehost-live&amp;scope=site</link>
      <author>Wong EC; Koh M; Yeung LF; Shin M; Rodriguez JD; Mai CT</author>
      <category>United States epidemiology</category>
      <category>Risk Assessment methods</category>
      <category>Obesity epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Pregnancy</category>
      <category>Risk Factors</category>
      <category>Adult</category>
      <category>Prevalence</category>
      <category>Young Adult</category>
      <category>Congenital Abnormalities epidemiology</category>
      <category>Congenital Abnormalities etiology</category>
      <category>Folic Acid administration &amp; dosage</category>
      <category>Vitamins administration &amp; dosage</category>
      <category>Diabetes Mellitus epidemiology</category>
      <title>Prevalence of Multivitamin/Folic Acid Intake, Diabetes, and Other Risk Factors for Birth Defects Among Women in the United States, Pregnancy Risk Assessment Monitoring System, 2017-2022.</title>
      <description>Birth defects research; 05/01/2026&lt;br/&gt;(AN 42135613); ISSN: 2472-1727&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42135613</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42202351&amp;site=ehost-live&amp;scope=site</link>
      <author>Green L MD; Dunlap C MD; Glass C MD</author>
      <category>Humans</category>
      <category>Diabetes Mellitus, Type 2</category>
      <category>United States</category>
      <category>Bariatric Surgery adverse effects</category>
      <category>Obesity surgery</category>
      <category>Obesity complications</category>
      <category>Postoperative Care methods</category>
      <category>Postoperative Complications therapy</category>
      <category>Physician's Role</category>
      <category>Physicians, Family</category>
      <title>Postoperative Management After Metabolic Surgery: Role of the Family Physician.</title>
      <description>American family physician; 05/01/2026&lt;br/&gt;(AN 42202351); ISSN: 1532-0650&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42202351</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42065211&amp;site=ehost-live&amp;scope=site</link>
      <author>Bian Y; Bian Y; Fu Z; Xu B; Zhao T; Wang J; Ma Q; Li X</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>Young Adult</category>
      <category>ROC Curve</category>
      <category>Anxiety</category>
      <category>Depression</category>
      <category>Acne Vulgaris</category>
      <category>Polycystic Ovary Syndrome psychology</category>
      <category>Polycystic Ovary Syndrome complications</category>
      <category>Overweight psychology</category>
      <category>Overweight complications</category>
      <category>Obesity psychology</category>
      <category>Obesity complications</category>
      <category>Social Stigma</category>
      <title>Building and validating a stigma prediction model for overweight and obese patients with polycystic ovary syndrome (PCOS): A observational study.</title>
      <description>Medicine; 05/01/2026&lt;br/&gt;(AN 42065211); ISSN: 1536-5964&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42065211</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41687055&amp;site=ehost-live&amp;scope=site</link>
      <author>Salingaros S; Zhang A; Rohde CH; Spector JA</author>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Retrospective Studies</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Body Mass Index</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications prevention &amp; control</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Diabetes Mellitus, Type 1 drug therapy</category>
      <category>Diabetes Mellitus, Type 1 complications</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Active GLP-1 RA Use Is Associated With Lower Rates of Surgical Complications Across Diabetic BMI Cohorts: A Retrospective Analysis of 72,578 Surgical Encounters.</title>
      <description>Annals of plastic surgery; 05/01/2026&lt;br/&gt;(AN 41687055); ISSN: 1536-3708&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41687055</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42067225&amp;site=ehost-live&amp;scope=site</link>
      <author>Sierra L; Liu L; Khurana A; Patel R; Chatterjee A; Firkins S; Simons-Linares R</author>
      <category>Bariatric Surgery methods</category>
      <category>Obesity complications</category>
      <category>Non-alcoholic Fatty Liver Disease therapy</category>
      <category>Humans</category>
      <category>Liver Cirrhosis etiology</category>
      <category>Liver Cirrhosis therapy</category>
      <category>Fatty Liver therapy</category>
      <category>Fatty Liver complications</category>
      <category>Weight Loss</category>
      <title>Reversing fibrosis in metabolic dysfunction-associated steatohepatitis-beyond telling patients to lose weight.</title>
      <description>Cleveland Clinic journal of medicine; 05/01/2026&lt;br/&gt;(AN 42067225); ISSN: 1939-2869&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42067225</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42186153&amp;site=ehost-live&amp;scope=site</link>
      <author>Im ST; Park HY; Kim HR; Son SJ; Ryu AR; Hong JS; Choi HD; Kang MC</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Blood Glucose metabolism</category>
      <category>Adiponectin blood</category>
      <category>Insulin blood</category>
      <category>Amylose analysis</category>
      <category>Functional Food analysis</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Insulin Resistance</category>
      <category>Mice, Obese</category>
      <category>Lipid Metabolism</category>
      <category>Dyslipidemias</category>
      <category>Oryza chemistry</category>
      <category>Oryza metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity diet therapy</category>
      <category>Obesity etiology</category>
      <category>Starch</category>
      <category>Resistant Starch</category>
      <title>Functional Rice Enriched With Resistant Starch Ameliorates Metabolic Dysregulation in High-Fat Diet-Induced Obese Mice.</title>
      <description>Journal of food science; 05/01/2026&lt;br/&gt;(AN 42186153); ISSN: 1750-3841&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42186153</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42178808&amp;site=ehost-live&amp;scope=site</link>
      <author>Gong Z; Tian W; Zhuang M; Shang H; Chen Y; Zheng L; Lv Y; Li J; Geng X</author>
      <category>Diet, High-Fat adverse effects</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Hyperlipidemias drug therapy</category>
      <category>Obesity drug therapy</category>
      <category>Liver metabolism</category>
      <category>Liver drug effects</category>
      <category>Oxidative Stress drug effects</category>
      <category>Lipids blood</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Male</category>
      <category>Mice, Inbred C57BL</category>
      <category>Polysaccharides pharmacology</category>
      <category>Polysaccharides administration &amp; dosage</category>
      <category>Raphanus chemistry</category>
      <category>Hypolipidemic Agents pharmacology</category>
      <title>Lipid-Lowering Mechanism of Cherry Radish Polysaccharides in High-Fat-Diet-Fed Mice.</title>
      <description>Journal of food science; 05/01/2026&lt;br/&gt;(AN 42178808); ISSN: 1750-3841&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42178808</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42183640&amp;site=ehost-live&amp;scope=site</link>
      <author>Neal SJ; Magden ER; Chitta S; Bisbal J; Simmons JH</author>
      <category>Biomarkers cerebrospinal fluid</category>
      <category>Biomarkers blood</category>
      <category>Obesity veterinary</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Female</category>
      <category>Papio anubis metabolism</category>
      <category>Neurodegenerative Diseases veterinary</category>
      <category>Neurodegenerative Diseases metabolism</category>
      <category>Neurodegenerative Diseases blood</category>
      <category>Neurodegenerative Diseases cerebrospinal fluid</category>
      <category>Neuroinflammatory Diseases veterinary</category>
      <category>Neuroinflammatory Diseases blood</category>
      <category>Neuroinflammatory Diseases metabolism</category>
      <category>Neuroinflammatory Diseases cerebrospinal fluid</category>
      <category>Monkey Diseases metabolism</category>
      <category>Monkey Diseases cerebrospinal fluid</category>
      <category>Monkey Diseases blood</category>
      <title>Metabolic Biomarkers in Captive Olive Baboons (Papio anubis): Characterization and Relationships With Biomarkers of Neurodegeneration and Neuroinflammation.</title>
      <description>American journal of primatology; 05/01/2026&lt;br/&gt;(AN 42183640); ISSN: 1098-2345&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42183640</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41628897&amp;site=ehost-live&amp;scope=site</link>
      <author>Selznick H; Lee KC; Hershberger M; Panchal N; Brandfon B; Ford BP</author>
      <category>Obesity complications</category>
      <category>Humans</category>
      <category>Retrospective Studies</category>
      <category>Male</category>
      <category>Female</category>
      <category>Risk Factors</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Peri-Implantitis etiology</category>
      <category>Peri-Implantitis epidemiology</category>
      <category>Dental Implants adverse effects</category>
      <category>Body Mass Index</category>
      <title>Is Body Mass Index an Independent Risk Factor for Peri-Implantitis?</title>
      <description>Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons; 05/01/2026&lt;br/&gt;(AN 41628897); ISSN: 1531-5053&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41628897</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40581794&amp;site=ehost-live&amp;scope=site</link>
      <author>Saban Güler M; Yıldıran H</author>
      <category>Adipose Tissue, White drug effects</category>
      <category>Adipose Tissue, White metabolism</category>
      <category>Adipose Tissue, Brown drug effects</category>
      <category>Adipose Tissue, Brown metabolism</category>
      <category>Thermogenesis drug effects</category>
      <category>Animals</category>
      <category>Rodentia</category>
      <category>Rats</category>
      <category>Disease Models, Animal</category>
      <category>Fatty Acids, Omega-3 pharmacology</category>
      <category>Fatty Acids, Omega-3 administration &amp; dosage</category>
      <category>Obesity etiology</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Diet, High-Fat adverse effects</category>
      <title>Effects of Omega-3 Fatty Acids on High-Fat Diet-Induced Obesity: A Systematic Review of Rodent Studies.</title>
      <description>Nutrition reviews; 05/01/2026&lt;br/&gt;(AN 40581794); ISSN: 1753-4887&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40581794</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40632615&amp;site=ehost-live&amp;scope=site</link>
      <author>Freer J; Orr J; Wells JCK; Prendergast AJ</author>
      <category>Diabetes Mellitus, Type 2 epidemiology</category>
      <category>Diabetes Mellitus, Type 2 etiology</category>
      <category>Coronary Disease epidemiology</category>
      <category>Coronary Disease etiology</category>
      <category>Hypertension epidemiology</category>
      <category>Hypertension etiology</category>
      <category>Obesity epidemiology</category>
      <category>Humans</category>
      <category>Child</category>
      <category>Developing Countries</category>
      <category>Cognition</category>
      <category>Child, Preschool</category>
      <category>Infant</category>
      <category>Cardiometabolic Risk Factors</category>
      <category>Growth Disorders complications</category>
      <category>Growth Disorders epidemiology</category>
      <category>Cardiovascular Diseases epidemiology</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Child Development</category>
      <category>Developed Countries</category>
      <category>Public Health</category>
      <title>The Impact of Early-Life Growth on Long-Term Cardiometabolic and Neurocognitive Outcomes in High-Income Countries: A Neglected Public Health Problem.</title>
      <description>Nutrition reviews; 05/01/2026&lt;br/&gt;(AN 40632615); ISSN: 1753-4887&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40632615</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41771234&amp;site=ehost-live&amp;scope=site</link>
      <author>Burdette ER; Soelling S; Flores MN; Pelletier A; Bartz D; Smink D; Johnson N</author>
      <category>Humans</category>
      <category>Cross-Sectional Studies</category>
      <category>Female</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Internship and Residency</category>
      <category>Surveys and Questionnaires</category>
      <category>Obesity psychology</category>
      <category>Surgeons psychology</category>
      <category>General Surgery education</category>
      <category>Clinical Decision-Making</category>
      <category>Attitude of Health Personnel</category>
      <category>Prejudice</category>
      <title>Anti-Obesity Bias Among Surgeons and Association With Clinical Decision Making.</title>
      <description>Journal of surgical education; 05/01/2026&lt;br/&gt;(AN 41771234); ISSN: 1878-7452&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41771234</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42008693&amp;site=ehost-live&amp;scope=site</link>
      <author>Lu X; Bai N; Lyu J; Sun J; Su Y; Ye Y; Hu T; Liu T; Li W; Li X; Ma X; Yang Y; Bao Y</author>
      <category>Intra-Abdominal Fat metabolism</category>
      <category>Adipocytes, Beige metabolism</category>
      <category>Animals</category>
      <category>Mice</category>
      <category>Humans</category>
      <category>Mice, Knockout</category>
      <category>Male</category>
      <category>DNA Methylation</category>
      <category>Energy Metabolism</category>
      <category>Thermogenesis genetics</category>
      <category>Thermogenesis physiology</category>
      <category>Isocitrate Dehydrogenase genetics</category>
      <category>Isocitrate Dehydrogenase metabolism</category>
      <category>Isocitrate Dehydrogenase deficiency</category>
      <category>Amino Acids, Branched-Chain metabolism</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <title>IDH3A Deficiency Compromises Adaptive Thermogenesis and Exacerbates Obesity-Induced Metabolic Dysfunction via Impaired BCKDHA-Dependent BCAA Catabolism.</title>
      <description>Diabetes; 05/01/2026&lt;br/&gt;(AN 42008693); ISSN: 1939-327X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42008693</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41568735&amp;site=ehost-live&amp;scope=site</link>
      <author>Sando M; Tsukada Y; Ikeda K; Hasegawa H; Nishizawa Y; Ito M</author>
      <category>Postoperative Complications epidemiology</category>
      <category>Anal Canal surgery</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Retrospective Studies</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Operative Time</category>
      <category>Margins of Excision</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Rectal Neoplasms surgery</category>
      <category>Rectal Neoplasms complications</category>
      <category>Rectal Neoplasms pathology</category>
      <category>Obesity complications</category>
      <category>Transanal Endoscopic Surgery methods</category>
      <category>Proctectomy methods</category>
      <title>Utility of Transanal Total Mesorectal Excision in Patients With Obesity and Mid-to-Low Rectal Cancer: A Single-Center, Retrospective Cohort Study.</title>
      <description>Diseases of the colon and rectum; 05/01/2026&lt;br/&gt;(AN 41568735); ISSN: 1530-0358&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41568735</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41247268&amp;site=ehost-live&amp;scope=site</link>
      <author>Varnado OJ; Liao B; Jerry M; Lew CR; Ross R; Janak JC; Shinde S</author>
      <category>Accidents, Traffic statistics &amp; numerical data</category>
      <category>Accidents, Traffic economics</category>
      <category>Sick Leave statistics &amp; numerical data</category>
      <category>Sick Leave economics</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Case-Control Studies</category>
      <category>Cost of Illness</category>
      <category>Prevalence</category>
      <category>Sleep Apnea, Obstructive complications</category>
      <category>Sleep Apnea, Obstructive economics</category>
      <category>Sleep Apnea, Obstructive epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity economics</category>
      <category>Obesity epidemiology</category>
      <category>Wounds and Injuries epidemiology</category>
      <category>Wounds and Injuries economics</category>
      <category>Efficiency</category>
      <title>Work Productivity Burden Among Patients With Obstructive Sleep Apnea and Obesity Versus Controls Without Obstructive Sleep Apnea or Obesity.</title>
      <description>Journal of occupational and environmental medicine; 05/01/2026&lt;br/&gt;(AN 41247268); ISSN: 1536-5948&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41247268</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41401389&amp;site=ehost-live&amp;scope=site</link>
      <author>Dawit L; Quon C; Bachu V; Jumo H; Micalo L; Issa D</author>
      <category>Humans</category>
      <category>Weight Loss</category>
      <category>Treatment Outcome</category>
      <category>Bariatric Surgery methods</category>
      <category>Bariatric Surgery adverse effects</category>
      <category>Obesity complications</category>
      <category>Obesity surgery</category>
      <category>Metabolic Syndrome complications</category>
      <category>Fatty Liver etiology</category>
      <category>Fatty Liver surgery</category>
      <category>Non-alcoholic Fatty Liver Disease</category>
      <title>The Role of Endoscopic Bariatric Treatments in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.</title>
      <description>Journal of clinical gastroenterology; 05/01/2026&lt;br/&gt;(AN 41401389); ISSN: 1539-2031&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41401389</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42066358&amp;site=ehost-live&amp;scope=site</link>
      <author>Khan FA; Chabot PJ; Bisson EF; Bydon M; Asher AL; Kim PK; Potts EA; Alentado VJ; Foley KT; Wang MY; Fu KM; Virk MS; Shaffrey CI; Gottfried ON; Knightly JJ; Meyer S; Park P; Upadhyaya CD; Yen CP; Tumialán LM; Chou D; Uribe JS; Turner JD; Yee TJ; Haid RW Jr; Mummaneni PV; Chan AK</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Patient Reported Outcome Measures</category>
      <category>Treatment Outcome</category>
      <category>Prospective Studies</category>
      <category>Databases, Factual</category>
      <category>Minimal Clinically Important Difference</category>
      <category>Spondylosis surgery</category>
      <category>Cervical Vertebrae surgery</category>
      <category>Obesity surgery</category>
      <category>Obesity complications</category>
      <category>Spinal Cord Diseases surgery</category>
      <category>Body Mass Index</category>
      <title>Should BMI influence anterior versus posterior approach surgery in patients with CSM? A 5-year Spine CORe™ analysis of QOD data.</title>
      <description>Neurosurgical focus; 05/01/2026&lt;br/&gt;(AN 42066358); ISSN: 1092-0684&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42066358</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41347395&amp;site=ehost-live&amp;scope=site</link>
      <author>Costa DN; Jensen MD</author>
      <category>Energy Metabolism physiology</category>
      <category>Fatty Acids, Nonesterified metabolism</category>
      <category>Fatty Acids, Nonesterified blood</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Palmitates metabolism</category>
      <category>Palmitic Acid metabolism</category>
      <category>Triglycerides metabolism</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Oxidation-Reduction</category>
      <category>Sex Factors</category>
      <category>Young Adult</category>
      <category>Calorimetry, Indirect</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Lipid Metabolism physiology</category>
      <category>Exercise physiology</category>
      <title>Effects of Sex and Obesity on Lipid Metabolism during Low-Intensity Exercise and Postexercise Period.</title>
      <description>Medicine and science in sports and exercise; 05/01/2026&lt;br/&gt;(AN 41347395); ISSN: 1530-0315&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41347395</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41396840&amp;site=ehost-live&amp;scope=site</link>
      <author>Demir H; Tece S; Yigit H; Filik L</author>
      <category>Liver diagnostic imaging</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Retrospective Studies</category>
      <category>Risk Factors</category>
      <category>Diabetes Mellitus</category>
      <category>Obesity</category>
      <category>Magnetic Resonance Imaging methods</category>
      <category>Pancreatic Diseases diagnostic imaging</category>
      <category>Pancreatic Diseases complications</category>
      <category>Pancreas diagnostic imaging</category>
      <category>Pancreas pathology</category>
      <category>Non-alcoholic Fatty Liver Disease diagnostic imaging</category>
      <category>Fatty Liver</category>
      <title>Investigation of Clinical and Laboratory Findings of 40-49-Year-Old Patients With Fatty Pancreas by Magnetic Resonance Imaging and Evaluation of the Potential Relationship With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD).</title>
      <description>Pancreas; 05/01/2026&lt;br/&gt;(AN 41396840); ISSN: 1536-4828&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41396840</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41361741&amp;site=ehost-live&amp;scope=site</link>
      <author>Douglas N; Segal R; O'Donnell K; Lee K; Krieser R; Mezzavia P; Hung S; Chen YW; Sindoni T; Ng I</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Oxygen Saturation</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Oxygen Inhalation Therapy methods</category>
      <category>Obesity complications</category>
      <category>Gastroscopy methods</category>
      <category>Oxygen administration &amp; dosage</category>
      <category>Oxygen blood</category>
      <title>A randomised controlled trial of high-flow nasal oxygen compared with standard oxygen delivery in obese patients undergoing gastroscopy.</title>
      <description>Anaesthesia and intensive care; 05/01/2026&lt;br/&gt;(AN 41361741); ISSN: 0310-057X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41361741</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42101823&amp;site=ehost-live&amp;scope=site</link>
      <author>Harvanek ZM; Milivojevic V; Hart R; Sinha R</author>
      <category>Insulin blood</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Craving physiology</category>
      <category>Insulin Resistance physiology</category>
      <category>Obesity blood</category>
      <category>Obesity psychology</category>
      <category>Obesity complications</category>
      <category>Blood Glucose metabolism</category>
      <category>Alcoholism psychology</category>
      <category>Alcoholism blood</category>
      <category>Alcoholism complications</category>
      <category>Stress, Psychological blood</category>
      <category>Stress, Psychological psychology</category>
      <category>Cues</category>
      <title>Alterations in glucose and insulin resistance following stress and alcohol cues predict alcohol craving in those with AUD and obesity: A preliminary study.</title>
      <description>Alcohol, clinical &amp; experimental research; 05/01/2026&lt;br/&gt;(AN 42101823); ISSN: 2993-7175&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42101823</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41388040&amp;site=ehost-live&amp;scope=site</link>
      <author>Jacobs H; Frost O; Rad AA; Chou WK; Al-Saegh S; Zubarevich A; Weymann A; Ruhparwar A; Amanov L; Nia PS; Kourliouros A; Athanasiou T</author>
      <category>Postoperative Complications etiology</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Humans</category>
      <category>Risk Factors</category>
      <category>Female</category>
      <category>Male</category>
      <category>Heart-Assist Devices adverse effects</category>
      <category>Heart Failure surgery</category>
      <category>Heart Failure mortality</category>
      <category>Heart Failure complications</category>
      <category>Obesity complications</category>
      <title>The Impact of Obesity on Durable Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis.</title>
      <description>Artificial organs; 05/01/2026&lt;br/&gt;(AN 41388040); ISSN: 1525-1594&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41388040</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41237290&amp;site=ehost-live&amp;scope=site</link>
      <author>Sattar N; Buse JB</author>
      <category>Humans</category>
      <category>Obesity</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Weight Loss physiology</category>
      <title>Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care.</title>
      <description>Diabetes care; 05/01/2026&lt;br/&gt;(AN 41237290); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41237290</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41429002&amp;site=ehost-live&amp;scope=site</link>
      <author>Karakus KE; Akturk HK; Kruger D; Ahmann A; Bharvaga A; Langel CR; Ackeifi CA; Rosen J; Pyle L; Snell-Bergeon JK; Shah VN</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Adult</category>
      <category>Female</category>
      <category>Male</category>
      <category>Double-Blind Method</category>
      <category>Middle Aged</category>
      <category>Insulin Infusion Systems</category>
      <category>Diabetes Mellitus, Type 1 drug therapy</category>
      <category>Diabetes Mellitus, Type 1 complications</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Insulin administration &amp; dosage</category>
      <category>Insulin therapeutic use</category>
      <category>Obesity drug therapy</category>
      <category>Obesity complications</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Hypoglycemic Agents administration &amp; dosage</category>
      <title>Effect of Semaglutide on Insulin Dose Reduction in Adults With Type 1 Diabetes and Obesity Using Automated Insulin Delivery Systems: ADJUST-T1D Post Hoc Analysis.</title>
      <description>Diabetes care; 05/01/2026&lt;br/&gt;(AN 41429002); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41429002</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41564347&amp;site=ehost-live&amp;scope=site</link>
      <author>Beals JW; Smith GI; Farabi SS; Patterson BW; Lucey BP; Broussard JL; Wright KP Jr; Klein S</author>
      <category>Blood Glucose metabolism</category>
      <category>Insulin blood</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Insulin Resistance physiology</category>
      <category>Sleep physiology</category>
      <category>Overweight physiopathology</category>
      <category>Obesity physiopathology</category>
      <category>Obesity metabolism</category>
      <title>Sleep Extension Improves Sleep Health but Not Insulin Sensitivity in People With Overweight or Obesity Who Maintain Habitual Short Sleep Schedules.</title>
      <description>Diabetes care; 05/01/2026&lt;br/&gt;(AN 41564347); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41564347</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41779453&amp;site=ehost-live&amp;scope=site</link>
      <author>Chehab RF; Greenberg MB; Lee C; Ngo AL; Feng J; Zhu Y; Ferrara A</author>
      <category>Blood Glucose metabolism</category>
      <category>Humans</category>
      <category>Pregnancy</category>
      <category>Female</category>
      <category>Child</category>
      <category>Child, Preschool</category>
      <category>Prospective Studies</category>
      <category>Male</category>
      <category>Adult</category>
      <category>Body Mass Index</category>
      <category>Risk Factors</category>
      <category>Diabetes, Gestational blood</category>
      <category>Diabetes, Gestational epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Pediatric Obesity epidemiology</category>
      <category>Glycemic Control</category>
      <category>Prenatal Exposure Delayed Effects</category>
      <title>Gestational Diabetes Mellitus, Glycemic Management Trajectories, and Offspring Growth Patterns and Obesity Risk.</title>
      <description>Diabetes care; 05/01/2026&lt;br/&gt;(AN 41779453); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41779453</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41778920&amp;site=ehost-live&amp;scope=site</link>
      <author>Ganeshalingam AA; Uhrenholt N; Arnfred S; Gæde P; Pedersen AK; Bilenberg N; Frystyk J</author>
      <category>Blood Glucose metabolism</category>
      <category>Blood Glucose drug effects</category>
      <category>Insulin blood</category>
      <category>C-Peptide blood</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Double-Blind Method</category>
      <category>Middle Aged</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Insulin Resistance physiology</category>
      <category>Insulin-Secreting Cells drug effects</category>
      <category>Insulin-Secreting Cells metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Schizophrenia drug therapy</category>
      <category>Prediabetic State drug therapy</category>
      <category>Prediabetic State metabolism</category>
      <category>Antipsychotic Agents therapeutic use</category>
      <title>Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly.</title>
      <description>Diabetes care; 05/01/2026&lt;br/&gt;(AN 41778920); ISSN: 1935-5548&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41778920</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41582853&amp;site=ehost-live&amp;scope=site</link>
      <author>Ha FJ; Prinsloo D; Xu E; Han HC; Nerlekar N; Brown AJ; Kotschet E</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Treatment Outcome</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Atrial Fibrillation surgery</category>
      <category>Atrial Fibrillation complications</category>
      <category>Catheter Ablation methods</category>
      <category>Obesity complications</category>
      <title>Pulsed Field Ablation for Atrial Fibrillation in Patients With Obesity: Procedural and Clinical Outcomes.</title>
      <description>Pacing and clinical electrophysiology : PACE; 05/01/2026&lt;br/&gt;(AN 41582853); ISSN: 1540-8159&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41582853</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41545757&amp;site=ehost-live&amp;scope=site</link>
      <author>Zhu ZN; You CZ; Yuan QN; Xu JY; Gu ZY; Huang Z; Liu M; Shan B; Wang JJ; Hu W; Wang K; Yin WC; Xu YW; Xu HE; Wu CR</author>
      <category>Obesity drug therapy</category>
      <category>Humans</category>
      <category>Cryoelectron Microscopy</category>
      <category>Drug Discovery</category>
      <category>Ligands</category>
      <category>Binding Sites</category>
      <category>Models, Molecular</category>
      <category>Protein Conformation</category>
      <category>Receptors, G-Protein-Coupled chemistry</category>
      <category>Receptors, G-Protein-Coupled metabolism</category>
      <category>Receptors, G-Protein-Coupled ultrastructure</category>
      <category>Anti-Obesity Agents chemistry</category>
      <category>Anti-Obesity Agents pharmacology</category>
      <title>Cryo-EM structures of GPR75 reveal an occluded orthosteric pocket challenging conventional drug discovery paradigms for an anti-obesity target.</title>
      <description>Acta pharmacologica Sinica; 05/01/2026&lt;br/&gt;(AN 41545757); ISSN: 1745-7254&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41545757</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42061031&amp;site=ehost-live&amp;scope=site</link>
      <author>Wang Y; He M; Tian Y; Deng Y; Deng W</author>
      <category>Humans</category>
      <category>Weight Loss</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Sleep Quality</category>
      <category>Male</category>
      <category>Sleep Apnea, Obstructive psychology</category>
      <category>Sleep Apnea, Obstructive therapy</category>
      <category>Sleep Apnea, Obstructive complications</category>
      <category>Obesity therapy</category>
      <category>Obesity complications</category>
      <category>Obesity psychology</category>
      <category>Psychosocial Intervention methods</category>
      <title>Psychological interventions for weight management of patients with obstructive sleep apnea syndrome: A systematic review.</title>
      <description>American journal of otolaryngology; 05/01/2026&lt;br/&gt;(AN 42061031); ISSN: 1532-818X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42061031</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41889076&amp;site=ehost-live&amp;scope=site</link>
      <author>Stefan N; Hartleb M; Fan J; Demir M; Schattenberg JM; Gietka J; Bułdak Ł; Popovic B; Varona R; De Fer BB</author>
      <category>Obesity complications</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Female</category>
      <category>Quality of Life</category>
      <category>Double-Blind Method</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Treatment Outcome</category>
      <category>Phospholipids therapeutic use</category>
      <category>Phospholipids administration &amp; dosage</category>
      <category>Fatty Liver drug therapy</category>
      <title>Effect of Essential Phospholipids in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomised Phase 4 Clinical Trial.</title>
      <description>Liver international : official journal of the International Association for the Study of the Liver; 05/01/2026&lt;br/&gt;(AN 41889076); ISSN: 1478-3231&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41889076</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41874854&amp;site=ehost-live&amp;scope=site</link>
      <author>Handelsman Y; Cheng AYY; Fadini GP; Kushner P; Bonnet F; Fioretto P; Kadowaki T; Kanumilli N; Cos X; Frese T; Ji L; Murton M; Foulcer S; Pentakota S; Rossing P</author>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Humans</category>
      <category>Sodium-Glucose Transporter 2 Inhibitors therapeutic use</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Renal Insufficiency, Chronic drug therapy</category>
      <category>Renal Insufficiency, Chronic complications</category>
      <category>Obesity complications</category>
      <category>Obesity drug therapy</category>
      <category>Overweight complications</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review.</title>
      <description>Advances in therapy; 05/01/2026&lt;br/&gt;(AN 41874854); ISSN: 1865-8652&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41874854</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41820778&amp;site=ehost-live&amp;scope=site</link>
      <author>Ciudin A; Sapin H; Fan L; Dimitriadis GK; Zimner-Rapuch S; Curteis T; Clark LJ; Rubinstein M; Johansson E</author>
      <category>Tirzepatide therapeutic use</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Gastric Inhibitory Polypeptide therapeutic use</category>
      <category>Gastric Inhibitory Polypeptide adverse effects</category>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Bayes Theorem</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Network Meta-Analysis as Topic</category>
      <category>Liraglutide therapeutic use</category>
      <category>Liraglutide adverse effects</category>
      <category>Liraglutide administration &amp; dosage</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Glucagon-Like Peptides adverse effects</category>
      <category>Glucagon-Like Peptides administration &amp; dosage</category>
      <category>Obesity drug therapy</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Hypoglycemic Agents adverse effects</category>
      <category>Hypoglycemic Agents administration &amp; dosage</category>
      <title>Comparison of Clinical Efficacy and Safety of Tirzepatide, Liraglutide and Semaglutide in Patients with Obesity and Without T2D: A Bayesian Network Meta-Analysis of Randomised Controlled Trials.</title>
      <description>Advances in therapy; 05/01/2026&lt;br/&gt;(AN 41820778); ISSN: 1865-8652&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41820778</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42090238&amp;site=ehost-live&amp;scope=site</link>
      <author>AlTaweel M</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Sex Factors</category>
      <category>Adult</category>
      <category>Ventricular Remodeling physiology</category>
      <category>Echocardiography methods</category>
      <category>Obesity complications</category>
      <category>Obesity physiopathology</category>
      <category>Overweight complications</category>
      <category>Overweight physiopathology</category>
      <category>Heart Ventricles diagnostic imaging</category>
      <category>Heart Ventricles physiopathology</category>
      <category>Hypertrophy, Left Ventricular diagnostic imaging</category>
      <category>Hypertrophy, Left Ventricular physiopathology</category>
      <title>Divergent Left Ventricular Remodeling by Sex in Adults With Overweight and Obesity: An Echocardiographic Geometry Analysis.</title>
      <description>Echocardiography (Mount Kisco, N.Y.); 05/01/2026&lt;br/&gt;(AN 42090238); ISSN: 1540-8175&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42090238</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41233692&amp;site=ehost-live&amp;scope=site</link>
      <author>McGinnis T; McCallum M; Pan Z; Cunningham C; Saxon DR; Thomas E</author>
      <category>United States Department of Veterans Affairs trends</category>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Retrospective Studies</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Veterans</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Glucagon-Like Peptides administration &amp; dosage</category>
      <category>Glucagon-Like Peptides pharmacology</category>
      <category>Weight Loss drug effects</category>
      <category>Weight Loss physiology</category>
      <category>Obesity drug therapy</category>
      <category>Obesity blood</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <title>Clinical Effectiveness of Semaglutide for Weight Loss in a Veterans Affairs' Anti-Obesity Pharmacotherapy Clinic.</title>
      <description>Journal of general internal medicine; 05/01/2026&lt;br/&gt;(AN 41233692); ISSN: 1525-1497&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41233692</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41361043&amp;site=ehost-live&amp;scope=site</link>
      <author>Kane RM; Stechuchak KM; Greene L; Blalock DV; Smith VA; Jacobs J; Rao M; Cohen AJ; Zulman DM; Maciejewski ML</author>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Cross-Sectional Studies</category>
      <category>Aged</category>
      <category>Adult</category>
      <category>Risk Factors</category>
      <category>United States Department of Veterans Affairs</category>
      <category>Body Mass Index</category>
      <category>Prevalence</category>
      <category>Obesity epidemiology</category>
      <category>Obesity psychology</category>
      <category>Veterans psychology</category>
      <category>Veterans statistics &amp; numerical data</category>
      <title>Associations Between Social Risks and Obesity in High-risk Veterans.</title>
      <description>Journal of general internal medicine; 05/01/2026&lt;br/&gt;(AN 41361043); ISSN: 1525-1497&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41361043</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40471490&amp;site=ehost-live&amp;scope=site</link>
      <author>Bajaj SS; Zhong A; Khunte M; Stanford FC</author>
      <category>Nutrition Surveys methods</category>
      <category>Nutrition Surveys trends</category>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Cross-Sectional Studies</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Young Adult</category>
      <category>Obesity diagnosis</category>
      <category>Obesity epidemiology</category>
      <category>Obesity ethnology</category>
      <category>Overweight diagnosis</category>
      <category>Overweight epidemiology</category>
      <category>Overweight ethnology</category>
      <category>Healthcare Disparities trends</category>
      <category>Healthcare Disparities ethnology</category>
      <title>Trends and Disparities in Clinician Diagnosis of Overweight and Obesity.</title>
      <description>Journal of general internal medicine; 05/01/2026&lt;br/&gt;(AN 40471490); ISSN: 1525-1497&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40471490</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41072554&amp;site=ehost-live&amp;scope=site</link>
      <author>Xu JJ; Johnson MC; Lama G; Budin JS; Tabbaa A; Chen AZ; Magruder ML</author>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Retrospective Studies</category>
      <category>Aged</category>
      <category>Middle Aged</category>
      <category>Propensity Score</category>
      <category>Treatment Outcome</category>
      <category>Arthroplasty, Replacement, Knee adverse effects</category>
      <category>Glucagon-Like Peptides therapeutic use</category>
      <category>Postoperative Complications epidemiology</category>
      <category>Postoperative Complications prevention &amp; control</category>
      <category>Postoperative Complications etiology</category>
      <category>Osteoarthritis, Knee surgery</category>
      <category>Osteoarthritis, Knee complications</category>
      <category>Obesity complications</category>
      <category>Body Mass Index</category>
      <title>The Effect of Body Mass Index on the Efficacy of Semaglutide Use at the Time of Total Knee Arthroplasty.</title>
      <description>The Journal of arthroplasty; 05/01/2026&lt;br/&gt;(AN 41072554); ISSN: 1532-8406&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41072554</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41802118&amp;site=ehost-live&amp;scope=site</link>
      <author>Costa TA; Vest AR; Harrington J</author>
      <category>Intra-Abdominal Fat metabolism</category>
      <category>Anti-Obesity Agents therapeutic use</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Clinical Trials as Topic</category>
      <category>Disease Management</category>
      <category>Cardiometabolic Risk Factors</category>
      <category>Stroke Volume</category>
      <category>Exercise Tolerance</category>
      <category>Functional Status</category>
      <category>Quality of Life</category>
      <category>Heart Failure etiology</category>
      <category>Heart Failure physiopathology</category>
      <category>Heart Failure prevention &amp; control</category>
      <category>Heart Failure therapy</category>
      <category>Weight Loss physiology</category>
      <category>Obesity complications</category>
      <category>Obesity metabolism</category>
      <category>Obesity physiopathology</category>
      <category>Obesity therapy</category>
      <category>Metabolic Syndrome complications</category>
      <category>Metabolic Syndrome metabolism</category>
      <category>Metabolic Syndrome physiopathology</category>
      <category>Metabolic Syndrome therapy</category>
      <title>Weight loss as the optimal cardiometabolic management strategy for preventing and treating heart failure.</title>
      <description>Current opinion in cardiology; 05/01/2026&lt;br/&gt;(AN 41802118); ISSN: 1531-7080&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41802118</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40693831&amp;site=ehost-live&amp;scope=site</link>
      <author>Li Y; Ma Y; Zhou X; Yao L; Li J; Gui M; Wang M; Chen X; Lu B; Fu D</author>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Cross-Sectional Studies</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Nutrition Surveys</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Hypertension etiology</category>
      <category>Hypertension epidemiology</category>
      <category>Obesity complications</category>
      <category>Obesity epidemiology</category>
      <category>Inflammation complications</category>
      <category>Diet adverse effects</category>
      <title>Association Between Dietary Inflammatory Index and Obesity-Related Hypertension: A Cross-sectional Study.</title>
      <description>The Journal of cardiovascular nursing; 05/01/2026&lt;br/&gt;(AN 40693831); ISSN: 1550-5049&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40693831</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42003036&amp;site=ehost-live&amp;scope=site</link>
      <author>Ganamurali N; Sabarathinam S</author>
      <category>Humans</category>
      <category>Animals</category>
      <category>Resveratrol pharmacology</category>
      <category>Resveratrol therapeutic use</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Obesity genetics</category>
      <category>Obesity microbiology</category>
      <category>Obesity pathology</category>
      <category>Epigenesis, Genetic drug effects</category>
      <category>Oxidative Stress drug effects</category>
      <category>Dysbiosis drug therapy</category>
      <category>Dysbiosis metabolism</category>
      <category>Gastrointestinal Microbiome drug effects</category>
      <category>Systems Biology</category>
      <title>Resveratrol as a Multi-Domain Modulator of Oxidative Stress, Gut Dysbiosis, and Epigenetic Remodeling in Obesity: A Systems Biology Interpretation.</title>
      <description>Journal of biochemical and molecular toxicology; 05/01/2026&lt;br/&gt;(AN 42003036); ISSN: 1099-0461&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42003036</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40886143&amp;site=ehost-live&amp;scope=site</link>
      <author>Kompaniyets L; Roy K; Freedman D; Belay B; Pierce SL; Blanck HM; Goodman AB</author>
      <category>United States epidemiology</category>
      <category>Humans</category>
      <category>Adult</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adolescent</category>
      <category>Young Adult</category>
      <category>Longitudinal Studies</category>
      <category>Hospitalization statistics &amp; numerical data</category>
      <category>Hospitalization economics</category>
      <category>Obesity economics</category>
      <category>Obesity epidemiology</category>
      <category>Health Expenditures statistics &amp; numerical data</category>
      <category>Health Care Costs statistics &amp; numerical data</category>
      <title>Longitudinal Medical Costs and Hospitalization Risk Associated With Sustained Obesity.</title>
      <description>American journal of health promotion : AJHP; 05/01/2026&lt;br/&gt;(AN 40886143); ISSN: 2168-6602&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40886143</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41348527&amp;site=ehost-live&amp;scope=site</link>
      <author>Thai A; Ayoub NF</author>
      <category>United States epidemiology</category>
      <category>Obesity epidemiology</category>
      <category>Asthma epidemiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Retrospective Studies</category>
      <category>Adult</category>
      <category>Nutrition Surveys</category>
      <category>Aged</category>
      <category>Self Report</category>
      <category>Food, Processed</category>
      <category>Sinusitis epidemiology</category>
      <category>Sinusitis etiology</category>
      <category>Fast Foods adverse effects</category>
      <title>Association Between Ultra-Processed Food Intake and Sinusitis.</title>
      <description>American journal of rhinology &amp; allergy; 05/01/2026&lt;br/&gt;(AN 41348527); ISSN: 1945-8932&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41348527</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41128495&amp;site=ehost-live&amp;scope=site</link>
      <author>Moiz A; Zolotarova T; Filion KB; Eisenberg MJ</author>
      <category>Glucagon-Like Peptide-1 Receptor metabolism</category>
      <category>Obesity drug therapy</category>
      <category>Obesity physiopathology</category>
      <category>Humans</category>
      <category>Treatment Outcome</category>
      <category>Animals</category>
      <category>Blood Pressure drug effects</category>
      <category>Hypertension drug therapy</category>
      <category>Hypertension physiopathology</category>
      <category>Hypertension diagnosis</category>
      <category>Hypertension epidemiology</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Diabetes Mellitus, Type 2 physiopathology</category>
      <category>Antihypertensive Agents therapeutic use</category>
      <category>Antihypertensive Agents adverse effects</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Hypoglycemic Agents adverse effects</category>
      <category>Incretins therapeutic use</category>
      <category>Incretins adverse effects</category>
      <category>Glucagon-Like Peptide-1 Receptor Agonists</category>
      <title>GLP-1 Receptor Agonists and Blood Pressure: A State-of-the-Art Review of Mechanisms, Evidence, and Clinical Implications.</title>
      <description>American journal of hypertension; 05/01/2026&lt;br/&gt;(AN 41128495); ISSN: 1941-7225&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41128495</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41865291&amp;site=ehost-live&amp;scope=site</link>
      <author>Vamos M; Vagvolgyi A; McKindley DS; Hohnloser SH</author>
      <category>Humans</category>
      <category>Dronedarone</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Double-Blind Method</category>
      <category>Aged</category>
      <category>Treatment Outcome</category>
      <category>Body Mass Index</category>
      <category>Risk Factors</category>
      <category>Time Factors</category>
      <category>Hospitalization</category>
      <category>Atrial Fibrillation drug therapy</category>
      <category>Atrial Fibrillation mortality</category>
      <category>Atrial Fibrillation diagnosis</category>
      <category>Atrial Fibrillation physiopathology</category>
      <category>Anti-Arrhythmia Agents therapeutic use</category>
      <category>Anti-Arrhythmia Agents adverse effects</category>
      <category>Amiodarone analogs &amp; derivatives</category>
      <category>Amiodarone therapeutic use</category>
      <category>Amiodarone adverse effects</category>
      <category>Obesity diagnosis</category>
      <category>Obesity mortality</category>
      <category>Obesity complications</category>
      <category>Overweight mortality</category>
      <category>Overweight diagnosis</category>
      <title>Efficacy and Safety of Dronedarone in Overweight and Obesity: Post Hoc Analysis of the ATHENA Trial.</title>
      <description>Journal of cardiovascular electrophysiology; 05/01/2026&lt;br/&gt;(AN 41865291); ISSN: 1540-8167&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41865291</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=40623099&amp;site=ehost-live&amp;scope=site</link>
      <author>Özdemir E; Arslanoğlu A; Göktaş K; Dalga Eren D; Cirik AA; Sünnetçi G; Gürpinar B; Atar Y; Saltürk Z</author>
      <category>Phonation physiology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Male</category>
      <category>Body Mass Index</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Weight Loss physiology</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Voice Quality physiology</category>
      <title>Does Weight Loss Impact Voice Quality in Obese Individuals?</title>
      <description>The Journal of craniofacial surgery; 05/01/2026&lt;br/&gt;(AN 40623099); ISSN: 1536-3732&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_40623099</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41922659&amp;site=ehost-live&amp;scope=site</link>
      <author>Zeybek DÖ; Yiğit V</author>
      <category>Humans</category>
      <category>Cost-Benefit Analysis</category>
      <category>Cost-Effectiveness Analysis</category>
      <category>Female</category>
      <category>Markov Chains</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Quality-Adjusted Life Years</category>
      <category>Adult</category>
      <category>Health Care Costs</category>
      <category>Diabetes Mellitus, Type 2 economics</category>
      <category>Diabetes Mellitus, Type 2 drug therapy</category>
      <category>Diabetes Mellitus, Type 2 complications</category>
      <category>Diabetes Mellitus, Type 2 therapy</category>
      <category>Bariatric Surgery economics</category>
      <category>Obesity, Morbid economics</category>
      <category>Obesity, Morbid surgery</category>
      <category>Obesity, Morbid complications</category>
      <category>Obesity, Morbid drug therapy</category>
      <category>Obesity, Morbid therapy</category>
      <category>Gastrectomy economics</category>
      <category>Hypoglycemic Agents economics</category>
      <category>Hypoglycemic Agents therapeutic use</category>
      <category>Obesity economics</category>
      <title>Cost-Effectiveness Analysis of Bariatric Surgery and Pharmacological Treatments for People with Obesity and Type 2 Diabetes Mellitus.</title>
      <description>Obesity surgery; 05/01/2026&lt;br/&gt;(AN 41922659); ISSN: 1708-0428&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41922659</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=42062212&amp;site=ehost-live&amp;scope=site</link>
      <author>Ruehman AJ; Covington E; Branan TN; Hawkins WA; Smith SE</author>
      <category>Vasoconstrictor Agents therapeutic use</category>
      <category>Resuscitation methods</category>
      <category>Adrenal Cortex Hormones therapeutic use</category>
      <category>Humans</category>
      <category>Cross-Sectional Studies</category>
      <category>Surveys and Questionnaires</category>
      <category>Practice Guidelines as Topic</category>
      <category>Female</category>
      <category>Male</category>
      <category>Middle Aged</category>
      <category>Obesity</category>
      <category>Sepsis therapy</category>
      <category>Sepsis physiopathology</category>
      <category>Fluid Therapy methods</category>
      <category>Fluid Therapy standards</category>
      <category>Hemodynamics physiology</category>
      <category>Critical Care standards</category>
      <category>Critical Care methods</category>
      <category>Practice Patterns, Physicians' statistics &amp; numerical data</category>
      <title>Current Practices and Opinions Related to Hemodynamic Optimization in Patients With Sepsis: An International Survey.</title>
      <description>American journal of critical care : an official publication, American Association of Critical-Care Nurses; 05/01/2026&lt;br/&gt;(AN 42062212); ISSN: 1937-710X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_42062212</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41392868&amp;site=ehost-live&amp;scope=site</link>
      <author>Gonzalez T; Govers R</author>
      <category>Cardiovascular Diseases prevention &amp; control</category>
      <category>Cardiovascular Diseases etiology</category>
      <category>Humans</category>
      <category>Taxes</category>
      <category>Carbonated Beverages adverse effects</category>
      <category>Obesity epidemiology</category>
      <category>Obesity prevention &amp; control</category>
      <category>Non-Nutritive Sweeteners adverse effects</category>
      <category>Sweetening Agents adverse effects</category>
      <category>Sugar-Sweetened Beverages adverse effects</category>
      <title>Soda Sugar Supertaxes Pave the Way for a Large Increase in Consumption of Sweeteners and Its Long-Term Effects.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41392868); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41392868</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41888476&amp;site=ehost-live&amp;scope=site</link>
      <author>Pandit A; Gupta M; Arabie DA; Milton P; Elbatreek M; Goodchild T; Lefer DJ; Francis J; Moll D; Allerton TD</author>
      <category>Muscle, Skeletal physiopathology</category>
      <category>Muscle, Skeletal metabolism</category>
      <category>Humans</category>
      <category>Exercise Test</category>
      <category>Oxygen Consumption</category>
      <category>Heart Failure physiopathology</category>
      <category>Heart Failure complications</category>
      <category>Obesity physiopathology</category>
      <category>Obesity complications</category>
      <category>Exercise Tolerance physiology</category>
      <category>Stroke Volume physiology</category>
      <title>Obesity and Heart Failure With Preserved Ejection Fraction: A Clinical Nexus for Exercise Intolerance.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41888476); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41888476</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41860387&amp;site=ehost-live&amp;scope=site</link>
      <author>Blew RM; Ziller SG; Odegaard AO; Caan BJ; Chen Z; Roe DJ; Manson JE; Rohan TE; Felix AS; Harris HR; Luo J; Lane DS; Bea JW</author>
      <category>Intra-Abdominal Fat diagnostic imaging</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Absorptiometry, Photon</category>
      <category>Middle Aged</category>
      <category>Aged</category>
      <category>Risk Factors</category>
      <category>Adiposity</category>
      <category>Waist Circumference</category>
      <category>Women's Health</category>
      <category>Body Mass Index</category>
      <category>Incidence</category>
      <category>Obesity complications</category>
      <category>Neoplasms epidemiology</category>
      <category>Neoplasms etiology</category>
      <category>Obesity, Abdominal complications</category>
      <category>Obesity, Abdominal diagnostic imaging</category>
      <category>Abdominal Fat diagnostic imaging</category>
      <category>Postmenopause</category>
      <title>DXA-Derived Abdominal Adiposity and Obesity-Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41860387); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41860387</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41914839&amp;site=ehost-live&amp;scope=site</link>
      <author>Tronieri JS; Kushner RF; Apovian CM; Fitch A; Still C; Wadden TA</author>
      <category>Weight Loss drug effects</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Double-Blind Method</category>
      <category>Adult</category>
      <category>Suicidal Ideation</category>
      <category>Treatment Outcome</category>
      <category>Drug Combinations</category>
      <category>Randomized Controlled Trials as Topic</category>
      <category>Naltrexone therapeutic use</category>
      <category>Naltrexone adverse effects</category>
      <category>Naltrexone administration &amp; dosage</category>
      <category>Bupropion therapeutic use</category>
      <category>Bupropion adverse effects</category>
      <category>Bupropion administration &amp; dosage</category>
      <category>Obesity drug therapy</category>
      <category>Obesity complications</category>
      <category>Obesity psychology</category>
      <category>Depression drug therapy</category>
      <category>Depression complications</category>
      <category>Overweight drug therapy</category>
      <category>Overweight complications</category>
      <category>Overweight psychology</category>
      <title>Use of Naltrexone-Bupropion in Persons With Overweight/Obesity and Symptoms of Depression: A Pooled Analysis.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41914839); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41914839</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41934198&amp;site=ehost-live&amp;scope=site</link>
      <author>Kasahara K; Okada H; Ide H; Nakajima H; Ushigome E; Nakanishi N; Hamaguchi M; Kurogi K; Murata H; Tsuda E; Yoshida N; Ito M; Furui Y; Fukui M</author>
      <category>Japan epidemiology</category>
      <category>Blood Glucose metabolism</category>
      <category>Triglycerides blood</category>
      <category>Cholesterol, LDL blood</category>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Cohort Studies</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Blood Pressure</category>
      <category>Body Weight</category>
      <category>Waist Circumference physiology</category>
      <category>Weight Loss</category>
      <category>Obesity</category>
      <title>Evaluating the "2cm2kg" Target in Japan's Specific Health Checkups: Evidence From the Panasonic Cohort Study 30.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41934198); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41934198</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41934285&amp;site=ehost-live&amp;scope=site</link>
      <author>Denstel KD; Mire EF; Martin CK; Apolzan JW; Arnold CL; Davis TC; Lavie CJ; Newton RL Jr; Zhang D; Price-Haywood EG; Katzmarzyk PT</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Primary Health Care</category>
      <category>Treatment Outcome</category>
      <category>Life Style</category>
      <category>Black or African American</category>
      <category>Body Mass Index</category>
      <category>White People</category>
      <category>Aged</category>
      <category>White</category>
      <category>Obesity therapy</category>
      <category>Obesity psychology</category>
      <category>Quality of Life</category>
      <category>Weight Loss</category>
      <category>Weight Reduction Programs</category>
      <title>Effects of a 2-Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41934285); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41934285</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41947527&amp;site=ehost-live&amp;scope=site</link>
      <author>Polak R; Budd MA; Finkelstein A; Goldsmith R; Goldstein R; Gray BE; Keshet R; Tirosh A</author>
      <category>Humans</category>
      <category>Male</category>
      <category>Female</category>
      <category>Middle Aged</category>
      <category>Adult</category>
      <category>Aged</category>
      <category>Body Mass Index</category>
      <category>Counseling</category>
      <category>Treatment Outcome</category>
      <category>Weight Loss physiology</category>
      <category>Obesity diet therapy</category>
      <category>Obesity therapy</category>
      <category>Cooking</category>
      <title>One-Year Weight Loss Following a Remote Culinary Medicine Program: A Bi-Center Randomized Controlled Trial.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41947527); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41947527</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41885053&amp;site=ehost-live&amp;scope=site</link>
      <author>Duran-Bertran J; Clavero-Mestres H; Mahmoudian R; Muñiz-Piera S; Aguilar C; Riesco D; Camaron J; Martínez S; Vives M; París M; Sabench F; Auguet T</author>
      <category>1-Alkyl-2-acetylglycerophosphocholine Esterase blood</category>
      <category>Liver metabolism</category>
      <category>Liver pathology</category>
      <category>Humans</category>
      <category>Female</category>
      <category>Adult</category>
      <category>Middle Aged</category>
      <category>Signal Transduction</category>
      <category>Platelet Activating Factor metabolism</category>
      <category>Platelet Membrane Glycoproteins metabolism</category>
      <category>Platelet Membrane Glycoproteins genetics</category>
      <category>Receptors, G-Protein-Coupled metabolism</category>
      <category>Receptors, G-Protein-Coupled genetics</category>
      <category>Fatty Liver metabolism</category>
      <category>Fatty Liver pathology</category>
      <category>Fatty Liver etiology</category>
      <category>Obesity metabolism</category>
      <category>Obesity complications</category>
      <category>Obesity, Morbid metabolism</category>
      <category>Obesity, Morbid complications</category>
      <category>Obesity, Morbid surgery</category>
      <title>Platelet-Activating Factor Pathway in Women With Metabolic Dysfunction-Associated Steatotic Liver Disease and Obesity.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41885053); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41885053</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41914648&amp;site=ehost-live&amp;scope=site</link>
      <author>Ostberg JE; Ahmed Z; Saatchi K; Pandher PK; Rahim Y; Häfeli UO; Gray SL</author>
      <category>PPAR gamma metabolism</category>
      <category>Adiponectin blood</category>
      <category>Adipocytes drug effects</category>
      <category>Animals</category>
      <category>Male</category>
      <category>Mice</category>
      <category>Mice, Inbred C57BL</category>
      <category>Drug Delivery Systems</category>
      <category>Rosiglitazone administration &amp; dosage</category>
      <category>Magnetic Iron Oxide Nanoparticles administration &amp; dosage</category>
      <category>Obesity drug therapy</category>
      <category>Obesity metabolism</category>
      <category>Hypoglycemic Agents administration &amp; dosage</category>
      <category>Hypoglycemic Agents pharmacology</category>
      <category>Adipose Tissue drug effects</category>
      <category>Adipose Tissue metabolism</category>
      <category>Adipose Tissue, White drug effects</category>
      <category>Adipose Tissue, White metabolism</category>
      <category>Insulin Resistance</category>
      <title>Adipose Tissue-Targeted Delivery of Rosiglitazone With Iron Oxide Nanoparticles Ameliorates Insulin Resistance in Male Mice.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41914648); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41914648</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;db=cmedm&amp;AN=41936389&amp;site=ehost-live&amp;scope=site</link>
      <author>Liu L; Xiong G; Zhao H; Shi H; Liang M; Nahata MC</author>
      <category>United States epidemiology</category>
      <category>Obesity therapy</category>
      <category>Humans</category>
      <category>Adolescent</category>
      <category>Male</category>
      <category>Female</category>
      <category>Nutrition Surveys</category>
      <category>Young Adult</category>
      <category>Body Mass Index</category>
      <category>Exercise</category>
      <category>Overweight therapy</category>
      <category>Overweight epidemiology</category>
      <category>Pediatric Obesity therapy</category>
      <category>Pediatric Obesity epidemiology</category>
      <category>Weight Loss</category>
      <title>Trends in Weight Loss Attempts and Strategies Among US Adolescents With Overweight or Obesity.</title>
      <description>Obesity (Silver Spring, Md.); 05/01/2026&lt;br/&gt;(AN 41936389); ISSN: 1930-739X&lt;br/&gt;MEDLINE</description>
      <pubDate>Fri, 01 May 2026 00:00:00 -0400</pubDate>
      <guid isPermaLink="false">cmedm_AN_41936389</guid>
    </item>
    <item>
      <link>https://search.ebscohost.com/login.aspx?direct=true&amp;an=&amp;site=ehost-live&amp;alertid=1152678</link>
      <title>More Results...</title>
      <description>We have found more results for your search</description>
      <guid>more results</guid>
    </item>
  </channel>
</rss>